Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014111	fp-laktaat	mmol/l (mmol/l)	26534	223155	0.01%
3014111	p-laktaat	mmol/l (mmol/l)	7235	21159	0.00%
3014111	fp-laktaat	— (—)	1719	3715	100.00%	Distribution not available
3014111	p-lakveka	mmol/l (—)	550	1581	100.00%	Distribution not available
3014111	p-lakthoi	— (—)	188	228	100.00%	Distribution not available
3014111	p-laktaat	— (—)	95	109	100.00%	Distribution not available
3014111	p-lakthoi	mmol/l (mmol/l)	31	31	0.00%
3014111	s-laktaat	mmol/l (mmol/l)	26	30	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Ischaemic heart disease, wide definition

5108

17961

1.89

321.06

9.1

6.8

1.39

1.33

mmol/l

2.81

4923

17353

Early onset COPD, excluding more controls

1541

5553

3.10

319.28

10.3

6.5

1.35

1.36

mmol/l

0.05

1471

5415

Polyarthropathies

4541

16437

1.94

319.16

8.0

7.5

1.36

mmol/l

0.01

4363

15769

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3804

20058

2.03

318.81

9.4

6.5

1.30

1.35

mmol/l

1.98

3686

19308

Infections of the skin and subcutaneous tissue

3769

19698

2.03

318.75

8.7

7.4

1.37

1.36

mmol/l

0.33

3625

18964

Bacterial pneumonia (organism specified)

3172

14247

2.19

318.44

9.0

6.3

1.41

1.38

mmol/l

0.71

3003

13680

Mood [affective] disorders

6412

25339

1.74

316.67

7.0

7.2

1.38

1.34

mmol/l

2.17

6102

24497

Other nutritional deficiencies

3926

20414

1.99

316.19

8.9

7.1

1.44

1.32

mmol/l

8.30

3757

19732

Mood disorders

6426

25386

1.74

315.98

7.0

7.2

1.38

1.34

mmol/l

2.26

6114

24542

GI-bleeding

2480

11288

2.43

315.29

8.5

6.6

1.49

1.39

mmol/l

3.30

2389

10790

Other chronic obstructive pulmonary disease

3204

13223

2.20

313.94

8.5

6.6

1.37

1.38

mmol/l

0.11

3047

12724

Other medical care

2824

13168

2.28

313.41

6.1

1.43

1.36

mmol/l

2.14

2710

12664

Diseases of the digestive system

3237

16255

2.15

312.79

8.5

6.6

1.47

1.37

mmol/l

3.74

3116

15559

Alcohol dependence

2100

8928

2.61

312.44

8.3

7.5

1.67

1.33

mmol/l

19.41

2003

8590

Ischemic heart diseases

5126

18222

1.87

311.11

9.1

6.8

1.39

1.33

mmol/l

2.81

4939

17608

Cardiomyopathy

1359

4660

3.32

310.48

12.6

6.2

1.47

1.35

mmol/l

3.07

1298

4475

Coronary atherosclerosis

4606

16397

1.93

309.95

8.8

6.8

1.41

1.34

mmol/l

3.43

4429

15837

Unspecified kidney failure

985

2829

4.32

309.28

10.9

5.8

1.38

1.42

mmol/l

0.39

932

2703

Neoplasms

4650

13505

1.92

308.42

8.3

7.6

1.32

1.40

mmol/l

5.26

4498

12916

Gout

2211

8782

2.57

307.71

8.6

7.0

1.40

1.41

mmol/l

0.09

2122

8391

Depression medications

1746

1857

5.03

307.65

7.6

4.7

1.38

1.31

mmol/l

1.36

1672

1785

Malaise and fatigue

4545

12128

3.55

307.65

7.1

6.7

1.40

1.34

mmol/l

3.37

4375

11683

Explicit Sepsis

4114

12918

3.54

307.65

10.7

5.8

1.51

1.33

mmol/l

12.61

3949

12397

Diseases of arteries, arterioles and capillaries

5249

18494

2.32

307.65

9.3

6.4

1.38

1.37

mmol/l

0.29

5034

17813

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4161

21213

2.10

307.65

9.4

6.5

1.32

1.35

mmol/l

0.97

4034

20427

Nephropathy related operations

1860

3689

7.56

307.65

19.6

7.1

1.20

1.38

mmol/l

7.97

1799

3544

Malignant neoplasm, wide definition for exclusion

6056

18111

2.10

307.65

8.3

7.4

1.27

1.38

mmol/l

11.19

5883

17406

Certain infectious and parasitic diseases

6993

16870

2.20

307.65

8.2

6.5

1.38

1.31

mmol/l

5.55

6718

16270

Symptoms and signs involving cognition, perception, emotional state and behaviour

6438

25109

1.90

307.65

6.3

7.3

1.38

1.34

mmol/l

1.84

6174

24201

Condition for Implicit Sepsis (Organ dysfunction codes)

7323

20701

2.85

307.65

10.5

6.1

1.47

1.30

mmol/l

20.67

7003

19985

Other disorders of fluid, electrolyte and acid-base balance

3051

8622

4.09

307.65

9.6

5.9

1.47

1.37

mmol/l

2.90

2895

8300

Kidney transplant status

836

1407

9.72

307.65

15.6

9.0

0.98

1.40

mmol/l

25.95

825

1344

Bacterial Sepsis

4577

12944

3.71

307.65

11.0

5.7

1.51

1.34

mmol/l

13.15

4358

12447

Persons encountering health services for specific procedures, not carried out

854

1764

6.25

307.65

9.1

7.3

1.41

1.38

mmol/l

0.28

826

1696

Peripheral artery disease

3345

12939

2.29

307.65

8.8

6.0

1.39

1.38

mmol/l

0.26

3181

12441

Asthma

5418

13137

2.35

307.65

7.2

6.3

1.34

1.36

mmol/l

0.44

5201

12772

Anxiety (asthma-related co-morbidities)

3476

13437

2.15

307.65

7.2

7.5

1.36

1.28

mmol/l

4.45

3321

13033

Benign neoplasm of colon, rectum, anus and anal canal

3695

12322

2.31

307.65

7.1

1.35

1.39

mmol/l

1.64

3548

11861

Hypertensive heart and/or renal disease

2084

5802

3.14

307.65

7.8

5.7

1.41

1.35

mmol/l

1.45

2000

5581

Implicit Sepsis

6860

19079

3.17

307.65

10.4

6.0

1.46

1.32

mmol/l

15.20

6554

18390

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3611

15581

2.56

307.65

8.5

7.5

1.65

1.34

mmol/l

27.14

3450

15020

Benign neoplasm: Colon

3280

11607

2.35

307.65

7.1

7.0

1.35

1.40

mmol/l

1.40

3156

11174

4804

19343

2.43

307.65

8.8

7.2

1.63

1.32

mmol/l

37.00

4594

18633

Other pulmonary diagnosis

5141

13254

2.04

307.65

8.2

6.3

1.34

1.35

mmol/l

0.36

4930

12887

Iron deficiency anaemia

2879

13547

2.29

307.65

8.1

6.3

1.42

1.36

mmol/l

1.86

2745

12988

Other and unspecified anaemias

3182

14069

2.42

307.65

8.3

6.2

1.38

mmol/l

0.05

3042

13463

Glomerular disorders in diseases classified elsewhere

1160

3474

4.12

307.65

14.3

7.3

1.20

1.38

mmol/l

6.71

1126

3340

Septicaemia

4004

12442

3.62

307.65

10.7

6.2

1.51

1.34

mmol/l

11.54

3846

11946

Persons encountering health services for specific procedures and health care

8484

23806

2.38

307.65

9.1

6.6

1.32

1.36

mmol/l

2.00

8142

22945

Viral pneumonia

1140

3204

4.24

307.65

14.1

6.7

1.38

1.35

mmol/l

0.33

1101

3081

Non-rheumatic valve diseases

3411

10294

2.65

307.65

9.3

6.2

1.30

1.33

mmol/l

1.04

3304

9905

Implicit viral Sepsis

1820

5334

4.07

307.65

11.2

5.7

1.49

1.33

mmol/l

5.70

1741

5114

Acute renal failure

2328

6341

4.66

307.65

14.6

5.9

1.54

1.38

mmol/l

4.84

2230

6066

Asthma, hospital admission 2, infections

4184

19594

2.27

307.65

7.8

6.9

1.38

1.36

mmol/l

0.27

3982

18804

Hypo-osmolality and hyponatraemia

1611

4760

4.05

307.65

9.3

5.7

1.40

1.38

mmol/l

0.24

1523

4584

Diseases of arteries, arterioles and capillaries (FINNGEN)

2312

3426

5.54

307.65

11.1

6.0

1.32

mmol/l

0.04

2248

3310

Persons encountering health services in other circumstances, wide

8212

24462

1.83

307.65

8.3

6.8

1.33

1.36

mmol/l

1.39

7792

23650

Cerebrovascular diseases

5130

20083

1.96

307.65

7.8

6.8

1.37

1.36

mmol/l

0.29

4916

19350

Parasetamol

5490

13008

2.27

307.65

7.5

7.3

1.34

1.37

mmol/l

1.07

5253

12554

Complications of medical and surgical care

5210

24509

2.17

307.65

8.9

6.6

1.33

1.35

mmol/l

0.54

5042

23593

Implicit bacterial Sepsis

4096

11567

3.87

307.65

11.3

5.7

1.51

1.34

mmol/l

12.31

3899

11119

Benzodiazepine use

6459

27014

1.78

307.65

6.5

7.2

1.39

1.35

mmol/l

2.15

6152

26069

Oral corticosteroids

7223

24362

1.89

307.65

7.7

6.9

1.39

1.34

mmol/l

2.72

6918

23485

Hypertensive diseases

5441

13922

2.36

307.65

9.8

6.6

1.35

1.33

mmol/l

0.49

5249

13428

Bacterial infection, other or unspecified

5161

15241

3.55

307.65

9.4

6.1

1.43

1.33

mmol/l

7.42

4902

14686

Malignant neoplasm

5834

19195

1.90

307.65

8.1

7.4

1.29

1.37

mmol/l

7.10

5661

18469

L04AD Calcineurin inhibitors

1237

2926

5.55

307.65

20.9

7.9

1.17

1.35

mmol/l

6.43

1209

2808

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6483

23905

1.95

307.65

10.8

6.5

1.33

1.36

mmol/l

1.22

6247

23007

Type 2 diabetes

6411

21358

1.87

307.65

8.8

6.4

1.51

1.28

mmol/l

42.13

6172

20572

Other antidepressants

6860

20913

1.79

307.65

6.7

7.2

1.40

1.34

mmol/l

3.77

6573

20180

Hypothyroidism and >3 levothyroxin purchases

1315

1728

4.64

307.65

8.3

5.0

1.33

1.31

mmol/l

0.19

1262

1666

Asthma (only as main-diagnosis)

4688

13137

2.28

307.65

7.0

6.3

1.34

1.36

mmol/l

0.45

4503

12772

Valvular heart disease excluding rheumatic fever

3463

10391

2.67

307.65

9.7

6.2

1.30

1.33

mmol/l

1.01

3354

9993

Oxycodone

2861

10505

2.96

307.65

7.0

6.5

1.40

1.37

mmol/l

0.86

2731

10101

Pneumonia, organism unspecified

7667

22132

2.76

307.65

8.9

6.6

1.40

1.33

mmol/l

5.70

7294

21424

Viral Sepsis

1822

5343

4.07

307.65

11.2

5.7

1.49

1.33

mmol/l

5.69

1743

5122

Cardiodefibrillation

2911

13399

2.44

307.65

9.0

6.6

1.35

1.38

mmol/l

0.93

2807

12901

Hypothyroidism (congenital or acquired)

1336

1743

4.67

307.65

8.6

5.0

1.33

1.31

mmol/l

0.20

1281

1679

Care involving dialysis

1174

2120

8.35

307.65

17.4

7.6

1.08

1.39

mmol/l

17.05

1140

2047

Secondary hypertension

717

1269

6.77

307.65

11.5

6.0

1.13

1.35

mmol/l

4.78

695

1216

Alcohol use disorder, ICD-based

3299

14307

2.55

307.65

8.5

7.6

1.67

1.34

mmol/l

25.86

3154

13776

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7596

24986

2.36

307.65

8.8

6.8

1.38

1.34

mmol/l

1.67

7298

24051

Heart failure,strict

5011

12432

3.38

307.65

10.6

6.1

1.47

1.32

mmol/l

12.87

4805

12007

Exposure to unspecified factor

6501

27904

1.91

307.65

7.9

7.0

1.35

mmol/l

0.21

6264

26842

Injuries to the head

7326

27039

1.86

307.65

6.9

7.3

1.42

1.33

mmol/l

8.12

7033

26018

Syncope and collapse

3041

12014

2.42

307.65

7.0

6.7

1.42

1.34

mmol/l

3.34

2902

11575

Hypertensive Heart Disease

1841

5449

3.11

307.65

7.8

5.8

1.44

1.35

mmol/l

2.57

1761

5239

Complications of procedures, not elsewhere classified

5917

24338

2.27

307.65

8.4

6.6

1.32

1.36

mmol/l

1.47

5724

23423

Other bacterial diseases

8895

22115

3.12

307.65

9.2

6.6

1.44

1.32

mmol/l

14.88

8517

21340

ILD differential diagnosis

5092

13243

2.02

307.65

8.2

6.4

1.34

1.36

mmol/l

0.54

4886

12873

Codeine

6707

17072

2.30

307.65

6.7

6.8

1.36

1.35

mmol/l

0.25

6466

16450

Atrial fibrillation and flutter with reimbursement

2510

3486

5.40

307.65

9.9

5.8

1.41

1.31

mmol/l

2.88

2443

3373

Erysipelas

4237

16741

2.53

307.65

7.9

6.4

1.42

1.33

mmol/l

4.93

4050

16140

Asthma-related pneumonia

2899

11786

2.74

307.65

8.4

6.5

1.39

1.38

mmol/l

0.26

2758

11272

Complications of surgical and medical care, not elsewhere classified

7434

25325

2.27

307.65

8.5

6.6

1.33

1.36

mmol/l

1.45

7183

24351

Metabolic disorders

7753

20260

2.59

307.65

8.9

6.7

1.37

1.34

mmol/l

1.53

7425

19564

Other diseases of the digestive system

2485

11185

2.47

307.65

8.6

6.6

1.50

1.39

mmol/l

3.42

2397

10696

Diseases of oesophagus, stomach and duodenum

6959

24687

1.80

307.65

7.9

6.9

1.38

1.35

mmol/l

1.39

6682

23768

Diarrhoea and gastroenteritis of presumed infectious origin

4956

22440

2.14

307.65

8.0

6.8

1.36

mmol/l

0.08

4717

21574

Any gastric operation

5764

11723

2.62

307.65

8.5

5.7

1.34

1.36

mmol/l

0.82

5550

11208

Chronic lower respiratory diseases

7645

25558

1.68

307.65

7.5

7.2

1.35

1.36

mmol/l

0.37

7342

24606

Chronic kidney disease

2976

9700

3.65

307.65

12.6

5.7

1.24

1.41

mmol/l

14.76

2855

9261

COPD

3346

13633

2.21

307.65

8.5

6.6

1.37

1.38

mmol/l

0.12

3186

13117

Disorders of lipoprotein metabolism and other lipidaemias

6042

18169

2.25

307.65

8.0

6.5

1.36

1.35

mmol/l

0.19

5802

17556

Asthma-related infections

4184

19594

2.27

307.65

7.8

6.9

1.38

1.36

mmol/l

0.27

3982

18804

Cardiac arrhythmias

4325

10020

3.09

307.65

9.5

6.1

1.37

1.25

mmol/l

7.94

4208

9680

Pneumonias (Asthma/COPD co-morbidities)

8450

23691

2.71

307.65

9.6

6.6

1.39

1.33

mmol/l

4.34

8067

22925

GASTRO-related operations

5764

11723

2.62

307.65

8.5

5.7

1.34

1.36

mmol/l

0.82

5550

11208

Paroxysmal tachycardia

1465

3674

3.70

307.65

9.6

5.6

1.38

1.32

mmol/l

0.95

1403

3537

Mental and behavioural disorders due to alcohol

4046

17401

2.48

307.65

8.4

7.5

1.64

1.33

mmol/l

30.75

3867

16765

Intestinal infectious diseases

6318

27010

1.92

307.65

7.9

6.9

1.37

1.35

mmol/l

0.53

6028

26010

Heart failure, strict

5347

14919

2.95

307.65

10.3

6.2

1.47

1.34

mmol/l

11.25

5114

14386

Renal failure

4722

14005

3.70

307.65

12.3

5.9

1.38

1.39

mmol/l

0.17

4524

13426

Asthma, unspecified (mode), excluding more controls

3666

10676

2.93

307.65

7.4

6.0

1.35

1.33

mmol/l

0.33

3517

10381

Mental and behavioural disorders due to psychoactive substance use

4790

19601

2.53

307.65

8.2

7.3

1.60

1.32

mmol/l

30.21

4579

18890

Other heart diseases

4130

6865

4.45

307.65

11.7

5.9

1.36

1.31

mmol/l

1.57

4001

6595

Dialysis

569

1034

8.30

307.65

16.4

7.9

1.06

1.41

mmol/l

13.68

563

984

Antihypertensive medication - note that there are other indications

3669

8170

2.59

307.65

8.9

5.9

1.34

1.30

mmol/l

1.13

3531

7839

Pure hypercholesterolaemia

5246

17023

2.23

307.65

7.5

6.5

1.35

mmol/l

0.09

5034

16444

Poisoning by drugs, medicaments and biological substances

1978

6311

3.57

307.65

7.0

7.5

1.45

1.33

mmol/l

4.66

1889

6079

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7741

18471

2.89

307.65

9.2

6.4

1.39

1.33

mmol/l

4.49

7394

17918

Dialysis, with operation codes

1913

3664

7.74

307.65

19.4

6.7

1.25

1.36

mmol/l

2.83

1848

3514

Cerebrovascular diseases (FINNGEN)

2495

4554

4.40

307.65

9.7

5.6

1.35

1.31

mmol/l

0.93

2398

4400

General symptoms and signs

8472

18305

2.48

307.65

7.3

7.1

1.39

1.32

mmol/l

5.18

8131

17665

Intracranial trauma

3815

13403

2.26

307.65

6.8

7.2

1.44

1.32

mmol/l

7.13

3659

12933

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1357

4094

3.80

307.65

7.6

1.48

1.31

mmol/l

6.22

1294

3949

Other CVD (FINNGEN)

942

1497

5.86

307.65

8.0

5.1

1.44

1.34

mmol/l

1.36

905

1441

Psychiatric diseases

7336

20622

1.87

307.65

7.1

7.4

1.43

1.30

mmol/l

15.03

7019

19943

Poisoning by medicine

1814

5598

3.71

307.65

7.1

7.6

1.45

1.33

mmol/l

4.47

1731

5388

Type 2 diabetes, wide definition

5914

18721

2.22

307.65

8.6

6.4

1.51

1.27

mmol/l

38.54

5670

18034

Hypertensive diseases (excluding secondary)

3723

6623

3.55

307.65

10.6

5.8

1.32

1.31

mmol/l

0.24

3587

6386

Aplastic and other anaemias

3499

15079

2.43

307.65

8.5

6.3

1.38

mmol/l

0.09

3344

14441

COPD/asthma related infections

7061

18488

2.01

307.65

8.0

6.4

1.36

1.33

mmol/l

1.98

6762

17935

COPD/asthma/ILD related infections

7061

18488

2.01

307.65

8.0

6.4

1.36

1.33

mmol/l

1.98

6762

17935

Other disorders of urethra and urinary system

4369

17379

1.99

307.65

6.7

1.31

1.33

mmol/l

0.74

4203

16713

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

6056

18107

2.10

307.65

8.3

7.4

1.27

1.38

mmol/l

11.22

5883

17402

Other septicaemia

3617

11261

3.70

307.65

10.8

6.1

1.51

1.34

mmol/l

10.92

3481

10810

Diabetes, varying definitions

6816

22359

1.92

307.65

9.0

6.5

1.49

1.28

mmol/l

38.57

6560

21517

Provisional assignment of new diseases of uncertain etiology

3549

13780

2.86

307.65

11.2

6.7

1.32

1.36

mmol/l

1.07

3440

13245

Suicide or other Intentional self-harm

1813

6753

2.98

307.65

7.3

7.5

1.48

1.33

mmol/l

6.14

1729

6508

Glomerular diseases

1630

5701

3.36

307.65

13.2

7.1

1.22

1.37

mmol/l

6.50

1581

5468

Other soft tissue disorders, not elsewhere classified

6268

21014

1.94

307.65

7.1

7.3

1.34

1.36

mmol/l

0.71

6048

20185

Diabetes medication

6717

23332

1.84

307.65

8.5

6.7

1.51

1.28

mmol/l

42.00

6460

22451

Renal tubulo-interstitial diseases

7961

22279

3.07

307.65

9.7

6.3

1.37

1.34

mmol/l

1.35

7629

21474

Heart failure and antihypertensive medication

2720

3741

5.81

307.65

13.2

6.0

1.45

1.28

mmol/l

7.46

2620

3596

Acute tubulo-interstitial nephritis

4687

17684

2.57

307.65

7.6

6.0

1.36

1.34

mmol/l

0.67

4489

17030

Substance use, excluding alcohol

1566

5066

3.52

307.65

7.7

7.6

1.46

1.29

mmol/l

6.75

1481

4890

Dentinal caries

2008

6782

3.38

307.65

13.6

7.0

1.29

1.38

mmol/l

3.23

1946

6519

Endocrine, nutritional and metabolic diseases

5296

13151

2.15

307.65

8.9

6.3

1.39

1.30

mmol/l

6.14

5081

12682

Transplanted organ and tissue status

1334

2633

7.21

307.65

22.2

7.3

1.14

1.36

mmol/l

9.56

1308

2532

Nutritional anaemias

3335

16249

2.16

307.65

8.1

6.2

1.43

1.36

mmol/l

2.07

3184

15567

Diabetes mellitus

6853

22384

1.92

307.65

9.0

6.5

1.49

1.28

mmol/l

38.71

6595

21539

Codeine or tramadol medication

7882

23973

1.92

307.65

6.7

7.1

1.35

mmol/l

0.11

7610

23069

Opioids

7017

17346

2.25

307.65

7.4

6.8

1.34

1.35

mmol/l

0.28

6749

16706

Anxiety disorders, excluding more controls

5117

18220

1.96

307.65

7.1

7.3

1.36

1.29

mmol/l

3.80

4898

17665

Asthma, excluding more controls

5226

11740

2.53

307.65

7.3

6.0

1.34

mmol/l

0.10

5016

11413

Asthma, unspecified (mode)

3753

11942

2.69

307.65

7.3

6.3

1.35

mmol/l

0.05

3601

11613

Other diseases of pleura

3501

14655

2.34

307.65

9.3

6.5

1.36

1.38

mmol/l

0.80

3333

14085

First line medication for Crohn's disease

7837

22407

2.01

307.65

8.4

6.8

1.35

mmol/l

0.09

7535

21572

Mood disorders, excluding more controls

6122

20309

1.93

307.65

7.0

7.2

1.38

1.30

mmol/l

6.21

5829

19673

Abdominal and pelvic pain

6786

19351

1.84

307.65

7.4

7.3

1.36

1.35

mmol/l

0.40

6546

18601

Ulcer of lower limb, not elsewhere classified

1415

4306

4.08

307.65

10.7

6.5

1.37

mmol/l

0.00

1373

4115

Excluding asthma or asthma-COPD overlap

5149

13254

2.04

307.65

8.2

6.3

1.34

1.35

mmol/l

0.56

4938

12887

4627

18934

2.46

307.65

8.8

7.2

1.64

1.32

mmol/l

36.34

4423

18240

Asthma, hospital admissions 3, pneumonia

2907

11814

2.75

307.65

8.4

6.5

1.39

1.38

mmol/l

0.26

2766

11298

Asthma (mode)

5093

13243

2.23

307.65

7.0

6.4

1.33

1.36

mmol/l

0.69

4913

12873

Substance abuse

4670

19268

2.54

307.65

8.3

7.3

1.60

1.32

mmol/l

28.84

4460

18580

Headache

3876

15626

2.19

307.65

6.3

7.0

1.32

1.31

mmol/l

0.09

3710

15091

Tramadol

6725

16062

2.96

307.65

7.9

6.9

1.34

1.35

mmol/l

0.20

6469

15478

Any reimbursement code in KELA

3574

6616

2.86

307.65

8.6

5.8

1.36

1.32

mmol/l

1.14

3440

6371

Asthma-related pneumonia or sepsis

2907

11814

2.75

307.65

8.4

6.5

1.39

1.38

mmol/l

0.26

2766

11298

Medical observation and evaluation for suspected diseases and conditions

4903

12461

2.13

307.65

6.9

7.0

1.36

1.35

mmol/l

0.43

4742

12054

Convulsions, not elsewhere classified

1945

5965

3.63

307.65

7.6

7.5

1.49

1.35

mmol/l

4.30

1826

5734

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

8142

23872

2.62

307.65

9.1

6.8

1.39

1.33

mmol/l

5.07

7759

23115

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6462

21624

1.93

307.65

8.5

6.5

1.51

1.28

mmol/l

44.33

6218

20811

Hypertension

5433

13912

2.36

307.65

9.8

6.6

1.35

1.33

mmol/l

0.50

5242

13419

Nausea and vomiting

2114

7404

3.14

307.65

8.8

6.7

1.40

1.35

mmol/l

1.13

2014

7076

Anaemias

2017

1649

9.30

307.65

11.4

5.2

1.35

1.31

mmol/l

0.56

1945

1576

2929

13835

2.26

307.65

7.3

1.36

mmol/l

0.03

2794

13296

Dyspnoea

6896

24345

2.35

307.65

7.5

6.9

1.39

1.34

mmol/l

2.82

6628

23432

Hernia of abdominal wall, postoperative

1299

3966

3.69

307.65

8.3

5.9

1.37

mmol/l

0.02

1263

3830

Intestinal stricture

2584

10195

2.89

307.65

7.7

6.6

1.38

1.36

mmol/l

0.31

2506

9774

Asthma (only as main-diagnosis), excluding more controls

4557

11740

2.46

307.65

7.1

6.0

1.34

mmol/l

0.01

4381

11413

Alcohol use disorder, Swedish definition

4458

18205

2.50

307.65

8.9

7.3

1.64

1.32

mmol/l

34.12

4260

17538

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7374

24250

1.82

307.65

8.4

6.8

1.30

1.36

mmol/l

4.14

7015

23464

Other diseases of intestines

7225

22338

1.98

307.65

7.7

7.3

1.33

1.35

mmol/l

0.98

6980

21469

Cardiovascular diseases (excluding rheumatic etc)

4339

8400

3.20

307.65

10.1

5.8

1.32

mmol/l

0.05

4187

8059

Other or unspecified ileus, impaction or obstruction

1570

5415

3.34

307.65

7.1

6.5

1.41

1.39

mmol/l

0.23

1523

5178

Extracorporeal dialysis

846

1736

7.31

307.65

18.8

8.1

1.07

1.43

mmol/l

18.00

819

1667

Alcohol abuse, main dg, excluding more controls

1249

3797

3.80

307.65

7.9

1.67

1.30

mmol/l

18.40

1191

3679

All pneumoniae

8486

23752

2.70

307.65

9.6

6.6

1.39

1.33

mmol/l

4.83

8102

22986

Other arrhythmias

3718

14420

2.08

307.65

7.0

6.3

1.30

1.32

mmol/l

0.42

3601

13923

Oedema, not elsewhere classified

2269

8539

2.93

307.65

7.5

6.6

1.37

1.33

mmol/l

0.86

2183

8203

Atrial fibrillation and flutter

2922

4341

5.05

307.65

10.3

5.6

1.40

1.32

mmol/l

2.11

2847

4197

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1970

6257

3.48

307.65

7.1

7.3

1.45

1.28

mmol/l

10.13

1877

6065

Paralytic ileus and intestinal obstruction

2212

7788

3.25

307.65

7.5

6.6

1.39

1.38

mmol/l

0.15

2146

7451

Bacterial pneumoniae

3011

11686

2.49

307.65

9.0

6.1

1.40

1.35

mmol/l

1.39

2850

11302

Influenza and pneumonia

8787

23472

2.69

307.65

9.4

6.6

1.39

1.33

mmol/l

4.52

8396

22713

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2075

8281

2.71

307.65

6.7

6.5

1.23

1.41

mmol/l

10.74

2006

7949

Abnormalities of breathing

6652

17766

2.38

307.65

7.5

7.2

1.37

1.35

mmol/l

0.66

6378

17115

Non-ischemic cardiomyopathy

2527

7499

3.17

307.65

10.0

5.9

1.43

1.32

mmol/l

3.67

2433

7229

Fever of other and unknown origin

4717

14906

3.28

307.65

8.1

6.9

1.38

1.33

mmol/l

2.06

4538

14374

Any mental disorder

7494

21254

1.85

307.65

7.1

7.3

1.43

1.31

mmol/l

15.37

7162

20557

Bleeding

6347

22326

2.24

307.65

8.9

6.8

1.42

1.35

mmol/l

4.60

6118

21482

Dental caries

2298

7706

3.38

307.65

13.9

6.9

1.30

1.38

mmol/l

2.51

2226

7412

Infections, IBD-co-morbidities

1357

2529

4.41

307.65

10.4

6.9

1.38

1.25

mmol/l

2.90

1307

2432

Bacterial pneumonia, not elsewhere classified

2839

11052

2.48

307.65

9.1

6.0

1.37

1.34

mmol/l

0.63

2685

10682

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

3368

11270

2.58

307.65

7.7

6.9

1.33

1.41

mmol/l

3.29

3263

10830

Examination and observation for other reasons

5293

12295

2.87

307.65

7.4

7.1

1.33

1.34

mmol/l

0.31

5163

11906

ILD medications

7908

23469

1.95

307.65

8.8

6.6

1.36

1.35

mmol/l

0.19

7590

22605

Pain, not elsewhere classified

1835

6749

2.98

307.65

7.9

6.9

1.31

1.32

mmol/l

0.11

1774

6509

ILD medications: prednisolone, methylprednisolone, prednisone

7841

23121

2.03

307.65

8.6

6.6

1.35

mmol/l

0.07

7521

22270

Inflammatory bowel disease treatment related agents

7631

25011

1.82

307.65

7.8

7.0

1.38

1.34

mmol/l

2.17

7307

24093

Fall on same level

7637

24579

1.82

307.65

7.6

7.2

1.38

1.34

mmol/l

2.21

7358

23642

Insulin medication

4405

18470

2.20

307.65

9.5

6.7

1.53

1.30

mmol/l

25.90

4218

17739

Pain in throat and chest

6038

17108

2.30

307.65

6.7

7.1

1.36

1.35

mmol/l

0.34

5803

16497

Asthma (diagnoses ohter than nonallergic)

5637

27190

1.87

307.65

7.1

7.0

1.35

mmol/l

0.15

5402

26171

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2291

4138

2.92

307.65

7.8

7.2

1.37

1.32

mmol/l

0.92

2191

4006

Continuous positive airway pressure

1326

3514

3.61

307.65

11.7

6.7

1.35

1.22

mmol/l

4.12

1218

3372

Hard cardiovascular diseases

5565

18391

2.09

307.65

9.2

6.8

1.38

1.33

mmol/l

2.15

5354

17781

Other anaemias

3214

14184

2.42

307.65

8.3

6.2

1.38

mmol/l

0.04

3072

13573

Symptoms and signs involving the digestive system and abdomen

6884

19363

1.87

307.65

7.4

7.3

1.37

1.35

mmol/l

0.70

6627

18611

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

6059

18113

2.10

307.65

8.3

7.4

1.27

1.38

mmol/l

11.40

5886

17408

Heart failure and bmi 25plus

2845

7512

2.97

307.65

9.6

6.2

1.45

1.40

mmol/l

1.28

2709

7285

Substance abuse, excluding more controls

4670

15954

2.83

307.65

8.3

7.5

1.60

1.32

mmol/l

29.59

4460

15431

COPD (mode)

2480

7346

3.00

307.65

9.0

6.1

1.37

1.36

mmol/l

0.07

2358

7157

Insulin, intermediate and long-acting

4060

19892

2.17

307.65

9.5

6.7

1.52

1.35

mmol/l

14.56

3892

19142

Heart failure, not strict

7279

17093

3.37

307.65

11.3

6.2

1.43

1.31

mmol/l

11.14

7005

16523

Diverticular disease of intestine

4820

16958

2.01

307.65

6.9

7.0

1.32

1.36

mmol/l

1.27

4651

16327

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1970

7600

2.84

307.65

7.1

7.4

1.45

1.33

mmol/l

5.38

1877

7331

ILD medications: immunosuppressive drugs

3953

19593

2.05

307.65

11.5

6.8

1.28

1.34

mmol/l

2.77

3812

18924

7741

18471

2.89

307.65

9.2

6.4

1.39

1.33

mmol/l

4.49

7394

17918

COPD differential diagnosis

5098

13243

2.02

307.65

8.1

6.4

1.34

1.36

mmol/l

0.54

4891

12873

Symptoms and signs involving the circulatory and respiratory systems

6652

17846

1.96

307.65

7.3

7.2

1.35

mmol/l

0.03

6362

17193

Hypothyroidism, levothyroxine purchases

1315

1728

4.64

307.65

8.3

5.0

1.33

1.31

mmol/l

0.19

1262

1666

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2465

6040

2.74

307.65

9.0

5.5

1.40

1.29

mmol/l

3.26

2388

5838

Hypertension, essential

5462

13506

2.48

307.65

8.9

6.5

1.34

1.33

mmol/l

0.48

5261

13040

Pain in limb

5561

20257

2.12

307.65

7.2

1.34

1.36

mmol/l

0.79

5381

19467

STROKE

4011

12474

2.41

307.65

8.7

6.4

1.36

1.30

mmol/l

2.11

3870

12084

Diabetes, insulin treatment (Kela reimbursement)

6769

23544

1.85

307.65

8.5

6.8

1.51

1.29

mmol/l

41.17

6517

22640

Cardiovascular diseases

3806

7508

2.93

307.65

9.9

5.9

1.31

1.33

mmol/l

0.52

3674

7205

Insulin, combination of fast acting with intermediate-acting or long-acting

4408

21407

2.04

307.65

9.5

6.7

1.53

1.35

mmol/l

16.53

4221

20576

Other heart diseases, wide

6924

17813

2.60

307.65

9.9

6.6

1.36

1.32

mmol/l

1.83

6703

17162

Personality disorders, excluding more controls

1763

5735

3.38

307.65

6.9

7.5

1.39

1.27

mmol/l

4.76

1675

5569

Covid-19 confirmed case

2807

8675

3.84

307.65

12.2

6.6

1.31

1.36

mmol/l

1.71

2709

8321

Codes for special purposes

3553

13800

2.86

307.65

11.2

6.7

1.32

1.36

mmol/l

1.04

3444

13264

All-cause Heart Failure

5210

14669

2.92

307.65

10.0

6.2

1.47

1.34

mmol/l

10.96

4986

14145

Haemorrhage from respiratory passages

2414

10081

2.42

306.63

8.4

6.8

1.38

mmol/l

0.11

2315

9701

Depression

5858

23933

1.76

305.53

7.1

7.3

1.38

1.34

mmol/l

2.00

5571

23158

Bronchitis

6660

26763

1.70

304.61

7.3

6.9

1.38

1.35

mmol/l

1.15

6342

25809

Insulin, fast-acting

2592

12129

2.33

304.16

10.1

6.8

1.46

1.35

mmol/l

4.75

2479

11668

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4249

21784

1.93

303.48

8.3

6.6

1.30

1.37

mmol/l

3.95

4108

20944

L04AA Selective immunosuppressants

1639

6303

2.93

302.19

15.1

7.1

1.21

1.34

mmol/l

5.13

1593

6063

Symptoms and signs involving the urinary system

5033

22441

1.83

300.75

7.4

6.9

1.35

1.36

mmol/l

0.50

4794

21631

Volume depletion

883

2383

4.51

300.62

8.7

5.7

1.58

1.43

mmol/l

2.53

821

2270

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2752

11554

2.27

298.60

6.0

6.9

1.43

1.40

mmol/l

0.36

2656

11104

Other diseases of urinary system

6407

21800

1.72

298.51

6.9

7.1

1.33

1.35

mmol/l

1.07

6160

20973

All influenza

1789

7188

2.75

298.45

7.6

6.6

1.39

1.36

mmol/l

0.72

1701

6926

Other chronic obstructive pulmonary disease, including avohilmo

3765

16723

2.02

298.02

8.3

6.6

1.37

1.38

mmol/l

0.21

3589

16104

Low back pain

4620

20019

1.87

297.32

6.2

7.4

1.35

1.36

mmol/l

0.31

4454

19279

Hypokalaemia

994

2922

4.03

296.29

9.6

6.0

1.50

1.34

mmol/l

3.07

943

2824

Need for other prophylactic measures

666

1499

6.05

295.95

14.2

7.4

1.13

1.36

mmol/l

6.44

582

1444

Other anxiety disorders

2636

10968

2.26

294.09

7.1

7.2

1.35

1.32

mmol/l

0.68

2511

10605

Care involving use of rehabilitation procedures

3975

20599

1.94

294.06

8.6

6.7

1.31

1.36

mmol/l

1.94

3781

19871

Adjustment and management of implanted device

1557

5965

3.01

292.88

11.0

6.2

1.35

1.39

mmol/l

0.78

1521

5726

Type 2 diabetes, definitions combined

5836

20745

1.76

292.03

8.2

6.4

1.53

1.27

mmol/l

47.01

5622

19986

Atherosclerosis, excluding cerebral and coronary sclerosis

3042

12135

2.19

291.85

8.7

5.8

1.41

1.39

mmol/l

0.39

2904

11664

Preparatory care for dialysis

580

1199

7.28

290.82

14.4

8.0

1.05

1.43

mmol/l

11.47

564

1153

Personality disorders

1763

7104

2.70

289.82

6.9

7.6

1.39

1.33

mmol/l

1.58

1675

6862

Type 2 diabetes, strict (exclude DM1)

5846

20905

1.74

286.63

8.2

6.4

1.53

1.27

mmol/l

47.75

5631

20138

Cystitis

5177

18367

1.80

285.31

6.6

6.8

1.33

1.34

mmol/l

0.29

4965

17657

Type 2 diabetes, definitions combined, including avohilmo

5833

20688

1.74

284.99

8.1

6.5

1.53

1.27

mmol/l

47.69

5615

19933

Dorsalgia

6275

20681

1.71

282.22

6.0

7.4

1.34

1.37

mmol/l

0.74

6051

19889

Other acute lower respiratory infections

3533

17996

1.99

282.06

7.4

7.0

1.39

1.38

mmol/l

0.17

3353

17252

Other functional intestinal disorders

2878

13644

2.15

281.17

6.6

6.7

1.33

1.36

mmol/l

0.81

2748

13061

7036

23275

1.66

280.68

7.2

6.8

1.35

mmol/l

0.04

6717

22478

Obesity and other hyperalimentation

3684

19771

1.95

280.16

8.8

7.0

1.43

1.32

mmol/l

6.64

3534

19119

All anxiety disorders

3520

14936

1.99

279.36

7.2

7.5

1.36

1.32

mmol/l

1.40

3362

14436

Obesity

3666

19685

1.95

278.99

8.8

7.1

1.43

1.32

mmol/l

6.58

3516

19036

Neurotic, stress-related and somatoform disorders

5280

22246

1.76

278.12

7.1

7.4

1.36

1.33

mmol/l

0.89

5047

21502

Other and unspecified iron deficiency

2243

10277

2.39

278.07

8.0

6.2

1.40

1.35

mmol/l

1.03

2138

9838

Anxiety disorders

5339

22519

1.75

276.84

7.1

7.4

1.36

1.33

mmol/l

0.85

5103

21769

Any event in cancer register

5612

19900

1.75

276.25

7.5

7.4

1.30

1.36

mmol/l

4.24

5436

19160

Neurological diseases, wide definition

1917

3745

2.71

275.98

7.7

7.5

1.37

1.31

mmol/l

1.06

1828

3595

1011

3116

3.70

275.76

11.4

6.7

1.33

mmol/l

0.03

956

3025

Insulin, fast-acting or short human

2604

12711

2.22

273.45

10.1

6.9

1.47

1.37

mmol/l

3.53

2491

12223

Concussion

3000

13126

2.08

272.50

6.3

7.2

1.43

1.32

mmol/l

4.99

2871

12661

Disorders of gallbladder, biliary tract and pancreas

6140

24445

1.69

272.27

8.0

6.9

1.41

1.34

mmol/l

4.06

5939

23517

Disorders of adult personality and behaviour

1797

7516

2.59

272.03

6.6

7.6

1.39

1.33

mmol/l

1.38

1707

7256

Lower back pain or/and sciatica

6289

27227

1.67

270.58

6.2

7.2

1.35

mmol/l

0.06

6076

26211

Other reaction to severe stress, and adjustment disorders

2123

9560

2.37

268.96

7.4

1.36

1.32

mmol/l

1.03

2027

9256

COPD, hospital admissions

3214

14330

2.06

266.72

8.4

6.5

1.37

1.38

mmol/l

0.23

3048

13798

COPD, early/later onset

3234

14416

2.05

266.43

8.5

6.5

1.37

1.38

mmol/l

0.15

3070

13883

Falls/tendency to fall

6802

21354

1.65

266.32

7.5

7.2

1.38

1.34

mmol/l

1.59

6547

20546

Statin medication

4098

12600

1.91

266.01

9.6

6.5

1.33

mmol/l

0.04

3934

12149

Heart failure and coronary heart disease

2511

8992

2.31

265.46

9.4

5.9

1.55

1.37

mmol/l

9.43

2371

8632

Venous thromboembolism

3586

19105

1.95

265.14

8.0

6.4

1.37

1.36

mmol/l

0.01

3439

18357

Valvular operations

1125

3803

3.39

264.37

13.0

6.3

1.29

1.35

mmol/l

1.17

1084

3645

Glucagon-like peptide-1 (GLP-1) analogues

3717

16880

1.94

263.62

8.0

6.5

1.56

1.29

mmol/l

36.09

3567

16240

Use of hypnotics and sedatives

6628

24172

1.65

263.49

7.1

7.3

1.38

1.34

mmol/l

1.38

6321

23356

Pain (limb, back, neck, head abdominally)

4739

13543

1.83

262.69

7.4

7.7

1.35

1.37

mmol/l

0.80

4560

12973

Gastrointestinal diseases

3554

9236

2.01

262.47

8.1

6.3

1.36

1.32

mmol/l

1.08

3427

8863

Gout, FINNGEN

2211

10390

2.37

261.52

8.6

6.6

1.40

mmol/l

0.03

2122

9974

COPD related to multimorbidity

2830

12153

2.14

258.86

8.5

6.3

1.40

1.38

mmol/l

0.31

2683

11687

Myocardial infarction

3497

13572

1.99

258.57

9.5

6.5

1.43

1.35

mmol/l

3.63

3345

13096

Constipation

5471

23965

1.71

258.44

6.9

7.1

1.34

1.35

mmol/l

0.25

5221

23077

Other (not insulin) diabetes medications

5878

21857

1.69

258.13

7.9

6.6

1.54

1.28

mmol/l

49.23

5660

21058

Pleural effusion

1311

4921

3.10

257.94

6.9

6.2

1.33

1.39

mmol/l

1.31

1251

4698

Pulmonary heart disease, diseases of pulmonary circulation

2274

10831

2.30

257.30

9.3

6.4

1.42

1.37

mmol/l

1.32

2174

10375

Sequelae of external causes of morbidity and mortality

1820

7926

2.55

257.12

9.2

6.7

1.31

1.35

mmol/l

0.80

1783

7624

Alcohol abuse, main dg

1249

4553

3.13

256.56

7.9

1.67

1.36

mmol/l

13.19

1191

4377

Abnormal findings on diagnostic imaging of lung

3223

16978

1.99

251.22

8.4

6.5

1.30

1.37

mmol/l

3.97

3120

16317

Schizophrenia or delusion, excluding more controls

1844

8000

2.45

250.87

6.0

7.4

1.45

1.29

mmol/l

6.02

1743

7756

Dizziness and giddiness

4551

21829

1.78

250.02

6.2

7.1

1.36

1.34

mmol/l

0.61

4380

21049

Major coronary heart disease event

4676

18465

1.79

249.98

8.8

6.7

1.42

1.35

mmol/l

3.91

4491

17804

Intestinal adhesions without obstruction

783

2217

4.31

249.54

7.3

6.5

1.38

1.35

mmol/l

0.24

756

2135

Obesity, other/unspecified

2055

9457

2.34

249.19

8.6

7.2

1.36

1.30

mmol/l

2.27

1971

9155

Acute alcohol intoxication, ICD10

1490

6007

2.77

249.08

7.6

7.8

1.72

1.34

mmol/l

20.22

1427

5775

Benign neoplasm of colon, rectum, anus and anal canal

3993

20755

1.85

248.68

7.0

6.7

1.34

1.37

mmol/l

0.80

3837

19989

Major coronary heart disease event excluding revascularizations

4356

17541

1.82

247.59

8.8

6.6

1.44

1.35

mmol/l

5.15

4170

16921

Gout, idiopatic and unspecified

1879

8488

2.49

246.67

8.9

6.8

1.41

1.40

mmol/l

0.10

1809

8125

Type 1 diabetes

1737

7483

2.52

246.37

10.5

6.7

1.37

1.30

mmol/l

1.55

1666

7178

Autoimmune diseases excluding thyroid diseases

6527

23071

1.63

245.97

8.2

6.9

1.35

1.36

mmol/l

0.11

6270

22213

Other disorders of skin and subcutaneous tissue

4252

22862

1.80

245.84

7.7

6.6

1.36

1.35

mmol/l

0.32

4086

22016

Hypothyroidism, drug reimbursement

655

1039

4.79

244.78

8.2

5.5

1.26

1.31

mmol/l

0.49

625

1006

Asthma, including avohilmo

7153

27128

1.59

244.54

7.0

7.2

1.34

1.36

mmol/l

0.90

6852

26114

Acute alcohol intoxication

1839

8199

2.46

243.91

7.5

7.2

1.66

1.34

mmol/l

19.69

1767

7863

Colectomy operation

1357

5338

2.92

242.45

8.8

6.6

1.28

1.36

mmol/l

1.68

1316

5128

Later onset COPD, excluding more controls

1539

4858

2.77

242.41

7.1

5.3

1.38

mmol/l

0.11

1469

4724

Diseases of pulp and periapical tissues

2304

11237

2.20

241.17

11.0

6.8

1.36

1.38

mmol/l

0.23

2217

10841

Artificial opening status

611

1512

5.44

241.14

10.4

7.3

1.31

1.41

mmol/l

1.11

584

1460

Stroke, including SAH

4145

17846

1.83

240.52

7.8

6.7

1.40

1.36

mmol/l

1.01

3965

17185

COPD, hospital admission 2, with asthma infections

2330

9712

2.24

240.26

9.0

6.3

1.40

1.39

mmol/l

0.06

2191

9309

Abnormalities of heart beat

2122

9922

2.26

240.01

6.6

1.36

1.35

mmol/l

0.21

2037

9561

DVT of lower extremities and pulmonary embolism

2809

14735

2.05

238.96

8.2

6.4

1.40

1.38

mmol/l

0.52

2688

14137

Viral hepatitis, IBD co-morbidity

453

845

6.25

238.59

9.0

6.1

1.43

1.29

mmol/l

1.40

433

821

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

852

1795

3.95

238.19

11.6

7.1

1.45

1.26

mmol/l

4.09

807

1724

Autoimmune diseases excluding thyroid diseases, strict definition

6327

22460

1.63

238.16

8.2

6.9

1.35

1.36

mmol/l

0.14

6078

21628

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

618

1513

4.87

238.09

7.6

7.2

1.44

1.38

mmol/l

0.52

582

1460

Acute bronchitis

2691

13677

2.06

235.95

6.9

6.7

1.38

mmol/l

0.11

2559

13089

Specific personality disorders

1480

6051

2.66

235.85

6.7

7.6

1.39

1.33

mmol/l

1.34

1400

5845

Pulmonary embolism

2064

9797

2.31

235.67

9.0

6.3

1.40

1.37

mmol/l

0.75

1969

9382

Conduction disorders

1835

6772

2.44

234.63

8.9

5.9

1.38

1.33

mmol/l

1.16

1763

6505

Other symptoms and signs involving cognitive functions and awareness

2907

14531

2.01

234.60

5.2

6.8

1.42

1.37

mmol/l

1.88

2767

13962

Pulmonary heart disease

2064

9820

2.31

234.27

9.0

6.4

1.40

1.37

mmol/l

0.77

1969

9408

Obesity related asthma

2129

10227

2.25

233.20

8.0

7.2

1.42

1.34

mmol/l

2.30

2054

9883

Diseases of liver

2265

11175

2.20

232.16

9.6

7.1

1.74

1.33

mmol/l

25.53

2169

10748

Viral pneumonia (unknown virus, not influenza)

645

1680

4.74

231.83

18.7

7.7

1.27

1.41

mmol/l

2.46

633

1614

Pain in joint

3433

12472

1.91

231.14

6.7

7.8

1.30

1.36

mmol/l

3.16

3311

12000

Spondylopathies

4982

18425

1.72

230.98

6.0

7.4

1.34

1.37

mmol/l

1.03

4800

17749

Injuries to the abdomen, lower back, lumbar spine and pelvis

2543

13006

2.08

229.08

6.8

6.6

1.42

1.37

mmol/l

1.49

2439

12447

Myocardial infarction, without ST-elevation

2805

13784

2.03

228.88

8.8

6.3

1.46

1.38

mmol/l

2.57

2674

13235

Injuries to the thorax

2938

15898

1.98

228.34

7.6

6.9

1.46

1.37

mmol/l

3.44

2811

15277

Depression or dysthymia

4317

14102

1.79

228.02

6.9

7.5

1.38

1.31

mmol/l

3.37

4136

13663

Intracranial injury

3536

19494

1.85

226.68

6.6

6.9

1.46

1.35

mmol/l

5.71

3381

18716

Type 1 diabetes, wide definition, subgroup 1

1406

5730

2.67

225.74

9.8

6.6

1.36

1.28

mmol/l

1.59

1340

5495

Benign neoplasms

4275

14103

1.78

225.58

7.5

1.30

1.39

mmol/l

6.69

4103

13521

Gout, unspecified

1558

6777

2.61

224.12

8.6

6.8

1.41

1.40

mmol/l

0.08

1500

6493

Other external causes of accidental injury

5045

15351

1.71

223.02

7.4

7.2

1.38

1.34

mmol/l

1.54

4842

14745

Chronic periodontitis

1160

4383

3.02

222.95

14.2

7.2

1.24

1.38

mmol/l

3.81

1127

4227

Problems related to lifestyle

796

2423

3.75

221.74

8.0

7.2

1.48

1.36

mmol/l

1.71

752

2352

Asthma, hospital admissions , main diagnosis only

4892

27315

1.67

220.54

6.9

7.1

1.34

1.35

mmol/l

0.46

4695

26269

Biguanides

5722

22488

1.63

220.26

7.7

6.8

1.57

1.28

mmol/l

52.99

5511

21664

Unspecified privation

906

3043

3.48

217.75

9.5

7.1

1.40

1.37

mmol/l

0.28

870

2928

Other dialysis

412

818

7.62

216.19

16.5

9.2

1.05

1.38

mmol/l

9.43

403

782

Amiodarone users

924

3191

3.52

215.86

14.2

7.0

1.37

1.38

mmol/l

0.11

887

3071

Stroke, excluding SAH

3884

17008

1.80

215.50

7.7

6.6

1.41

1.37

mmol/l

1.39

3709

16370

Open wound of head

3275

18322

1.86

214.85

7.2

1.45

1.36

mmol/l

3.97

3135

17592

Cutaneous abscess, furuncle and carbuncle

1669

7543

2.41

213.30

9.5

7.4

1.38

1.35

mmol/l

0.47

1607

7260

Hernia

5618

24483

1.62

213.20

7.6

7.1

1.34

1.36

mmol/l

0.74

5422

23550

Accidents

4991

15351

1.69

211.62

7.3

7.2

1.38

1.34

mmol/l

1.41

4790

14745

Vocal cord dysfunction

775

2163

3.61

211.28

9.5

5.7

1.30

1.19

mmol/l

1.91

746

2089

Lung cancer and mesothelioma

1344

4687

2.71

211.26

7.0

5.7

1.24

1.38

mmol/l

5.24

1290

4561

Non-allergic asthma (mode), excluding more controls

1190

4574

2.79

210.18

7.3

5.9

1.34

1.33

mmol/l

0.08

1136

4436

Invasive ventilation

706

2108

4.15

209.51

14.9

7.0

1.45

1.41

mmol/l

0.36

664

2017

Presence of cardiac and vascular implants and grafts

3160

13432

1.91

209.47

10.0

6.3

1.42

1.39

mmol/l

0.92

3012

12915

Myocardial infarction, strict

3157

12895

1.91

209.41

9.3

6.5

1.44

1.35

mmol/l

3.47

3014

12438

Emotionally unstable personality disorder

805

2554

3.50

207.45

5.7

6.9

1.38

1.29

mmol/l

1.79

766

2463

Benign neoplasm: Colon

3350

19028

1.84

206.97

7.1

6.7

1.35

1.36

mmol/l

0.42

3224

18333

Peripheral arterial reconstruction

1345

5687

2.70

206.38

9.9

6.1

1.39

1.41

mmol/l

0.34

1295

5414

COPD, hospital admissions 3, with asthma pneumonia sepsis

1960

8091

2.26

205.88

8.9

6.2

1.41

1.40

mmol/l

0.08

1838

7741

Diseases of the respiratory system

3821

11006

1.81

205.82

7.3

6.4

1.33

1.35

mmol/l

0.55

3660

10695

Epilepsy

2053

10163

2.16

204.80

6.4

7.3

1.44

1.36

mmol/l

2.05

1927

9749

Retention of urine

2323

10126

2.10

204.51

6.8

6.7

1.39

mmol/l

0.04

2218

9731

Asthma/COPD (KELA code 203)

5571

25447

1.60

203.83

7.2

7.1

1.34

1.36

mmol/l

0.78

5351

24502

Osteopathies and chondropathies

3311

18211

1.82

201.04

8.2

6.6

1.34

1.35

mmol/l

0.38

3194

17528

Gout, strict definition

1375

5982

2.62

198.44

8.8

6.9

1.43

1.41

mmol/l

0.22

1315

5736

Hyperkalaemia

535

1370

4.92

198.10

10.5

5.4

1.42

1.40

mmol/l

0.12

507

1319

Other dorsopathies, not elsewhere classified

6015

20775

1.58

198.01

6.3

7.4

1.34

1.37

mmol/l

0.94

5787

19979

Peripheral artery operations in Hilmo

1034

3939

3.00

195.93

11.0

6.1

1.41

mmol/l

0.03

993

3757

External causes of morbidity and mortality

3926

11566

1.76

195.14

7.2

7.1

1.35

1.32

mmol/l

0.56

3771

11098

Diaphragmatic hernia

2293

12084

2.04

194.22

7.2

6.4

1.32

1.36

mmol/l

1.31

2208

11636

Sequelae with surgical and medical care as external cause

1405

6196

2.53

193.58

9.6

6.7

1.29

1.35

mmol/l

1.27

1376

5963

Fracture of rib(s), sternum and thoracic spine

1994

10049

2.16

193.44

7.5

7.0

1.48

1.37

mmol/l

3.38

1903

9650

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

584

1602

4.34

193.15

6.6

7.2

1.52

1.38

mmol/l

1.65

549

1533

Neurological diseases

5183

16563

1.63

192.54

7.2

7.3

1.35

1.34

mmol/l

0.20

4953

15959

Injuries to the hip and thigh

2951

15338

1.87

192.49

7.0

6.4

1.36

1.38

mmol/l

0.36

2812

14694

Type 1 diabetes, wide definition

1436

6345

2.44

191.95

9.8

6.7

1.36

1.29

mmol/l

1.36

1369

6069

AV-block

1143

4118

2.77

191.63

8.9

5.4

1.42

1.35

mmol/l

1.24

1106

3947

Chronic pancreatitis

981

3698

3.06

190.90

10.9

7.4

1.62

1.37

mmol/l

3.98

955

3558

Diseases of the skin and subcutaneous tissue

6159

20438

1.56

190.74

7.6

7.0

1.38

1.35

mmol/l

0.76

5924

19658

Chronic periapical parodontitis

1393

6150

2.48

189.05

12.8

6.9

1.32

1.37

mmol/l

0.99

1340

5942

Episodal and paroxysmal disorders

6585

22719

1.53

188.91

7.0

7.2

1.36

mmol/l

0.20

6291

21877

Acute pancreatitis

1394

6194

2.49

187.79

9.8

7.2

1.49

1.37

mmol/l

2.38

1341

5919

Diabetic nephropathy, excluding more controls

1175

4021

2.81

186.91

12.8

8.2

1.29

1.53

mmol/l

11.10

1133

3890

Ascites

616

1806

4.10

185.65

9.8

6.5

1.63

1.34

mmol/l

3.90

587

1748

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1300

5635

2.56

185.63

6.8

6.4

1.25

1.42

mmol/l

6.14

1250

5414

Cardiomyopathy (excluding other)

902

3279

3.10

185.12

15.2

6.3

1.52

1.34

mmol/l

4.01

856

3149

Cardiomyopathies, Primary/intrinsic

878

3147

3.14

185.05

15.4

6.3

1.52

1.34

mmol/l

3.89

834

3023

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1111

4542

2.80

183.41

10.6

7.6

1.92

1.34

mmol/l

20.12

1060

4356

Hyperlipidaemia, other/unspecified

2373

12142

1.98

183.41

7.7

6.2

1.36

1.37

mmol/l

0.13

2261

11721

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

908

3364

3.11

182.22

7.8

6.3

1.17

1.42

mmol/l

13.32

883

3212

Obesity due to excess calories

2541

14129

1.90

178.72

8.9

7.1

1.46

1.32

mmol/l

6.92

2437

13682

Amputation

837

3012

3.25

178.66

11.7

6.6

1.40

1.41

mmol/l

0.08

805

2881

Non-allergic asthma (mode)

1190

4946

2.57

178.47

7.3

6.1

1.34

1.36

mmol/l

0.26

1136

4798

Abnormal findings on examination of blood, without diagnosis

2984

16314

1.82

178.16

8.3

7.1

1.40

1.38

mmol/l

0.34

2858

15673

Unspecified haematuria

2684

12980

1.89

177.67

8.1

6.9

1.37

1.38

mmol/l

0.20

2576

12497

Mental and behavioural disorders due to sedatives or hypnotics

574

1655

4.11

176.35

8.0

7.3

1.44

1.38

mmol/l

0.43

534

1592

Cellulitis

1428

6566

2.38

175.91

8.4

7.3

1.37

1.36

mmol/l

0.10

1374

6308

Early onset COPD

1541

7339

2.31

174.93

10.3

7.4

1.35

1.37

mmol/l

0.34

1471

7062

Sciatica+with lumbago

2900

15994

1.81

173.74

6.1

7.5

1.35

mmol/l

0.06

2819

15461

Ischaemic Stroke, excluding all haemorrhages

3544

16336

1.73

173.61

7.1

6.6

1.41

1.37

mmol/l

1.19

3379

15718

Cardiomyopathy, other and unspecified

615

1872

3.83

173.03

11.4

6.1

1.49

1.31

mmol/l

2.70

585

1805

Calcific aortic valvular stenosis

2028

10474

2.06

172.72

7.6

6.0

1.36

1.41

mmol/l

1.14

1968

9979

Calcific aortic valvular stenosis, operated

2028

10474

2.06

172.72

7.6

6.0

1.36

1.41

mmol/l

1.14

1968

9979

Acute upper respiratory infections of multiple and unspecified sites

4206

19942

1.64

172.66

7.6

7.2

1.36

mmol/l

0.04

4004

19214

Operations 2 for CAVS

2024

10455

2.06

172.28

7.6

6.0

1.36

1.41

mmol/l

1.10

1964

9963

Calcific aortic valvular stenosis, diagnosis (helper)

2024

10455

2.06

172.28

7.6

6.0

1.36

1.41

mmol/l

1.10

1964

9963

Calcific aortic valvular stenosis, including rheumatic fever

2030

10505

2.06

171.36

7.6

6.0

1.36

1.41

mmol/l

1.05

1970

10011

Selective serotonin reuptake inhibitors

5934

21043

1.53

170.86

6.6

7.2

1.38

1.34

mmol/l

2.04

5682

20302

Other/unspecified dorsalgia

2209

11865

1.96

170.79

6.3

7.1

1.33

1.36

mmol/l

0.79

2137

11430

Superficial injury of head

1444

6739

2.32

170.35

6.3

6.6

1.45

1.34

mmol/l

3.57

1381

6460

Genitourinary diseases

3733

11303

1.72

169.19

9.4

7.4

1.35

1.40

mmol/l

2.14

3573

10870

Explicit bacterial Sepsis

764

2673

3.26

169.08

9.8

6.2

1.51

1.33

mmol/l

2.41

729

2572

Soft tissue disorders

6069

21374

1.52

168.63

7.0

7.3

1.35

1.36

mmol/l

0.13

5838

20516

Cardiac arrest

460

965

4.67

168.24

15.0

5.8

1.70

1.31

mmol/l

3.66

437

928

Acute pancreatitis (for exclusion)

1394

6506

2.36

166.85

9.8

7.2

1.49

1.37

mmol/l

2.44

1341

6225

Streptococcal septicaemia

662

2162

3.57

166.58

9.8

6.9

1.52

1.35

mmol/l

1.77

631

2087

Used for control exclusion in common control thyroid runs

6273

21747

1.51

166.25

7.9

7.0

1.35

1.36

mmol/l

0.31

6006

20942

Other neurological diseases

4272

22155

1.62

165.79

6.7

6.8

1.36

mmol/l

0.01

4093

21327

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

909

3534

2.92

165.27

6.6

6.8

1.20

1.40

mmol/l

6.58

883

3396

Autoimmune diseases

6565

23189

1.49

164.50

8.0

7.0

1.36

mmol/l

0.17

6296

22325

COPD, hospital admissions 1, only main diagnosis

2317

10933

1.94

164.40

8.8

6.3

1.37

1.40

mmol/l

0.52

2177

10488

Injury, poisoning and certain other consequences of external causes

3122

9062

1.79

163.48

7.1

1.37

1.32

mmol/l

1.51

2999

8704

Recurrent or chronic depression

2115

8067

1.98

162.86

6.8

7.8

1.32

1.27

mmol/l

1.54

2027

7827

Other bacterial intestinal infections

1198

5299

2.48

162.32

9.2

6.5

1.41

1.36

mmol/l

0.71

1137

5082

Spinal stenosis

3148

14882

1.75

160.94

5.9

7.2

1.34

1.37

mmol/l

0.95

3020

14320

Other CVD

1340

6273

2.37

159.86

7.0

6.2

1.43

1.40

mmol/l

0.44

1272

5996

Pacemaker

2167

11632

1.95

159.39

9.0

6.0

1.44

1.39

mmol/l

1.18

2070

11119

Vascular disorders of the intestines

574

1777

3.86

158.97

10.6

6.1

1.58

1.40

mmol/l

1.88

553

1694

Bipolar affective disorders

1074

4535

2.55

158.96

6.2

7.5

1.39

1.30

mmol/l

1.42

1027

4388

Schizophrenia or delusion

1844

9618

2.04

158.92

6.0

7.6

1.45

1.33

mmol/l

3.56

1743

9274

General examination and investigation of persons without complaint and reported diagnosis

3773

12426

1.67

157.81

7.3

7.0

1.44

1.34

mmol/l

4.22

3564

12024

Parodontitis or operation codes

5143

25585

1.53

157.66

8.4

6.9

1.31

1.36

mmol/l

2.39

4971

24689

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1411

6752

2.28

157.58

5.2

6.9

1.47

1.39

mmol/l

1.17

1338

6509

Parodontitis

5137

25581

1.53

157.33

8.4

6.9

1.31

1.36

mmol/l

2.44

4965

24685

Factors influencing health status and contact with health services

1989

5059

2.06

157.31

7.8

6.4

1.43

1.38

mmol/l

0.97

1908

4903

Unspecified mental disorder

2307

12962

1.87

156.45

6.2

7.4

1.43

1.33

mmol/l

3.13

2191

12517

Unspecified fall

2877

17091

1.76

156.36

8.3

6.9

1.43

1.37

mmol/l

1.77

2764

16381

Schizophrenia, schizotypal and delusional disorders

1844

9674

2.02

156.17

6.0

7.6

1.45

1.33

mmol/l

3.49

1742

9324

Benign neoplasms

5682

21643

1.51

155.57

7.1

7.3

1.31

1.38

mmol/l

4.87

5448

20796

Hypotension

1177

5294

2.49

155.51

7.0

5.9

1.45

1.41

mmol/l

0.62

1116

5061

Direct fill therapy

939

3814

2.75

154.82

14.8

7.6

1.25

1.34

mmol/l

2.23

916

3646

Disorders of thyroid, IBD co-morbidities

946

2668

2.73

154.59

8.1

6.3

1.24

1.26

mmol/l

0.18

910

2574

Chronic periodontitis, including avohilmo

5103

25573

1.53

154.41

8.4

6.9

1.31

1.36

mmol/l

2.40

4931

24683

Dorsopathies

5966

20930

1.50

154.03

6.5

7.4

1.32

1.37

mmol/l

2.31

5722

20119

ILD, hospital admission 2, with pulmonary infections

706

2502

3.24

153.61

11.4

6.2

1.47

1.37

mmol/l

1.39

675

2408

Exposure to other specified factors

4073

24880

1.59

153.20

7.5

7.3

1.35

mmol/l

0.07

3933

23966

Other and unspecified nonorganic psychotic disorders

1141

5051

2.43

152.05

6.6

7.7

1.51

1.33

mmol/l

3.76

1067

4870

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

777

2920

3.05

151.77

7.7

6.4

1.16

1.40

mmol/l

12.03

757

2793

Mental and behavioural disorders due to opioids

337

734

5.60

151.29

9.4

7.6

1.28

1.39

mmol/l

0.88

319

707

Cough

2202

11797

1.88

151.07

6.9

7.1

1.32

1.34

mmol/l

0.51

2128

11371

Nonorganic sleeping disorders, excluding more controls

984

4090

2.58

150.63

6.8

7.4

1.42

1.29

mmol/l

2.29

928

3962

Deposits [accretions] on teeth

588

1834

3.62

149.83

18.2

7.8

1.29

1.41

mmol/l

1.57

571

1743

Transport accidents

2441

12414

1.82

149.81

6.3

7.2

1.42

1.33

mmol/l

2.97

2362

11946

Any operation in hilmo

236

110

11.51

149.78

7.5

3.3

1.45

1.51

mmol/l

0.11

224

Follow-up examination after treatment for conditions other than malignant neoplasms

2553

9570

1.82

149.58

6.9

1.31

1.32

mmol/l

0.17

2488

9280

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1082

4591

2.51

148.73

12.4

8.2

1.20

1.35

mmol/l

4.82

1044

4376

Other specific joint derangements/joint disorders

4031

17457

1.60

148.31

6.7

7.6

1.30

1.36

mmol/l

2.92

3884

16779

Persons encountering health services for examination and investigation

3930

12461

1.63

148.05

7.6

7.0

1.39

1.35

mmol/l

1.44

3746

12054

Disorders resulting from impaired renal tubular function

385

973

5.28

147.87

14.6

8.7

1.05

1.41

mmol/l

12.69

378

936

Respiratory insufficiency

604

1993

3.46

147.71

14.9

5.7

1.36

1.41

mmol/l

0.45

560

1935

Injuries to the knee and lower leg

6678

27207

1.44

146.91

7.2

7.1

1.36

1.35

mmol/l

0.39

6428

26177

Other respiratory disorders and diseases

1387

6787

2.24

146.79

12.4

6.3

1.40

1.39

mmol/l

0.05

1306

6470

Other diseases of the respiratory system

1387

6787

2.24

146.79

12.4

6.3

1.40

1.39

mmol/l

0.05

1306

6470

Aortic aneurysm

1538

7676

2.14

145.94

10.0

6.4

1.35

1.41

mmol/l

1.15

1487

7346

Gastroduodenal ulcer

1721

9055

2.04

145.55

8.0

6.2

1.49

1.39

mmol/l

2.61

1658

8658

Other special examinations and investigations of persons without complaint or reported diagnosis

3879

12461

1.63

144.23

7.5

7.0

1.37

1.35

mmol/l

0.48

3646

12054

Other disorders of teeth and supporting structures

1322

6365

2.24

144.12

9.2

6.7

1.32

1.38

mmol/l

1.38

1270

6128

Sub-endpoint used in defining T1D endpoints

1834

9765

1.96

141.04

10.2

6.9

1.37

1.38

mmol/l

0.21

1751

9319

Alcohol withdrawal state with delirium

603

2074

3.46

140.80

9.2

7.9

1.79

1.38

mmol/l

5.47

565

1999

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1528

6503

2.13

140.62

7.5

6.6

1.26

1.42

mmol/l

6.45

1464

6230

Angina pectoris

3518

15145

1.64

140.14

7.4

6.6

1.41

1.33

mmol/l

3.88

3370

14628

Diseases of the myoneural junction and muscle

870

3600

2.73

139.17

9.2

7.1

1.50

1.36

mmol/l

2.50

834

3451

Allergic asthma (mode), excluding more controls

1137

5071

2.31

139.04

6.8

5.9

1.33

mmol/l

0.01

1096

4915

Fracture of lumbar spine and pelvis

1383

6878

2.18

138.88

6.7

6.0

1.46

1.37

mmol/l

1.66

1319

6583

Disorders of lens

3986

16461

1.59

138.54

8.0

7.3

1.37

1.35

mmol/l

0.62

3836

15892

Focal epilepsy

1338

6583

2.20

138.06

6.1

7.4

1.41

1.35

mmol/l

1.20

1258

6302

Finngen Rheumatological endpoints

5417

21390

1.48

137.79

7.2

1.36

1.35

mmol/l

0.17

5202

20548

Coronary revascularization (ANGIO or CABG)

2857

12165

1.73

137.62

8.8

6.4

1.44

1.35

mmol/l

2.95

2739

11742

Bacterial intestinal infections, IBD co-morbidities

1191

5639

2.31

136.79

9.2

6.5

1.40

1.36

mmol/l

0.51

1132

5394

Assault

814

3261

2.73

136.29

7.9

8.1

1.45

1.37

mmol/l

1.01

777

3144

Fracture of femur

1680

8193

2.01

134.76

7.1

5.7

1.39

1.41

mmol/l

0.21

1597

7801

Behavioural syndromes associated with physiological disturbances and physical factors

1657

8793

1.98

134.55

7.0

7.3

1.35

1.33

mmol/l

0.32

1572

8464

Other gastritis (incl. Duodenitis)

1444

7377

2.11

134.30

7.7

6.5

1.40

1.35

mmol/l

0.90

1394

7104

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1090

5031

2.38

133.83

6.3

6.7

1.39

mmol/l

0.03

1063

4846

Kela-code for severe mental illness

2057

11732

1.84

132.90

5.8

7.5

1.45

1.33

mmol/l

3.78

1950

11318

Gingivitis and periodontal diseases

5275

18842

1.49

132.70

7.5

6.5

1.30

1.38

mmol/l

5.99

5072

18112

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1012

4446

2.43

132.43

5.5

5.3

1.21

1.35

mmol/l

3.63

985

4286

Spondylosis

3048

16499

1.65

131.06

5.9

7.4

1.31

1.36

mmol/l

1.94

2950

15911

Vascular diseases of the intestine

367

973

4.76

130.01

12.2

6.1

1.68

1.44

mmol/l

1.51

350

930

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1207

5860

2.24

129.80

6.1

6.5

1.30

1.42

mmol/l

3.43

1152

5628

Alcoholic liver disease

750

3001

2.86

129.72

10.6

7.9

2.08

1.36

mmol/l

16.16

709

2875

ILD, hospital admissions 3, with pneumonia sepsis

608

2192

3.20

128.71

11.3

6.0

1.50

1.36

mmol/l

1.70

580

2114

Other cataract

2567

12054

1.73

128.31

7.7

7.0

1.37

1.34

mmol/l

0.56

2458

11613

ILD medications: azathioprine

900

3880

2.51

128.18

12.7

6.8

1.30

1.35

mmol/l

0.89

861

3727

Symptoms and signs involving the skin and subcutaneous tissue

3707

24543

1.56

127.89

7.0

1.32

1.34

mmol/l

0.86

3570

23634

Congenital malformations, deformations and chromosomal abnormalities

3000

18200

1.64

127.60

8.4

7.2

1.32

1.34

mmol/l

0.47

2906

17528

Other specified and unspecified personality disorders

608

2181

3.11

127.55

7.7

7.3

1.39

1.34

mmol/l

0.51

571

2100

Disorder of lipoprotein metabolism, unspecified

909

3974

2.53

127.54

8.9

6.1

1.39

1.37

mmol/l

0.20

881

3826

Undetermined asthma, excluding more controls

701

2684

2.82

127.53

7.8

5.5

1.25

1.33

mmol/l

1.46

664

2599

Other diseases of intestine

815

3395

2.67

127.35

11.8

6.8

1.40

1.36

mmol/l

0.38

791

3252

Sleep disorders (combined)

5459

25352

1.45

126.82

7.4

7.1

1.36

1.34

mmol/l

0.38

5230

24483

Panic disorder

775

3124

2.66

126.49

8.1

7.0

1.37

1.33

mmol/l

0.44

738

3016

Abnormalities of gait and mobility

862

3718

2.62

126.49

8.6

6.9

1.31

1.37

mmol/l

0.85

835

3564

Disorders of other endocrine glands

2385

14132

1.74

126.22

8.4

6.8

1.31

1.35

mmol/l

1.14

2307

13558

Malignant neoplasm of digestive organs

2320

13725

1.77

126.00

6.9

6.4

1.40

1.38

mmol/l

0.19

2227

13158

Diseases of oral cavity, salivary glands and jaws

5335

19158

1.47

125.84

7.8

6.6

1.33

1.38

mmol/l

3.36

5123

18386

Enterocolitis due to Clostridium difficile

769

3146

2.75

125.78

9.8

6.4

1.45

1.38

mmol/l

0.73

728

3008

Delirium, not induced by alcohol and other psychoactive substances

811

3412

2.67

124.82

9.2

6.2

1.54

1.40

mmol/l

1.61

769

3247

Other pleural conditions

762

3133

2.76

124.08

7.2

6.2

1.33

1.41

mmol/l

1.16

719

2995

Hernia of abdominal wall

2614

16237

1.69

123.92

7.7

7.1

1.38

1.36

mmol/l

0.33

2532

15626

Chronic periodontitis, complicated

706

2814

2.88

123.27

15.1

7.7

1.27

1.37

mmol/l

1.23

683

2707

Disorders of choroid and retina

4565

23029

1.49

123.19

7.8

6.8

1.36

mmol/l

0.02

4370

22189

Primary_lymphoid and hematopoietic malignant neoplasms

1378

7128

2.08

123.17

8.6

6.7

1.41

mmol/l

0.03

1333

6831

Other retinal disorders

3631

19395

1.57

122.96

7.6

6.6

1.36

mmol/l

0.11

3464

18673

Dysphagia

1374

7096

2.07

122.74

7.4

6.6

1.34

1.35

mmol/l

0.15

1315

6815

Focal epilepsy, strict definition

1225

6103

2.17

122.39

6.2

7.3

1.44

1.35

mmol/l

1.59

1153

5839

Other complications of surgical and medical care, not elsewhere classified

638

2407

2.96

122.03

10.2

6.6

1.29

1.35

mmol/l

0.77

614

2326

Amputation of toe

579

2108

3.25

122.03

11.6

7.0

1.39

1.41

mmol/l

0.13

556

2029

Traumatic subdural haemorrhage

869

3730

2.52

121.42

7.4

6.3

1.53

1.36

mmol/l

3.05

832

3572

Coronary artery bypass grafting

1810

7726

1.91

121.24

10.4

6.3

1.39

1.36

mmol/l

0.54

1743

7443

Autoimmune diseases related-to ILD

4578

28098

1.48

121.04

7.6

6.9

1.35

mmol/l

0.02

4388

27088

Mental and behavioural disorders due to use of other stimulants, including caffeine

256

535

5.87

120.88

8.8

7.8

1.40

1.43

mmol/l

0.16

241

515

Allergic asthma (mode)

1137

5362

2.18

120.87

6.8

6.1

1.33

1.34

mmol/l

0.10

1096

5197

Polyneuropathies and other disorders of the peripheral nervous system

1381

7238

2.07

120.40

7.9

7.1

1.36

1.37

mmol/l

0.08

1333

6938

Cholelithiasis, broad definition with cholecystitis

4697

22443

1.48

120.30

6.9

6.7

1.39

1.33

mmol/l

2.49

4537

21588

Chronic viral hepatitis

402

1178

3.96

119.86

8.7

7.9

1.43

1.38

mmol/l

0.35

384

1139

Other and unspecified effects of external causes

1467

7795

1.99

119.56

7.4

7.5

1.41

1.33

mmol/l

1.70

1411

7497

Other intervertebral disc disorders

4564

19315

1.49

119.33

7.2

7.4

1.34

1.36

mmol/l

0.87

4409

18602

Benign neoplasm: Colon, unspecified

1368

7123

2.05

118.39

7.0

6.7

1.36

1.40

mmol/l

0.76

1303

6838

Decubitus ulcer and pressure area

481

1606

3.56

118.08

10.2

6.6

1.46

1.40

mmol/l

0.43

461

1532

Diabetic nephropathy

1185

5925

2.23

117.46

12.8

7.8

1.29

1.55

mmol/l

13.93

1141

5669

Fracture of lower leg, including ankle

2985

19248

1.61

117.07

8.0

7.0

1.37

1.35

mmol/l

0.54

2871

18563

Focal epilepsy, mode (most common among epilepsy diagnosis)

1156

5731

2.18

117.06

5.8

7.3

1.43

1.35

mmol/l

1.60

1090

5487

Other disorders of kidney and ureter

876

3928

2.49

116.80

11.3

6.9

1.17

1.37

mmol/l

6.61

857

3787

Mixed and other personality disorders

525

1828

3.21

116.30

5.9

7.6

1.35

1.33

mmol/l

0.13

502

1766

Azathioprine

900

4048

2.40

116.21

12.7

7.2

1.30

1.35

mmol/l

0.73

861

3889

Alcohol-induced chronic pancreatitis

527

1874

3.31

115.54

12.1

8.0

1.69

1.39

mmol/l

2.54

512

1807

Other and unspecified polyneuropathies, also in other diseases

1223

6249

2.14

115.19

7.9

7.0

1.36

1.37

mmol/l

0.07

1181

5979

Parodontitis and operation codes

4647

25467

1.46

114.87

8.5

7.0

1.30

1.35

mmol/l

2.35

4500

24588

Other disorders of glucose regulation and pancreatic internal secretion

609

2325

2.96

114.71

10.4

7.5

1.47

1.41

mmol/l

0.73

580

2233

Visual disturbances and blindness

2741

17523

1.63

114.29

7.7

6.8

1.30

1.36

mmol/l

2.37

2640

16842

Osteoporosis

1499

7789

1.97

114.23

7.5

5.6

1.36

mmol/l

0.03

1438

7474

Acute peritonitis

512

1801

3.33

114.17

12.2

7.4

1.43

1.40

mmol/l

0.19

491

1732

Other viral hepatitis

453

1473

3.51

114.02

9.6

8.2

1.42

1.35

mmol/l

0.55

434

1418

Speech therapy

1585

8808

1.92

113.71

7.5

7.0

1.29

1.34

mmol/l

1.14

1550

8457

Diseases of the eye and adnexa

4511

15605

1.48

112.81

8.1

7.7

1.35

mmol/l

0.04

4322

15055

Injuries to the shoulder and upper arm

4583

27158

1.46

112.72

6.9

7.1

1.38

1.36

mmol/l

0.74

4425

26142

Ventral hernia

1416

7626

1.99

112.32

7.5

6.6

1.37

1.36

mmol/l

0.17

1375

7346

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

979

4361

2.31

111.82

7.3

6.1

1.19

1.43

mmol/l

10.19

942

4159

Gastric ulcer

1152

5806

2.15

111.79

7.9

6.2

1.48

1.37

mmol/l

2.40

1112

5563

Undetermined asthma

701

2866

2.64

111.51

7.8

5.8

1.25

1.34

mmol/l

1.73

664

2777

Senile cataract

3601

14984

1.55

111.47

7.6

7.3

1.38

1.34

mmol/l

1.02

3463

14470

Other and unspecified myopathies

632

2508

2.88

111.21

9.6

6.7

1.53

1.39

mmol/l

1.97

607

2408

Non-selective monoamine reuptake inhibitors

2107

12346

1.73

109.98

6.4

6.7

1.40

1.32

mmol/l

2.29

2038

11922

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

591

2266

2.92

109.91

7.4

6.8

1.43

1.37

mmol/l

0.64

569

2180

Benign neoplasm of other and ill-defined parts of digestive system

986

4719

2.26

109.62

8.2

6.4

1.31

1.39

mmol/l

1.47

942

4548

Injuries to the ankle and foot

3472

21343

1.53

109.58

7.3

7.4

1.33

1.34

mmol/l

0.29

3346

20569

Fungal Sepsis

322

875

4.53

109.51

16.4

6.0

1.41

1.35

mmol/l

0.33

311

843

Other diseases of anus and rectum

1624

9152

1.87

109.51

6.9

6.5

1.39

1.37

mmol/l

0.20

1560

8772

Acidosis

224

469

6.60

108.96

11.3

6.7

2.21

1.37

mmol/l

3.96

214

450

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1293

5646

2.05

108.65

7.1

6.4

1.25

1.42

mmol/l

6.83

1241

5399

Dental pulpitis 4

6056

23117

1.39

107.90

7.3

6.8

1.35

mmol/l

0.12

5824

22225

Diseases of pulp and periapical tissues, including avohilmo

6044

23071

1.39

107.73

7.4

6.8

1.35

mmol/l

0.08

5813

22178

Visual disturbances

2512

15966

1.64

107.48

7.7

6.8

1.28

1.36

mmol/l

3.45

2421

15352

Acute upper respiratory infections

5683

26069

1.40

107.42

7.3

6.9

1.33

1.35

mmol/l

0.69

5437

25121

Dental pulpitis 1

6052

23122

1.39

107.37

7.4

6.8

1.35

mmol/l

0.12

5821

22229

Persons encountering health services in other circumstances

1931

11469

1.75

107.02

6.8

6.7

1.38

1.36

mmol/l

0.39

1773

11098

COPD-related respiratory insufficiency

827

3761

2.46

106.86

13.1

6.2

1.34

1.40

mmol/l

0.96

769

3597

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5275

24920

1.42

106.76

7.5

7.1

1.38

1.35

mmol/l

1.11

5087

23991

Noninfective enteritis and colitis

2493

15807

1.64

106.67

7.7

7.3

1.33

1.36

mmol/l

0.85

2389

15194

Symptoms and signs concerning food and fluid intake

617

2445

2.77

105.88

8.0

7.3

1.37

1.32

mmol/l

0.44

587

2345

Other noninfective gastroenteritis and colitis

1398

7624

1.95

105.60

7.7

7.1

1.31

1.35

mmol/l

0.93

1337

7291

Dermatitis

3216

21626

1.54

105.55

7.5

6.9

1.38

1.34

mmol/l

0.92

3097

20846

Mycoses

1479

8225

1.91

105.49

9.2

6.9

1.37

1.34

mmol/l

0.52

1428

7905

Persistent mood disorders

1076

5379

2.13

105.19

6.7

7.0

1.42

1.31

mmol/l

2.35

1023

5191

KRA_PSY_EATING, excluding more controls

372

1100

3.61

105.07

7.9

6.5

1.20

1.25

mmol/l

0.51

350

1065

Hypoglycaemia, other or unspecified

497

1791

3.17

104.86

10.6

7.8

1.49

1.42

mmol/l

0.68

470

1722

Insulin, fast-acting (human)

848

3882

2.35

104.59

10.8

6.7

1.34

mmol/l

0.02

816

3731

Glomerulonephritis

701

2999

2.62

104.11

12.3

7.5

1.21

1.37

mmol/l

3.96

678

2880

Sequelae of cerebrovascular disease

2041

10899

1.74

103.60

6.6

6.3

1.42

1.39

mmol/l

0.77

1936

10449

Nerve, nerve root and plexus disorders

5741

26639

1.39

103.09

6.9

7.1

1.35

mmol/l

0.05

5550

25632

Benign neoplasm: Sigmoid colon

1025

5100

2.18

103.04

7.5

6.8

1.31

1.40

mmol/l

2.41

996

4914

Fracture of shoulder and upper arm

1983

12022

1.73

103.02

7.4

6.9

1.40

1.35

mmol/l

0.85

1898

11533

Cystic kidney disease

306

842

4.55

102.95

9.2

8.0

1.04

1.40

mmol/l

5.84

296

803

Cholelithiasis

4432

22080

1.45

102.78

6.8

6.6

1.39

1.33

mmol/l

2.39

4282

21238

Unspecified acute lower respiratory infection

915

4365

2.27

102.66

9.5

7.3

1.42

1.40

mmol/l

0.31

874

4182

Other and unspecified dermatitis

2676

17420

1.60

102.61

7.4

6.8

1.39

1.35

mmol/l

1.39

2577

16786

Chronic gastritis

1632

9433

1.84

102.17

7.8

6.1

1.38

1.35

mmol/l

0.51

1575

9064

Transient ischemic attack

2940

16157

1.57

101.80

6.5

1.35

1.36

mmol/l

0.28

2816

15552

Other headache syndromes

2092

12875

1.69

101.17

6.7

6.9

1.31

1.32

mmol/l

0.10

2016

12473

Poisoning by narcotics and psychodysleptics [hallucinogens]

171

295

7.60

100.72

8.0

7.3

1.42

1.43

mmol/l

0.03

158

281

Fracture of skull and facial bones

1187

6238

2.02

100.66

8.1

7.4

1.48

1.34

mmol/l

3.44

1137

6008

Other respiratory diseases principally affecting the interstitium

1117

5803

2.09

100.17

11.2

6.5

1.43

1.38

mmol/l

0.74

1058

5556

Colorectal cancer

1425

7995

1.91

100.00

6.1

6.6

1.32

1.38

mmol/l

1.10

1367

7679

Elevated blood glucose level

578

2310

2.82

99.54

11.5

7.3

1.44

1.39

mmol/l

0.60

555

2220

Misadventures to patients during surgical and medical care

839

3933

2.32

98.81

8.5

6.5

1.34

1.35

mmol/l

0.07

808

3779

Implicit fungal Sepsis

292

797

4.50

98.75

16.8

6.0

1.41

1.36

mmol/l

0.31

282

768

All influenza (not pneumonia)

849

3998

2.28

97.56

8.8

6.6

1.34

1.37

mmol/l

0.48

817

3844

Emergency coronary revascularization (for ACS)

3267

16026

1.53

96.53

8.4

6.5

1.44

1.38

mmol/l

2.15

3125

15399

Endocarditis

290

796

4.38

96.52

14.7

6.3

1.29

1.35

mmol/l

0.39

274

766

Other and unspecified drugs and medicaments

561

2244

2.81

96.27

7.5

7.3

1.44

1.36

mmol/l

0.89

539

2158

Use of disulfiram, acamprosate or naltrexone

592

2430

2.72

95.88

8.1

8.5

1.59

1.35

mmol/l

5.46

561

2347

Cirrhosis of liver, NAS

410

1415

3.48

95.79

10.6

7.7

1.90

1.39

mmol/l

7.15

392

1356

Haemorrhage, not elsewhere classified

298

842

4.23

95.04

10.5

6.8

1.48

1.38

mmol/l

0.48

287

810

Iron deficiency anaemia secondary to blood loss (chronic)

966

4854

2.15

94.55

8.9

6.2

1.45

1.37

mmol/l

1.11

920

4668

Total colectomy operation

341

1059

3.83

94.23

9.4

7.7

1.37

1.36

mmol/l

0.03

330

1020

Total colectomy

341

1059

3.83

94.23

9.4

7.7

1.37

1.36

mmol/l

0.03

330

1020

Superficial injury of lower leg

1288

7088

1.92

94.20

6.7

7.0

1.44

1.33

mmol/l

2.32

1242

6825

Diseases of the musculoskeletal system and connective tissue

3021

10009

1.55

94.04

7.4

7.9

1.35

1.38

mmol/l

0.49

2893

9571

Diseases of peritoneum

673

2955

2.53

93.82

10.5

7.0

1.43

1.37

mmol/l

0.53

647

2834

Open wound of lower leg

869

4211

2.23

93.70

7.8

7.0

1.38

1.35

mmol/l

0.18

830

4031

Missing teeth due to accident, extraction or parodontitis

713

3202

2.44

93.62

9.9

6.8

1.26

1.37

mmol/l

2.17

689

3095

Shoulder lesions

4210

18382

1.44

93.41

6.1

7.2

1.32

1.36

mmol/l

1.20

4073

17723

Fibrosis and cirrhosis of liver

530

2107

2.88

93.11

10.3

7.0

1.80

1.35

mmol/l

8.31

510

2024

Disorders of mineral metabolism

516

2009

2.87

93.07

9.5

6.3

1.46

1.35

mmol/l

0.80

496

1945

Viral hepatitis

486

1835

2.96

93.07

9.5

7.9

1.41

1.35

mmol/l

0.46

466

1765

Congenital malformations of the urinary system

433

1551

3.21

92.84

9.2

8.1

1.07

1.40

mmol/l

8.14

418

1477

Other and unspecified mood [affective] disorders

395

1339

3.22

90.79

6.8

7.0

1.45

1.30

mmol/l

1.62

376

1286

Dental caries 1

4489

16520

1.43

90.68

7.1

6.8

1.36

mmol/l

0.01

4313

15856

Other diseases of pericardium

328

1014

3.78

90.62

11.8

6.6

1.36

mmol/l

0.02

314

979

severe traumatic brain injury, does not include concussion

1315

7410

1.90

90.51

7.9

6.6

1.52

1.39

mmol/l

3.21

1257

7071

Dental caries, including avohilmo

4484

16507

1.43

90.50

7.1

6.8

1.36

mmol/l

0.03

4308

15841

Sleep disorders

1108

5894

1.99

90.29

6.8

7.4

1.41

1.33

mmol/l

1.14

1045

5668

Disturbances of skin sensation

1350

7640

1.86

89.75

6.1

7.3

1.27

1.33

mmol/l

1.62

1302

7391

Enlarged lymph nodes

809

3869

2.22

88.87

8.1

7.3

1.38

1.31

mmol/l

0.92

782

3732

Gastro-oesophageal reflux disease

3513

21916

1.46

88.86

7.1

6.9

1.33

1.34

mmol/l

0.37

3366

21130

In situ neoplasms

1669

9559

1.74

88.84

6.6

6.0

1.32

1.37

mmol/l

1.21

1611

9168

Nonorganic sleeping disorders

984

5060

2.06

88.81

6.8

7.3

1.42

1.34

mmol/l

1.11

928

4870

Colorectal adenocarcinoma

1207

6684

1.95

88.77

6.1

6.6

1.30

1.38

mmol/l

1.74

1152

6417

Hydronephrosis

671

3001

2.44

88.74

7.6

6.1

1.37

1.35

mmol/l

0.17

647

2886

Suppurative and necrotic conditions of lower respiratory tract

425

1554

3.20

88.61

10.7

7.4

1.32

1.44

mmol/l

1.65

405

1493

Cerebral palsy and other paralytic syndromes

708

3243

2.38

88.51

7.7

7.4

1.33

1.37

mmol/l

0.38

674

3113

Coagulation defects, purpura and other haemorrhagic conditions

1075

5721

2.01

88.46

9.6

6.9

1.45

1.35

mmol/l

1.69

1037

5481

Myocarditis

272

743

4.05

88.25

15.8

5.9

1.35

1.36

mmol/l

0.04

262

717

Complications of internal orthopaedic prosthetic devices, implants and grafts

1258

7047

1.90

88.13

7.6

5.8

1.36

mmol/l

0.02

1216

6774

Other local infections of skin and subcutaneous tissue

634

2784

2.51

88.03

10.1

7.2

1.31

1.35

mmol/l

0.46

606

2670

Lumbar disc prolapse

3278

18104

1.48

87.57

7.6

1.33

1.35

mmol/l

0.59

3172

17481

Other and unspecified local infections of skin and subcutaneous tissue

602

2592

2.57

87.57

10.3

7.4

1.31

1.36

mmol/l

0.65

580

2484

ILD, hospital admissions

931

4770

2.13

87.39

11.0

6.6

1.46

1.38

mmol/l

1.25

884

4572

Oesophageal varices

346

1143

3.66

87.30

10.7

8.2

1.97

1.36

mmol/l

6.82

330

1093

Unstable angina pectoris

2222

11908

1.62

87.06

6.6

6.2

1.45

1.35

mmol/l

3.22

2116

11481

Generalized anxiety disorder

703

3197

2.32

87.06

5.9

6.9

1.36

1.32

mmol/l

0.37

669

3085

Dental pulpitis 2

4054

14789

1.44

87.05

6.9

6.7

1.36

1.35

mmol/l

0.22

3888

14178

Benign neoplasm: Rectum, anus and anal canal

1064

5679

2.01

86.92

6.8

6.6

1.31

1.41

mmol/l

2.31

1018

5464

Later onset COPD

1716

8232

1.74

85.40

6.7

5.6

1.39

1.41

mmol/l

0.45

1620

7873

Other interstitial pulmonary diseases

938

4856

2.11

85.38

11.0

6.5

1.46

1.38

mmol/l

1.22

891

4655

Mental and behavioural disorders due to cannabinoids

221

539

4.76

85.24

8.1

7.6

1.61

1.47

mmol/l

0.49

209

519

Symptoms and signs involving the nervous and musculoskeletal systems

2993

20700

1.50

85.23

7.2

6.9

1.35

mmol/l

0.00

2877

19927

Persons with potential health hazards related to communicable diseases

1741

10585

1.69

85.20

11.3

7.5

1.24

1.34

mmol/l

3.03

1467

10263

Dental pulpitis 2, only avohilmo

4122

15136

1.43

85.02

7.0

6.8

1.36

mmol/l

0.15

3953

14513

Interstitial lung disease

938

4867

2.10

84.82

11.0

6.5

1.46

1.38

mmol/l

1.25

891

4662

Interstitial lung disease endpoints

938

4867

2.10

84.82

11.0

6.5

1.46

1.38

mmol/l

1.25

891

4662

Disorders of eyelid, lacrimal system and orbit

4405

25429

1.39

84.29

6.0

7.1

1.32

1.36

mmol/l

1.70

4258

24464

Benign neoplasm: Rectum

954

4970

2.06

84.11

6.9

6.8

1.29

1.40

mmol/l

2.93

915

4800

Other diseases of biliary tract

571

2454

2.60

84.03

9.3

6.8

1.44

1.37

mmol/l

0.65

556

2347

Dental pulpitis 4, only avohilmo

6020

23966

1.34

83.99

6.9

7.0

1.34

1.35

mmol/l

0.28

5786

23053

Other diseases of blood and blood-forming organs, wide

1219

6882

1.89

83.12

9.2

6.9

1.43

1.33

mmol/l

1.69

1182

6621

Idiopathic gout

633

2875

2.48

82.82

9.5

7.1

1.43

1.40

mmol/l

0.15

601

2762

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

754

3634

2.26

82.58

7.8

6.1

1.36

1.45

mmol/l

0.88

728

3461

Migraine

2121

11604

1.60

82.46

6.1

7.0

1.27

1.30

mmol/l

1.04

2036

11234

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

341

1154

3.51

82.02

7.4

6.8

1.18

1.42

mmol/l

5.93

333

1115

Systemic connective tissue disorders

1818

11426

1.66

81.90

8.1

6.2

1.34

mmol/l

0.05

1743

10995

Hyperkinetic disorders, excluding more controls

401

1396

2.95

81.72

8.2

8.4

1.40

1.30

mmol/l

0.76

376

1339

Thoracic aortic aneurysm

838

4237

2.16

81.65

10.6

7.1

1.32

1.39

mmol/l

1.15

819

4090

Viral infections characterized by skin and mucous membrane lesions

2142

13965

1.59

81.59

8.1

7.2

1.34

1.36

mmol/l

0.32

2061

13435

Other embolism and thrombosis

786

3874

2.20

81.40

9.4

7.0

1.45

1.34

mmol/l

1.15

768

3721

Benign neoplasm: Transverse colon

604

2697

2.48

81.17

6.4

6.6

1.41

1.40

mmol/l

0.05

589

2593

Malignant neoplasm of urinary organs

667

3117

2.39

80.87

7.9

6.8

1.16

1.39

mmol/l

11.51

648

2993

Dental caries 3

4664

17615

1.39

80.42

6.9

1.37

1.36

mmol/l

0.35

4475

16903

Exclusions for E4_PCOS_CONSORTIUM

3366

14841

1.46

80.39

6.8

1.27

1.32

mmol/l

1.53

3230

14301

Myalgia

1125

6230

1.90

80.38

7.5

7.0

1.31

1.32

mmol/l

0.13

1084

6015

Acute sinusitis

2475

15492

1.53

80.38

7.0

7.1

1.32

1.34

mmol/l

0.34

2374

14977

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

855

3907

2.08

80.04

8.3

8.2

1.39

1.34

mmol/l

0.62

811

3728

Dental pulpitis 1, only avohilmo

6006

24067

1.33

80.03

6.8

7.1

1.34

1.35

mmol/l

0.33

5773

23151

Primary_lymphoid and hematopoietic malignant neoplasms

1378

8151

1.80

80.03

8.6

6.8

1.41

1.37

mmol/l

0.57

1333

7825

Sequelae of other external causes

373

1334

3.19

79.94

9.0

7.2

1.40

1.37

mmol/l

0.13

368

1279

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

391

1428

3.07

79.92

6.1

5.3

1.14

1.32

mmol/l

2.40

385

1378

Pneumonitis due to solids and liquids

553

2398

2.57

79.74

10.1

6.3

1.52

1.44

mmol/l

0.71

518

2281

Other arthritis (FG)

1605

9850

1.70

79.38

7.9

7.1

1.32

1.35

mmol/l

0.42

1545

9467

Abdominal aortic aneurysm (AAA)

678

3168

2.32

79.12

10.1

5.5

1.37

1.46

mmol/l

0.88

648

3016

Toxic effects of substances chiefly nonmedicinal as to source

665

3103

2.32

79.12

8.0

7.5

1.46

1.38

mmol/l

0.97

642

2979

Chronic ulcer of skin, not elsewhere classified

478

1955

2.77

78.96

6.8

1.43

1.38

mmol/l

0.44

458

1878

Speech and linguistic disorders, excluding more controls

405

1402

2.92

78.80

9.3

9.4

1.35

mmol/l

0.04

388

1336

Insomnia

826

4171

2.11

78.79

6.8

7.2

1.38

1.34

mmol/l

0.51

773

4026

Asthma and allergy, excluding more controls

566

2411

2.43

78.74

7.2

5.9

1.32

1.33

mmol/l

0.02

545

2322

Other diseases of liver

964

5149

2.00

78.53

8.9

7.1

1.60

1.30

mmol/l

8.70

933

4962

Non-small cell lung cancer

979

5289

2.00

77.92

7.3

6.1

1.19

1.40

mmol/l

8.12

942

5024

Emphysema

484

2001

2.72

77.71

8.9

6.6

1.41

1.42

mmol/l

0.11

466

1917

ILD, hospital admissions 1, main diag only

824

4228

2.13

77.20

11.1

6.6

1.47

1.37

mmol/l

1.69

789

4055

Congenital malformations of the circulatory system

819

4030

2.12

77.18

13.8

8.2

1.29

1.36

mmol/l

1.03

788

3840

Malignant neoplasm of kidney, except renal pelvis

617

2850

2.42

77.16

7.5

6.8

1.15

1.39

mmol/l

11.35

600

2739

Abnormal involuntary movements

769

3834

2.17

77.09

6.4

7.0

1.36

1.35

mmol/l

0.10

731

3684

Cholecystectomy

3582

22984

1.42

76.26

7.4

6.6

1.33

1.34

mmol/l

0.21

3479

22102

Dermatitis and eczema

5682

28728

1.32

76.14

7.2

1.35

mmol/l

0.03

5457

27648

Failure and rejection of transplanted organs and tissues

151

307

6.82

76.08

14.9

7.8

1.24

1.34

mmol/l

0.34

146

296

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2681

12538

1.51

76.02

6.2

7.0

1.35

1.39

mmol/l

1.12

2578

12067

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

610

2806

2.39

76.02

6.1

6.5

1.31

1.41

mmol/l

1.22

587

2696

Phobic anxiety disorders

594

2668

2.35

75.72

8.2

7.2

1.35

1.34

mmol/l

0.10

573

2567

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1574

9739

1.69

75.58

6.7

7.0

1.47

1.35

mmol/l

3.00

1459

9374

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

594

2711

2.41

75.50

6.0

6.3

1.31

1.41

mmol/l

1.37

571

2603

Benign neoplasm: Ascending colon

715

3503

2.22

75.45

6.8

6.4

1.29

1.39

mmol/l

1.69

682

3377

Diabetic retinopathy, excluding more controls

1508

5099

1.77

75.30

10.9

8.0

1.43

1.52

mmol/l

1.88

1452

4941

Diagnoses used for exclusion with ILD

1419

8583

1.74

75.18

9.4

6.7

1.45

1.38

mmol/l

1.69

1360

8212

Noninfectious colitis NAS

769

3864

2.14

75.03

7.2

6.9

1.30

1.36

mmol/l

0.84

740

3706

Attention to artificial openings

304

1014

3.54

74.78

9.6

7.4

1.21

1.44

mmol/l

3.48

271

975

Hypertensive Renal Disease

269

833

3.75

74.07

9.3

5.6

1.15

1.40

mmol/l

4.33

259

796

Other diseases of pancreas

498

2136

2.62

73.95

10.4

7.1

1.51

1.38

mmol/l

1.39

487

2057

Mental and behavioural disorders due to tobacco

518

2254

2.54

73.69

7.1

7.4

1.43

1.35

mmol/l

0.98

497

2172

Disorders of calcium metabolism

391

1494

2.94

73.53

9.6

5.9

1.49

1.35

mmol/l

0.84

376

1447

Other viral diseases

1410

8507

1.72

73.36

10.7

7.8

1.33

1.35

mmol/l

0.31

1346

8167

Asthma and allergy

566

2490

2.35

73.09

7.2

6.2

1.32

1.33

mmol/l

0.07

545

2402

Subjective visual disturbances

1235

7252

1.79

72.80

6.9

6.6

1.24

1.33

mmol/l

2.14

1189

6997

Appendectomy

3127

21556

1.43

72.66

7.2

1.29

1.34

mmol/l

2.01

3044

20796

Sleep apnoea

4764

24527

1.35

72.57

7.8

7.2

1.35

1.34

mmol/l

0.12

4579

23704

Fall on and from stairs and steps

1329

7973

1.75

72.47

7.4

6.9

1.35

mmol/l

0.00

1270

7673

Left ventricular outflow tract obstruction (LVOTO), broad definition

622

2941

2.32

72.35

14.5

9.2

1.29

1.36

mmol/l

0.83

609

2831

Dental caries 1 and operation codes

4868

18877

1.35

72.30

7.1

6.8

1.35

1.37

mmol/l

0.42

4689

18102

Alcohol-induced acute pancreatitis

297

1001

3.54

72.23

11.7

8.7

1.64

1.41

mmol/l

1.69

287

970

Type 1 diabetes, definitions combined

527

2303

2.44

71.93

9.8

7.5

1.31

1.32

mmol/l

0.08

506

2195

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

427

1724

2.77

71.90

8.0

6.6

1.16

1.40

mmol/l

5.06

419

1657

Osteomyelitis

443

1829

2.74

71.74

10.4

7.2

1.28

1.42

mmol/l

1.73

431

1765

Arthropathies

4784

18351

1.35

71.68

6.9

7.6

1.33

1.36

mmol/l

1.08

4590

17592

Extreme obesity with alveolar hypoventilation

308

1061

3.41

71.67

11.0

7.2

1.48

1.36

mmol/l

0.95

294

1025

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1234

7284

1.78

71.46

8.8

7.4

1.52

1.26

mmol/l

21.05

1202

7058

Smoking dependency

518

2287

2.50

71.30

7.1

7.4

1.43

1.36

mmol/l

0.91

497

2207

L04AX Other immunosuppressants

2710

19041

1.47

70.81

9.0

7.1

1.31

1.34

mmol/l

0.58

2601

18375

Soft tissue disorders related to use, overuse and pressure

1376

8372

1.72

70.75

6.9

7.1

1.31

1.35

mmol/l

0.93

1325

8072

Parodontitis or/and operation codes

3180

13482

1.44

70.55

8.5

6.9

1.31

1.34

mmol/l

0.81

3075

13056

Benign neoplasm of other and ill-defined parts of digestive system

986

5503

1.92

70.37

8.2

6.6

1.31

1.33

mmol/l

0.24

942

5319

Type 1 diabetes, strict (exclude DM2)

522

2297

2.42

70.14

9.8

8.0

1.31

1.32

mmol/l

0.07

501

2190

Assault by bodily force

426

1725

2.69

70.01

7.6

7.7

1.40

1.37

mmol/l

0.25

405

1662

Second line medication for Crohn's disease

2763

19523

1.46

69.92

9.0

7.1

1.31

1.34

mmol/l

0.74

2652

18844

Schizophrenia

861

4595

1.99

69.86

6.0

8.0

1.45

1.35

mmol/l

1.68

818

4430

Polyuria

1209

7163

1.79

69.52

6.7

6.8

1.30

1.37

mmol/l

1.46

1157

6897

Benign neoplasm: Colon, unspecified

1368

8387

1.73

69.51

7.0

6.6

1.36

mmol/l

0.04

1303

8074

Pyothorax

322

1160

3.25

69.21

11.0

7.5

1.31

1.45

mmol/l

1.62

308

1115

Injuries to the elbow and forearm

3414

22582

1.40

68.95

7.1

7.0

1.33

1.35

mmol/l

0.33

3258

21765

Aneurysms, operations, SAH

897

4884

1.96

68.94

7.6

6.7

1.33

1.35

mmol/l

0.22

867

4706

Lung diseases due to external agents

839

4488

2.01

68.72

8.8

6.3

1.48

1.41

mmol/l

0.98

798

4270

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

670

3323

2.19

68.41

6.1

5.8

1.30

1.41

mmol/l

1.99

636

3177

Certain disorders involving the immune mechanism

1033

5884

1.86

68.31

12.7

7.2

1.33

1.34

mmol/l

0.09

993

5668

Benign neoplasm: Caecum

575

2700

2.34

68.17

7.7

6.5

1.31

1.39

mmol/l

0.95

554

2599

Abnormal serum enzyme levels

1720

11044

1.62

67.89

7.4

7.6

1.37

1.39

mmol/l

0.27

1647

10620

Progressive vascular leukoencephalopathy

278

940

3.59

67.84

3.8

5.1

1.52

1.40

mmol/l

0.80

268

893

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1198

7002

1.76

67.53

10.6

7.0

1.29

1.33

mmol/l

0.78

1142

6713

Other joint disorders

4537

18268

1.35

67.26

6.4

7.5

1.33

1.36

mmol/l

0.94

4370

17518

Disorders of parathyroid gland

1121

6487

1.81

66.98

8.6

5.8

1.27

1.35

mmol/l

1.58

1095

6233

Dental caries 1, only avohilmo

4475

17310

1.35

66.22

6.6

7.3

1.37

1.36

mmol/l

0.33

4296

16617

Adverse effects, not elsewhere classified

953

5334

1.88

66.13

7.8

7.2

1.37

1.32

mmol/l

0.75

928

5132

Other specified/unspecified arthritis

1354

8345

1.69

65.91

8.0

7.3

1.29

1.35

mmol/l

1.81

1302

8009

Dental caries 3 and operation codes

5004

19751

1.33

65.55

7.2

6.9

1.35

1.36

mmol/l

0.27

4820

18943

Other disorders involving the immune mechanism, not elsewhere classified

247

789

3.72

65.49

15.7

9.3

1.10

1.35

mmol/l

3.81

240

758

Other systemic involvement of connective tissue (FG)

1286

7798

1.71

65.04

6.9

6.3

1.34

1.33

mmol/l

0.04

1234

7484

Benign neoplasm: Sigmoid colon

1025

5936

1.85

64.75

7.5

6.7

1.31

1.35

mmol/l

0.59

996

5717

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

234

729

3.84

64.72

15.7

9.5

1.07

1.36

mmol/l

5.03

228

702

Nephrotic syndrome

259

860

3.59

64.60

14.6

9.0

1.16

1.35

mmol/l

2.96

249

819

Gonarthrosis [arthrosis of knee](FG)

4025

17801

1.36

64.19

6.0

7.2

1.37

1.35

mmol/l

0.49

3892

17111

Type 1 diabetes, strict definition, subgroup 1

385

1538

2.67

64.04

8.7

6.8

1.33

1.34

mmol/l

0.01

367

1465

Injuries to unspecified part of trunk, limb or body region

582

2811

2.25

63.90

9.2

7.3

1.35

1.39

mmol/l

0.33

564

2700

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

720

3747

2.06

63.81

7.3

6.6

1.54

1.40

mmol/l

1.54

698

3590

Superficial injury of hip and thigh

798

4288

1.98

63.78

5.7

6.1

1.34

1.39

mmol/l

0.93

753

4088

Aortic valve malfunction, age under 60 years

563

2691

2.29

63.77

12.8

8.7

1.30

1.36

mmol/l

0.68

550

2596

Injuries to the neck

1108

6549

1.77

63.45

6.7

7.2

1.35

1.34

mmol/l

0.08

1073

6299

Other/unspecified cytomegaloviral diseases

175

459

4.85

63.44

16.3

10.1

1.35

1.33

mmol/l

0.06

170

444

Emotional disorders starting during childhood or adolecense, excluding more controls

212

596

3.75

63.09

6.3

8.7

1.40

1.38

mmol/l

0.09

192

560

Migraine with aura

986

5626

1.82

63.07

6.0

6.7

1.27

1.28

mmol/l

0.14

941

5460

Dental caries 3, only avohilmo

4674

18320

1.33

62.96

6.4

7.2

1.38

1.35

mmol/l

0.64

4481

17587

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

572

2768

2.26

62.75

9.6

7.1

1.46

1.35

mmol/l

0.97

552

2670

Nonischemic cardiomyopathy

377

1535

2.76

62.72

16.0

7.2

1.50

1.35

mmol/l

1.22

362

1480

IgA nephropathy (IgA glomerulonephritis)

206

607

4.14

62.53

12.3

8.4

1.08

1.36

mmol/l

3.99

201

589

Cytomegalovirus infection, IBD co-morbidity

192

543

4.37

62.13

15.4

9.5

1.33

1.32

mmol/l

0.04

186

523

Clear cell adenocarcinoma of kidney

341

1344

2.97

62.04

7.4

7.3

1.18

1.40

mmol/l

5.24

333

1295

Exclusions for E4_PCOS_BROAD

878

4899

1.90

61.89

9.1

7.8

1.32

1.35

mmol/l

0.32

839

4690

Sleep apnoea, including avohilmo

4928

24930

1.31

61.08

7.5

7.1

1.34

mmol/l

0.08

4734

24083

Hyperparathyroidism

988

5672

1.83

61.05

8.4

5.7

1.27

1.36

mmol/l

1.64

965

5461

Coxarthrosis

2681

12974

1.44

60.99

6.5

7.3

1.36

1.37

mmol/l

0.11

2598

12434

Other metabolic disorders

599

2952

2.15

60.93

9.3

6.1

1.27

1.31

mmol/l

0.57

581

2857

Benign neoplasm of other and unspecified endocrine glands

629

3170

2.12

60.79

6.9

1.23

1.37

mmol/l

3.44

604

3061

Viral and other specified intestinal infections

951

5302

1.82

60.64

8.8

7.3

1.37

1.38

mmol/l

0.02

908

5070

Chronic nephritic syndrome

297

1098

3.13

60.58

12.1

7.6

1.18

1.37

mmol/l

3.04

289

1056

Irritable bowel syndrome

1206

7362

1.70

60.48

6.2

6.5

1.29

1.32

mmol/l

0.44

1150

7104

Pain in thoracic spine

737

3915

1.99

60.44

5.9

7.5

1.30

1.33

mmol/l

0.34

713

3787

Other aneurysm

365

1491

2.76

60.41

10.2

6.6

1.52

1.42

mmol/l

0.47

358

1428

Rotator cuff syndrome

3150

17210

1.40

60.30

6.3

7.3

1.35

mmol/l

0.08

3049

16598

Post-traumatic stress disorder

347

1360

2.71

60.10

7.1

6.8

1.31

mmol/l

0.04

331

1309

Other arthrosis

2713

13941

1.43

59.75

6.8

7.5

1.31

1.36

mmol/l

1.94

2623

13407

Sequelae of injuries, of poisoning and of other consequences of external causes

1179

7229

1.71

58.93

7.8

7.6

1.44

1.34

mmol/l

2.13

1131

6984

Pericarditis

235

771

3.46

58.47

9.9

6.3

1.28

1.36

mmol/l

0.61

223

743

Cytomegaloviral disease

192

565

4.14

58.37

15.4

9.0

1.33

1.32

mmol/l

0.04

186

545

Somatoform disorder

761

4145

1.93

57.67

6.1

7.0

1.32

1.31

mmol/l

0.09

728

4002

Gonarthrosis

3434

14681

1.37

57.61

6.0

7.5

1.38

1.36

mmol/l

0.20

3315

14090

Injury of other and unspecified intrathoracic organs

407

1781

2.54

57.59

8.3

7.4

1.68

1.41

mmol/l

2.24

389

1710

Candidiasis

683

3608

2.02

57.59

12.6

6.7

1.38

1.34

mmol/l

0.37

659

3473

Congenital malformations of heart and great arteries

699

3600

2.01

57.56

14.2

8.5

1.30

1.37

mmol/l

1.00

678

3428

Disorders of psychological development

563

2552

2.16

57.52

8.4

9.1

1.41

1.38

mmol/l

0.27

531

2420

Migraine without aura

775

4228

1.90

57.50

6.8

7.0

1.24

1.28

mmol/l

0.66

743

4091

Type 1 diabetes, strict definition

399

1703

2.49

57.47

9.0

7.3

1.32

1.33

mmol/l

0.01

380

1623

Superficial injury of abdomen, lower back and pelvis

753

4106

1.94

57.16

6.9

1.36

1.35

mmol/l

0.07

729

3933

Paracetamol of NSAID medication

981

2778

1.83

57.13

7.2

8.4

1.40

mmol/l

0.00

938

2644

Coxarthrosis [arthrosis of hip](FG)

2860

15119

1.41

57.03

6.6

6.9

1.36

mmol/l

0.04

2774

14516

Fentanyl

544

2663

2.19

56.84

7.3

5.8

1.33

1.42

mmol/l

1.02

521

2539

Postprocedural disorders of digestive system, not elsewhere classified

242

830

3.42

56.77

8.6

7.9

1.41

1.32

mmol/l

0.62

231

795

Other postsurgical states

391

1690

2.56

56.73

7.0

7.1

1.45

1.38

mmol/l

0.47

375

1623

Other and unspecified injuries of head

369

1555

2.62

56.50

6.8

7.4

1.47

1.36

mmol/l

0.87

356

1500

Arterial embolism and thrombosis

374

1591

2.61

56.20

11.4

5.7

1.41

1.43

mmol/l

0.16

358

1522

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2341

11350

1.46

56.20

6.0

6.8

1.35

1.40

mmol/l

1.06

2255

10913

Other symptoms and signs involving the urinary system

593

3024

2.12

56.11

7.0

7.4

1.25

1.38

mmol/l

2.34

472

2910

Coronary angioplasty

2016

10716

1.50

56.04

6.6

6.4

1.47

1.35

mmol/l

4.17

1919

10343

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

260

934

3.22

55.96

17.7

6.7

1.26

1.48

mmol/l

2.53

251

900

Laparoscopic left hemicolectomy

165

458

4.66

55.78

9.1

7.4

1.12

1.42

mmol/l

2.21

165

438

Deforming dorsopathies

1314

8367

1.63

55.72

6.7

7.2

1.32

1.34

mmol/l

0.21

1273

8080

Phlebitis and thrombophlebitis (not including DVT)

1147

7098

1.70

55.56

7.3

6.9

1.29

1.34

mmol/l

0.72

1103

6834

Functional dyspepsia

1249

7871

1.65

55.54

7.3

6.4

1.33

1.32

mmol/l

0.17

1197

7596

Other infectious diseases

481

2289

2.30

55.23

9.0

6.9

1.34

1.39

mmol/l

0.39

470

2202

Acute and transient psychotic disorders

608

3129

2.07

55.22

6.2

7.8

1.39

1.34

mmol/l

0.57

574

3015

Malignant neoplasm of colon

842

4831

1.87

55.12

6.1

1.33

1.38

mmol/l

0.61

805

4636

Charcot foot

152

397

4.76

55.07

10.2

7.7

1.18

1.37

mmol/l

1.84

146

381

Type of accident

1384

8959

1.61

54.97

6.3

7.1

1.46

1.35

mmol/l

1.99

1277

8627

Injuries to the wrist and hand

4873

27903

1.29

54.94

7.4

7.3

1.37

1.34

mmol/l

0.69

4716

26869

Benign neoplasm: Transverse colon

604

3139

2.11

54.89

6.4

6.8

1.41

1.37

mmol/l

0.41

589

3029

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2265

11033

1.46

54.88

6.0

6.7

1.36

1.39

mmol/l

0.75

2189

10607

Symptoms and signs involving speech and voice

1577

10509

1.56

54.82

7.9

6.7

1.31

1.34

mmol/l

0.55

1516

10132

Arthrosis

3732

15568

1.35

54.76

6.3

7.5

1.38

1.36

mmol/l

0.38

3593

14953

Other viral diseases, not elsewhere classified

912

5313

1.80

54.69

11.6

7.7

1.33

1.36

mmol/l

0.33

872

5091

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2292

11168

1.46

54.58

5.9

6.8

1.36

1.39

mmol/l

0.48

2210

10737

Umbilical hernia

1373

8899

1.61

54.56

8.1

7.5

1.41

1.38

mmol/l

0.31

1327

8571

Volvulus

202

637

3.73

54.50

6.5

6.2

1.40

1.39

mmol/l

0.02

195

608

Purpura and other haemorrhagic conditions

721

3956

1.95

54.36

8.8

7.0

1.48

1.36

mmol/l

1.94

700

3796

Familial hypercholesterolemia

829

4742

1.85

54.20

6.5

6.1

1.46

1.38

mmol/l

0.84

795

4567

Other maltreatment syndromes

214

696

3.50

54.13

7.1

7.5

1.37

1.38

mmol/l

0.05

204

670

Cholangitis (primary sclerosing, PSC)

383

1677

2.53

54.06

10.3

7.2

1.40

mmol/l

0.02

366

1601

Zoster [herpes zoster]

924

5456

1.79

54.01

7.1

6.4

1.31

1.36

mmol/l

0.84

881

5249

Cervicalgia

989

5924

1.75

53.96

5.7

7.1

1.33

1.34

mmol/l

0.09

959

5715

Schizoaffective disorder

413

1857

2.40

53.84

5.2

7.4

1.47

1.32

mmol/l

1.45

395

1786

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

465

2208

2.30

53.69

6.8

6.0

1.31

1.42

mmol/l

1.42

452

2121

Toxic effect of other and unspecified substances

117

253

5.75

53.62

11.1

8.5

1.34

1.33

mmol/l

0.05

112

245

Blood alcohol or alcohol intoxication level

182

542

3.92

53.47

9.0

7.4

1.73

1.35

mmol/l

3.76

171

521

Other diseases of arteries and capillaries

510

2506

2.20

53.43

8.2

6.2

1.34

1.37

mmol/l

0.26

488

2415

Cholecystitis

765

4295

1.89

53.37

6.7

6.3

1.44

1.37

mmol/l

0.91

732

4100

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

236

816

3.23

53.33

13.3

7.7

1.08

1.30

mmol/l

5.19

230

791

Organic, including symptomatic, mental disorders

2600

13687

1.42

53.29

6.0

6.2

1.49

1.36

mmol/l

6.29

2480

13128

Cerebral aneurysm, nonruptured

482

2323

2.25

53.25

6.9

7.0

1.26

1.33

mmol/l

0.93

464

2246

Collagenous colitis

498

2433

2.22

53.14

7.1

6.9

1.31

1.35

mmol/l

0.35

474

2345

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

302

1192

2.81

53.13

6.3

6.7

1.38

1.43

mmol/l

0.34

288

1143

Fracture of foot, except ankle

1105

6836

1.68

53.00

7.7

7.5

1.37

1.33

mmol/l

0.47

1070

6570

Maltreatment syndromes

279

1056

2.88

52.73

6.5

7.9

1.45

1.37

mmol/l

0.51

258

1017

Eating disorder

373

1605

2.45

52.72

7.9

6.5

1.20

1.28

mmol/l

0.95

351

1530

Open wound of ankle and foot

553

2808

2.11

52.65

7.9

7.7

1.35

1.38

mmol/l

0.26

539

2686

Superficial injury of thorax

775

4384

1.87

52.51

8.2

7.0

1.36

1.35

mmol/l

0.12

742

4199

Benign neoplasm: Rectum, anus and anal canal

1064

6583

1.71

52.24

6.8

6.7

1.31

1.36

mmol/l

0.84

1018

6339

Other disorders of eye and adnexa

686

3753

1.94

51.77

7.1

1.27

1.34

mmol/l

1.19

655

3616

Non-follicular lymphoma, hilmo, excluding all cancers

510

2542

2.17

51.50

7.4

6.4

1.54

1.39

mmol/l

1.26

494

2434

Memory loss

551

2836

2.12

51.37

5.1

6.2

1.31

1.36

mmol/l

0.51

524

2717

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1553

10402

1.53

51.30

7.4

7.7

1.31

1.34

mmol/l

0.50

1490

10018

Benign neoplasm: Stomach

492

2421

2.19

51.20

8.1

6.4

1.34

1.38

mmol/l

0.34

468

2342

Vitreous haemorrhage

569

2959

2.08

51.07

10.8

6.9

1.24

1.38

mmol/l

3.15

547

2848

Hepatic failure, not elsewhere classified

253

942

3.09

50.94

15.8

7.8

2.30

1.37

mmol/l

5.63

240

899

Nontraumatic intracranial haemmorrhage

1051

6512

1.70

50.80

8.9

6.3

1.40

1.39

mmol/l

0.17

1007

6237

Radiculopathy

852

4995

1.80

50.76

5.7

7.0

1.34

1.36

mmol/l

0.22

832

4808

Anaemia in chronic diseases classified elsewhere

193

623

3.73

50.73

11.0

8.3

1.29

1.41

mmol/l

0.67

184

594

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1537

10347

1.54

50.71

7.8

6.9

1.26

1.32

mmol/l

1.68

1474

9973

Intentional self-harm by sharp object

170

499

3.89

50.63

7.7

7.2

1.45

1.42

mmol/l

0.09

159

480

Special screening examination for infectious and parasitic diseases

1001

4501

1.71

50.05

7.2

7.4

1.35

1.32

mmol/l

0.35

949

4382

Benign neoplasm: Rectum

954

5816

1.74

49.89

6.9

6.8

1.29

1.35

mmol/l

1.12

915

5599

Mixed disorders of conduct and emotions, excluding more controls

120

273

4.84

49.87

8.6

6.6

1.34

1.40

mmol/l

0.20

110

258

Other diseases of hard tissues of teeth

3045

17091

1.36

49.76

8.9

6.8

1.30

1.36

mmol/l

2.79

2954

16500

Postprocedural endocrine and metabolic disorders, not elsewhere classified

528

2678

2.08

49.63

7.8

6.0

1.24

1.29

mmol/l

0.61

513

2594

Cervicobrachial syndrome

1010

6213

1.69

49.52

4.5

7.6

1.33

1.32

mmol/l

0.03

975

6014

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

392

1791

2.38

49.42

6.5

6.9

1.39

1.43

mmol/l

0.29

374

1716

Pneumothorax

421

1988

2.32

49.31

9.5

6.8

1.30

1.43

mmol/l

1.75

401

1911

Other condition

700

3917

1.89

49.22

7.0

7.3

1.44

1.37

mmol/l

0.57

668

3764

Right hemicolectomy

380

1733

2.44

49.14

9.5

6.3

1.39

1.42

mmol/l

0.14

367

1668

Need for immunization against other single viral diseases

168

508

4.02

49.12

13.0

7.8

1.28

1.37

mmol/l

0.25

163

490

Traumatic subarachnoid haemorrhage

238

874

3.09

48.74

10.1

7.0

1.53

1.35

mmol/l

1.56

230

846

Injury of unspecified body region

436

2098

2.27

48.60

9.9

7.3

1.30

1.40

mmol/l

1.03

420

2008

Laparoscopic right hemicolectomy

364

1647

2.50

48.53

6.5

1.13

1.39

mmol/l

5.98

350

1585

DVT of lower extremities

992

6135

1.70

48.44

6.6

6.7

1.41

1.36

mmol/l

0.56

961

5897

Event of undetermined intent

353

1560

2.47

48.34

6.9

7.8

1.31

1.40

mmol/l

1.08

348

1499

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

364

1638

2.44

48.09

8.9

6.0

1.80

1.44

mmol/l

2.97

348

1563

Disorders of conjunctiva

3814

24958

1.30

48.01

6.9

7.2

1.32

1.34

mmol/l

0.78

3662

24055

Duodenal ulcer

634

3485

1.95

47.73

8.6

6.4

1.53

1.39

mmol/l

1.57

607

3325

Other problems related to primary support group, including family circumstances

522

2603

2.06

47.65

15.9

7.1

1.27

1.34

mmol/l

1.15

501

2465

Other systemic involvement of connective tissue

1311

8667

1.57

47.44

7.0

6.2

1.35

1.33

mmol/l

0.26

1257

8346

Other disorders of lacrimal gland

1550

10599

1.51

47.35

6.3

6.8

1.29

1.33

mmol/l

1.04

1501

10208

Heart failure and hypertrophic cardiomyopathy

159

481

4.17

47.16

17.0

7.5

1.58

1.39

mmol/l

1.01

148

459

Injury of intra-abdominal organs

184

599

3.57

47.00

8.0

7.4

1.65

1.41

mmol/l

1.14

177

576

Overexertion and strenuous or repetitive movements

528

2745

2.06

46.99

8.8

7.4

1.34

1.36

mmol/l

0.17

511

2639

Conjunctivitis

3362

22633

1.32

46.53

6.8

7.3

1.31

1.33

mmol/l

0.55

3231

21820

Benign neoplasm: Ascending colon

715

4123

1.86

46.29

6.8

6.6

1.29

1.36

mmol/l

0.96

682

3975

Dissociative [conversion] disorders

207

718

3.16

46.17

5.7

6.2

1.42

1.37

mmol/l

0.23

190

690

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

357

1622

2.42

46.17

7.6

5.7

1.18

1.45

mmol/l

6.75

338

1559

Agranulocytosis

579

3127

1.98

46.08

8.9

7.3

1.37

1.33

mmol/l

0.34

564

3014

Temporomandibular joint disorders

627

3436

1.89

46.02

6.4

7.0

1.36

1.31

mmol/l

0.54

604

3314

Superficial injury of wrist and hand

882

5362

1.71

45.39

6.9

7.6

1.38

1.33

mmol/l

0.62

846

5150

Budesonide

634

3521

1.89

45.36

6.6

1.30

1.32

mmol/l

0.21

611

3389

Benign neoplasm: Caecum

575

3131

1.99

45.28

7.7

6.7

1.31

1.36

mmol/l

0.50

554

3023

Mental disorders, not otherwise specified

393

1856

2.25

45.05

8.4

7.4

1.34

1.30

mmol/l

0.24

376

1795

Dentofacial anomalies [including malocclusion]

1139

7275

1.60

45.03

9.3

6.8

1.29

1.34

mmol/l

0.92

1095

7018

Chronic rhinitis, nasopharyngitis and pharyngitis

1451

9889

1.51

44.88

7.2

1.25

1.34

mmol/l

3.32

1399

9560

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

524

2761

2.03

44.84

9.0

6.7

1.26

1.42

mmol/l

3.33

497

2643

Disorders of skin appendages

2097

15256

1.41

44.62

8.0

7.1

1.29

1.34

mmol/l

1.16

2026

14703

Tubulo-interstitial nephritis, not specified as acute or chronic

369

1716

2.31

44.37

8.2

5.7

1.25

1.38

mmol/l

2.22

347

1633

Somnolence, stupor and coma

270

1105

2.71

44.20

7.6

7.3

1.49

1.41

mmol/l

0.58

253

1060

Colon adenocarcinoma

670

3843

1.87

44.18

6.1

1.30

1.38

mmol/l

1.27

636

3681

Other eating disorders

232

871

2.85

44.18

7.5

6.8

1.19

1.28

mmol/l

0.97

217

829

Lack of expected normal physiological development

143

346

4.03

44.17

17.1

10.9

1.49

1.34

mmol/l

0.60

132

317

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

573

3151

1.97

43.72

6.2

6.7

1.31

1.38

mmol/l

0.68

550

3032

Adenocarcinoma and papilloma adenocarcinoma of rectum

553

3008

1.99

43.70

6.1

6.8

1.31

1.38

mmol/l

0.82

530

2897

Status epilepticus

240

938

2.88

43.56

7.7

8.1

1.52

1.41

mmol/l

0.57

225

896

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

132

368

4.35

43.45

8.7

7.2

1.05

1.36

mmol/l

5.07

132

357

Other arterial embolism and thrombosis

195

686

3.25

43.42

13.2

5.9

1.29

1.46

mmol/l

1.55

188

656

Pneumonia due to Streptococcus pneumoniae

248

982

2.79

43.35

7.7

6.7

1.72

1.40

mmol/l

1.57

239

949

Other disorders of the musculoskeletal system and connective tissue

743

4395

1.79

43.34

6.9

7.0

1.28

1.35

mmol/l

1.30

712

4240

Other necrotizing vasculopathies

410

2027

2.21

42.78

9.6

6.8

1.31

1.37

mmol/l

0.53

393

1958

Dermatophytosis

683

3969

1.83

42.66

5.9

7.3

1.40

1.36

mmol/l

0.49

664

3820

Heartburn

478

2474

2.04

42.63

7.5

6.9

1.30

1.34

mmol/l

0.35

458

2382

Other diseases of lip and oral mucosa

764

4560

1.76

42.62

8.2

6.6

1.32

1.36

mmol/l

0.44

739

4402

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

706

4133

1.80

42.56

6.0

7.1

1.48

1.40

mmol/l

0.64

688

3974

Neuromuscular dysfunction of bladder

474

2462

2.06

42.43

8.6

7.0

1.31

1.35

mmol/l

0.35

446

2375

Eating disorders

442

2220

2.09

42.41

7.3

6.6

1.21

1.31

mmol/l

1.77

420

2114

Conjunctivitis (acute, non atopic)

1251

8347

1.54

42.37

6.2

7.6

1.35

1.34

mmol/l

0.05

1201

8026

Speech and linguistic disorders

424

2023

2.13

42.10

10.3

9.1

1.35

1.38

mmol/l

0.18

404

1898

Disorders of muscles

513

2737

1.99

42.07

8.8

7.5

1.43

1.34

mmol/l

0.84

496

2632

Open wound of forearm

486

2555

2.03

41.91

7.0

7.1

1.44

1.40

mmol/l

0.33

458

2457

Benign neoplasm: Adrenal gland

374

1796

2.26

41.85

7.6

6.7

1.25

1.39

mmol/l

1.74

364

1742

Hypertrophic cardiomyopathy

274

1170

2.66

41.75

14.1

7.7

1.46

1.39

mmol/l

0.48

260

1126

Diseases of salivary glands

876

5438

1.68

41.62

7.8

6.6

1.34

1.36

mmol/l

0.19

850

5248

Unknown and unspecified causes of morbidity

345

1596

2.30

41.62

4.8

7.1

1.43

1.33

mmol/l

1.03

297

1548

Obsessive-compulsive disorder

272

1134

2.54

41.57

8.8

7.0

1.34

1.36

mmol/l

0.09

261

1086

Other disorders of adrenal gland

265

1108

2.65

41.55

10.6

7.8

1.35

1.36

mmol/l

0.04

252

1062

Other disorders of veins

1780

12773

1.43

41.54

6.8

6.6

1.29

1.31

mmol/l

0.41

1727

12327

Other degenerative diseases of the nervous system

1274

6463

1.54

41.50

5.1

6.2

1.52

1.32

mmol/l

6.56

1213

6211

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

266

1115

2.65

41.49

10.1

6.2

1.20

1.43

mmol/l

4.25

251

1082

Other symptoms and signs involving general sensations and perceptions

244

984

2.77

41.48

6.6

7.0

1.36

1.34

mmol/l

0.14

232

940

Infection of intervertebral disc (pyogenic)

114

301

4.78

41.04

9.1

8.2

1.33

1.39

mmol/l

0.20

109

290

Extrapyramidal and movement disorders

1782

12846

1.43

41.04

5.5

6.6

1.33

1.36

mmol/l

0.75

1721

12329

Toxic effect of ethanol

242

976

2.73

40.74

9.7

8.4

1.62

1.37

mmol/l

2.27

233

939

Inflammatory bowel disease

1450

10070

1.48

40.74

7.7

7.5

1.33

1.35

mmol/l

0.19

1389

9705

Other obstructive and reflux uropathy

241

968

2.72

40.70

6.9

6.4

1.22

1.38

mmol/l

2.14

234

927

Localized swelling, mass and lump of skin and subcutaneous tissue

1455

10127

1.48

40.63

7.7

7.2

1.32

1.35

mmol/l

0.41

1401

9748

Other pulmonary heart/vessel disease

294

1306

2.51

40.60

17.1

7.3

1.56

1.42

mmol/l

0.92

287

1251

Other necrotizing vasculopathies (FG)

350

1662

2.30

40.59

9.0

6.6

1.30

1.37

mmol/l

0.73

335

1598

Disorders of lacrimal system

1872

13608

1.41

40.58

6.1

6.7

1.30

1.33

mmol/l

0.66

1812

13098

Malignant neoplasm of bladder

433

2225

2.11

40.55

8.2

6.3

1.42

1.47

mmol/l

0.23

415

2116

In situ neoplasms

1669

11914

1.45

40.54

6.6

6.0

1.32

1.34

mmol/l

0.39

1611

11441

Adrenocortical insufficiency

224

878

2.87

40.51

10.4

7.7

1.34

1.36

mmol/l

0.10

212

844

Other disorders starting during childhood or adolecense, excluding more controls

204

719

2.91

40.43

10.6

11.8

1.39

1.36

mmol/l

0.13

198

672

Trochanteric bursitis

638

3679

1.82

40.42

6.1

6.2

1.22

1.31

mmol/l

2.02

612

3558

Other disorders of skin and subcutaneous tissue, not elsewhere classified

714

4268

1.76

39.94

6.7

6.5

1.40

1.35

mmol/l

0.74

685

4097

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

414

2101

2.13

39.89

8.5

6.3

1.26

1.36

mmol/l

1.21

399

2019

Viral pneumonia (known virus, not influenza)

175

613

3.36

39.87

9.0

8.3

1.58

1.41

mmol/l

0.71

170

578

Behavioural disorders, excluding more controls

114

298

4.23

39.62

8.0

7.1

1.34

1.39

mmol/l

0.18

107

288

Psychotic depression

291

1281

2.42

39.62

6.6

6.8

1.42

1.31

mmol/l

0.72

275

1242

Abnormal findings on examination of urine, without diagnosis

272

1181

2.56

39.42

9.7

7.3

1.24

1.39

mmol/l

1.62

258

1134

Artrosis, including avohilmo

4293

18981

1.26

39.22

6.2

7.6

1.36

mmol/l

0.03

4121

18255

Secondary right heart disease

270

1176

2.58

39.15

16.6

6.8

1.59

1.40

mmol/l

1.31

264

1125

Emotional disorders and disorders of social functioning with onset specific to childhood

241

970

2.62

38.72

6.4

8.0

1.37

1.39

mmol/l

0.10

221

909

Monoamine oxidase A inhibitors

574

3251

1.86

38.70

7.0

7.2

1.31

1.30

mmol/l

0.04

549

3149

Social phobias

326

1513

2.26

38.64

7.9

7.0

1.39

1.36

mmol/l

0.18

314

1449

Vitamin deficiency, wide

275

1206

2.50

38.61

9.2

7.0

1.58

1.38

mmol/l

1.76

255

1160

Vitamin deficiency

275

1206

2.50

38.61

9.2

7.0

1.58

1.38

mmol/l

1.76

255

1160

Stomatitis and related lesions

403

2039

2.10

38.58

11.5

6.9

1.37

1.40

mmol/l

0.22

393

1965

malignant neoplasm of female genital organs

706

4253

1.75

38.46

5.5

5.2

1.23

1.31

mmol/l

1.29

687

4105

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1620

7476

1.45

38.38

5.0

6.3

1.28

1.31

mmol/l

0.52

1566

7214

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1620

7478

1.45

38.32

5.0

6.3

1.28

1.31

mmol/l

0.52

1566

7216

Mental retardation, excluding more controls

210

800

2.83

38.07

9.1

10.8

1.43

1.32

mmol/l

0.60

193

766

Hemiplegia

298

1359

2.39

38.06

8.0

7.2

1.32

1.37

mmol/l

0.50

285

1304

Oesophagitis

319

1499

2.33

38.02

10.0

7.3

1.45

1.35

mmol/l

0.63

310

1445

Other general symptoms and signs

242

990

2.60

38.01

9.3

8.7

1.34

1.32

mmol/l

0.11

233

943

Coxibs

1528

5661

1.47

38.00

6.0

7.7

1.36

1.40

mmol/l

0.92

1457

5415

Abscess of anal and rectal regions

424

2198

2.05

37.94

8.4

7.6

1.28

1.40

mmol/l

1.72

412

2107

Nonalcoholic fatty liver disease

457

2435

2.00

37.91

8.9

7.6

1.65

1.32

mmol/l

5.05

443

2351

Sequelae of injuries of lower limb

472

2539

1.98

37.89

7.9

7.3

1.39

1.34

mmol/l

0.50

450

2447

Acute posthaemorrhagic anaemia

224

907

2.76

37.86

8.5

6.7

1.52

1.41

mmol/l

0.70

209

869

Dental operations

3626

14756

1.28

37.81

7.1

6.9

1.33

1.38

mmol/l

2.03

3490

14109

Acetic acid derivatives and related substances

1547

5626

1.47

37.66

6.0

7.7

1.38

1.40

mmol/l

0.35

1475

5381

Other diseases of stomach and duodenum

356

1749

2.21

37.64

7.7

6.5

1.46

1.37

mmol/l

0.49

342

1694

Other specified/unspecified hearing loss

459

2463

2.00

37.62

6.7

6.8

1.36

mmol/l

0.02

405

2361

Complications of cardiac and vascular prosthetic devices, implants and grafts

152

508

3.53

37.60

14.9

7.2

1.36

1.41

mmol/l

0.23

143

480

Rheumatoid arthritis

1502

9675

1.45

37.31

6.5

7.1

1.38

1.35

mmol/l

0.41

1447

9283

Cramp and spasm

270

1195

2.49

37.31

5.8

8.4

1.40

1.35

mmol/l

0.21

255

1148

Arthropathies in other diseases classified elsewhere

227

932

2.72

37.24

9.5

7.8

1.26

1.36

mmol/l

0.86

219

900

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

183

679

3.08

37.13

9.2

6.7

1.78

1.50

mmol/l

1.54

174

644

Childhood asthma (age<16), excluding more controls

451

1860

1.98

37.09

7.7

6.5

1.45

1.37

mmol/l

0.56

432

1779

Other and unspecified tonsillitis

1392

8230

1.47

37.03

8.7

8.3

1.36

mmol/l

0.03

1331

7951

Left ventricular outflow tract obstruction, narrow definition

294

1355

2.39

36.94

15.9

9.5

1.23

1.38

mmol/l

2.00

287

1290

Diplopia

641

3806

1.78

36.88

9.2

6.7

1.29

1.36

mmol/l

1.19

618

3665

Other diseases of upper respiratory tract

5779

25159

1.21

36.83

7.2

1.32

1.37

mmol/l

3.56

5552

24190

Immunodeficiencies

272

1214

2.46

36.74

14.0

8.2

1.32

1.35

mmol/l

0.18

254

1161

Urolithiasis

1623

11744

1.43

36.70

6.7

7.2

1.35

1.38

mmol/l

0.52

1572

11274

Unspecified misadventure during surgical and medical care

310

1467

2.32

36.49

8.6

7.2

1.42

1.38

mmol/l

0.24

300

1407

Sulfonylureas

1870

11004

1.40

36.45

7.8

5.9

1.61

1.31

mmol/l

17.16

1778

10527

Unspecified jaundice

278

1259

2.40

36.06

9.9

7.0

1.62

1.36

mmol/l

2.10

263

1203

Migraine with aura and triptan purchases

563

3223

1.81

35.98

4.9

7.2

1.26

1.27

mmol/l

0.07

539

3114

Other orthopaedic follow-up care

302

1415

2.31

35.95

5.7

7.3

1.29

1.35

mmol/l

0.48

297

1373

Fall on same level involving ice and snow

2590

20095

1.32

35.81

7.0

6.9

1.34

1.35

mmol/l

0.14

2478

19401

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

210

844

2.75

35.79

8.4

7.3

1.29

1.34

mmol/l

0.29

203

810

Chronic sinusitis

1919

14270

1.38

35.70

7.0

7.1

1.29

1.34

mmol/l

1.79

1851

13792

Benign neoplasm of other and unspecified endocrine glands

629

3753

1.77

35.65

6.9

7.1

1.23

1.34

mmol/l

2.44

604

3623

Lesion of ulnar nerve

691

4221

1.72

35.59

8.2

7.7

1.37

1.34

mmol/l

0.28

671

4076

Disorders of the thyroid gland

4609

24787

1.23

35.57

7.1

6.9

1.33

1.36

mmol/l

0.76

4430

23868

Fibromyalgia

359

1790

2.11

35.52

6.5

6.0

1.24

1.26

mmol/l

0.17

349

1731

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

266

1197

2.45

35.43

7.4

5.7

1.37

1.48

mmol/l

0.76

259

1151

Calculus of kidney and ureter

1496

10745

1.44

35.41

6.8

7.2

1.35

1.38

mmol/l

0.44

1452

10319

Tobacco use

281

1290

2.37

35.38

7.9

7.8

1.34

1.37

mmol/l

0.12

270

1240

Use of pramipexole

1045

7027

1.55

35.36

7.4

6.6

1.31

1.34

mmol/l

0.38

1011

6767

Personal history of other diseases and conditions

457

2463

1.93

35.35

9.0

6.5

1.31

mmol/l

0.02

429

2341

Childhood asthma (age<16)

451

1893

1.94

35.28

7.7

6.9

1.45

1.39

mmol/l

0.44

432

1812

Other coagulation defects

355

1778

2.14

35.27

10.9

7.3

1.34

1.35

mmol/l

0.07

340

1702

Hypothyroidism, strict autoimmune

3428

18109

1.27

35.23

7.1

6.5

1.35

mmol/l

0.08

3287

17469

Other symptoms and signs involving the digestive system and abdomen

679

4122

1.71

35.20

6.9

6.5

1.26

1.31

mmol/l

0.79

631

3981

Malignant neoplasm of rectum

526

3009

1.88

35.20

6.1

6.7

1.30

1.38

mmol/l

0.73

504

2898

Other extrapyramidal and movement disorders in other diseases

1053

7098

1.54

35.13

5.9

6.7

1.35

mmol/l

0.01

1018

6841

Ulcerative colitis

1115

7583

1.52

35.10

7.3

7.4

1.35

1.34

mmol/l

0.10

1070

7295

Voice disturbances

1176

8092

1.50

35.05

7.9

6.8

1.31

1.32

mmol/l

0.05

1129

7811

Other or ill-defined heart diseases

259

1147

2.42

34.99

11.5

6.7

1.24

1.37

mmol/l

1.44

251

1091

Reimbursement for rheumatic diseases

2643

20574

1.31

34.94

7.8

6.8

1.35

1.34

mmol/l

0.13

2537

19839

Other symptoms and signs involving the circulatory and respiratory systems

314

1505

2.23

34.93

7.7

7.1

1.39

1.37

mmol/l

0.12

270

1454

Ptosis of eyelid

560

3264

1.83

34.87

8.0

6.8

1.24

1.35

mmol/l

2.50

542

3143

Amputation of ankle bones

160

575

3.25

34.81

13.7

7.2

1.41

1.50

mmol/l

0.38

154

547

Dipeptidyl peptidase 4 (DPP-4) inhibitors

607

3618

1.78

34.77

8.9

6.6

1.57

1.27

mmol/l

6.98

581

3489

Carcinoma in situ of skin of other and unspecified parts of face

405

2146

2.04

34.64

5.2

1.38

1.48

mmol/l

1.11

386

2052

Melanocytic naevi

1102

7487

1.51

34.55

7.0

6.8

1.28

1.37

mmol/l

2.52

1066

7216

Benign neoplasm: Descending colon

339

1691

2.17

34.46

6.2

6.3

1.35

1.41

mmol/l

0.45

326

1634

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

319

1555

2.21

34.30

9.8

5.8

1.32

1.49

mmol/l

1.64

312

1483

Focal brain injury

339

1684

2.15

34.30

8.8

7.2

1.55

1.33

mmol/l

2.84

323

1628

Degeneration of macula and posterior pole

2302

14571

1.34

34.24

5.5

6.1

1.37

mmol/l

0.04

2197

14000

Benign neoplasm of meninges

440

2396

1.94

33.97

6.3

6.1

1.44

1.38

mmol/l

0.43

427

2316

Superficial injury of ankle and foot

508

2881

1.84

33.93

6.7

7.6

1.31

1.34

mmol/l

0.41

491

2751

Thrombocytopenia, unspecified

381

1992

2.06

33.90

9.6

7.4

1.53

1.39

mmol/l

1.32

368

1917

Covid-19 suspected case

838

5400

1.60

33.83

8.2

6.7

1.37

1.33

mmol/l

0.57

826

5193

Isolated proteinuria

188

743

2.86

33.66

9.5

7.5

1.26

1.40

mmol/l

1.08

182

711

Abscess of lung

122

384

3.82

33.59

7.2

7.3

1.41

mmol/l

0.03

116

370

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

419

2262

1.98

33.56

6.0

5.8

1.50

1.43

mmol/l

0.49

410

2165

Urticaria and erythema

1531

11119

1.41

33.27

7.3

7.2

1.30

1.32

mmol/l

0.37

1470

10718

Immunodeficiency with predominantly antibody defects

165

613

3.04

33.25

17.2

7.5

1.35

1.32

mmol/l

0.10

155

583

Amputation of thigh

189

754

2.84

33.20

11.2

6.0

1.48

1.47

mmol/l

0.02

179

718

Combinations of oral blood glucose lowering drugs

1357

9699

1.45

33.13

8.8

7.0

1.54

1.28

mmol/l

15.60

1315

9372

Chronic tubulo-interstitial nephritis

209

867

2.63

33.11

8.7

5.9

1.20

1.35

mmol/l

1.47

199

837

Cervicocranial syndrome

486

2746

1.86

33.03

5.2

6.9

1.25

1.34

mmol/l

1.71

466

2656

Other shoulder lesions

434

2373

1.93

32.96

5.6

7.4

1.28

1.33

mmol/l

0.68

421

2296

Disorders of tooth development and eruption

253

1106

2.38

32.91

18.9

7.7

1.18

1.42

mmol/l

3.80

241

1044

Dissection of aorta

203

841

2.71

32.85

15.9

5.8

1.37

1.45

mmol/l

0.45

198

808

Other and unspecified visual disturbances

459

2564

1.90

32.84

7.7

6.9

1.27

1.35

mmol/l

1.15

440

2471

Other inflammatory liver diseases

346

1767

2.11

32.81

8.8

7.4

1.45

1.33

mmol/l

1.06

330

1700

Abnormal spermatozoa

183

4256

0.41

32.76

4.7

8.0

1.38

1.40

mmol/l

0.11

174

4090

Fracture of neck

335

1700

2.15

32.75

9.2

6.9

1.39

1.40

mmol/l

0.08

329

1634

Follow-up examination after treatment for malignant neoplasms

513

2959

1.83

32.70

6.9

6.3

1.33

1.32

mmol/l

0.09

500

2860

Other benign neoplasms of skin

1500

10680

1.41

32.69

6.1

6.6

1.29

1.38

mmol/l

3.14

1461

10255

Car occupant injured in other and unspecified transport accidents

810

5231

1.60

32.60

5.9

7.1

1.46

1.33

mmol/l

2.39

788

5027

Early complications of trauma

242

1084

2.45

32.54

6.1

7.7

1.49

1.40

mmol/l

0.38

232

1043

!Aliquae complicationes praecoces traumatis

242

1084

2.45

32.54

6.1

7.7

1.49

1.40

mmol/l

0.38

232

1043

Drug-induced neutropenia

369

1936

2.05

32.48

6.6

7.2

1.40

1.31

mmol/l

0.99

360

1872

Non-small cell lung cancer, adenocarcinoma, helper endpoint

357

1860

2.09

32.37

7.6

6.3

1.18

1.40

mmol/l

4.90

338

1786

Non-small cell lung cancer, adenocarcinoma

357

1860

2.09

32.37

7.6

6.3

1.18

1.40

mmol/l

4.90

338

1786

Asthma and opportunity respiratory infection

266

1246

2.35

32.26

7.5

6.3

1.31

1.41

mmol/l

0.80

249

1196

Amenorrhoea

268

1240

2.27

32.11

8.6

6.2

1.34

1.27

mmol/l

0.39

252

1189

Crohn disease

585

3514

1.74

31.92

7.9

7.5

1.29

1.35

mmol/l

0.77

560

3381

Mucosal proctocolitis

578

3462

1.74

31.89

7.9

7.6

1.33

1.37

mmol/l

0.32

556

3330

Motor disorders, excluding more controls

104

285

3.99

31.87

14.2

17.5

1.35

1.45

mmol/l

0.46

264

Congenital malformations of cardiac septa

354

1776

2.07

31.85

15.2

9.2

1.33

1.39

mmol/l

0.44

341

1674

Benign neoplasm: Small intestine

221

963

2.54

31.83

6.7

5.5

1.34

1.43

mmol/l

0.67

214

929

Migraine without aura and triptan purchases

566

3359

1.74

31.76

6.4

7.2

1.23

1.28

mmol/l

0.79

541

3237

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2395

18287

1.31

31.75

8.8

7.5

1.28

1.36

mmol/l

3.92

2290

17672

Gonarthrosis,primary

4465

23321

1.22

31.56

6.3

7.2

1.36

mmol/l

0.15

4326

22429

Type1 diabetes, definitions combined, early onset

306

1499

2.15

31.55

10.5

9.0

1.25

1.36

mmol/l

1.25

289

1424

Non-follicular lymphoma

510

2989

1.82

31.35

7.4

6.9

1.54

1.36

mmol/l

1.72

494

2867

Malignant neoplasm of skin

3052

18435

1.27

31.22

5.8

6.6

1.38

1.36

mmol/l

0.34

2934

17719

Benign neoplasm of mouth and pharynx

481

2759

1.83

31.21

6.6

6.7

1.40

1.38

mmol/l

0.15

458

2650

Injuries involving multiple body regions

209

894

2.56

31.14

10.4

7.7

1.43

1.36

mmol/l

0.36

198

858

Diabetic neuropathy

669

4209

1.70

31.11

10.2

8.6

1.41

1.54

mmol/l

2.39

645

4029

Disturbance of activity and attention

375

1956

1.97

31.09

8.5

1.39

1.36

mmol/l

0.16

352

1851

Other disorders of eyelid

2076

15434

1.33

30.84

6.1

6.6

1.32

1.36

mmol/l

0.87

2005

14812

Orchitis and epididymitis

497

2899

1.82

30.78

9.3

8.5

1.39

1.43

mmol/l

0.38

470

2781

Bronchiectasis

416

2309

1.93

30.74

6.7

6.1

1.35

1.38

mmol/l

0.16

390

2230

Inflammatory diseases of the central nervous system

410

2258

1.93

30.74

7.9

7.5

1.33

1.38

mmol/l

0.62

392

2170

Congenital malformations of aortic and mitral valves

240

1103

2.39

30.47

15.2

9.1

1.25

1.39

mmol/l

1.47

233

1054

Disorders of continuity of bone

431

2413

1.88

30.43

8.7

7.2

1.28

1.34

mmol/l

0.52

415

2323

Osteonecrosis

311

1578

2.14

30.31

10.5

7.0

1.23

1.34

mmol/l

1.49

305

1525

Spondylolisthesis/Spondylolysis

800

5248

1.58

30.19

6.2

7.5

1.36

1.33

mmol/l

0.25

777

5086

Irregular menses

1660

9996

1.37

30.18

6.6

6.4

1.28

1.25

mmol/l

0.53

1588

9688

Fracture of forearm

2406

17685

1.30

30.12

7.4

6.8

1.30

1.34

mmol/l

1.24

2307

17054

Diabetic retinopathy

1856

8878

1.37

30.07

10.1

8.0

1.45

1.53

mmol/l

2.02

1775

8562

Prurigo nodularis

163

637

2.92

30.05

7.4

6.7

1.39

1.33

mmol/l

0.21

158

608

Evidence of alcohol involvement determined by blood alcohol level

109

341

3.73

29.94

8.6

6.9

1.70

1.37

mmol/l

2.82

103

328

Cerebral cysts

275

1334

2.21

29.89

8.6

7.7

1.50

1.36

mmol/l

0.97

257

1280

Other and unspecified coagulation defects

247

1152

2.32

29.87

12.0

7.2

1.20

1.34

mmol/l

1.66

236

1099

Abnormal results of function studies

412

2295

1.90

29.77

9.6

7.1

1.31

1.38

mmol/l

0.61

400

2203

Idiopathic pulmonary fibrosis

417

2346

1.91

29.72

12.8

6.2

1.42

1.41

mmol/l

0.06

391

2251

Intracerebral haemorrhage

628

3924

1.68

29.72

10.2

6.0

1.41

mmol/l

0.03

597

3747

Hyperkinetic disorders

405

2198

1.89

29.72

8.3

8.8

1.39

1.35

mmol/l

0.26

380

2080

Benign neoplasm: Stomach

492

2894

1.81

29.72

8.1

6.5

1.34

1.35

mmol/l

0.12

468

2802

Intestinal malabsorption

241

1117

2.34

29.70

11.1

7.0

1.59

1.36

mmol/l

1.73

234

1074

Superficial injury of forearm

435

2458

1.86

29.68

6.0

7.6

1.41

1.36

mmol/l

0.35

414

2361

Acute pharyngitis

607

3714

1.68

29.66

9.1

8.3

1.30

1.37

mmol/l

0.58

571

3563

Dental operations, only avohilmo

3788

15893

1.24

29.66

6.7

7.2

1.34

1.38

mmol/l

1.15

3642

15216

Abnormal findings on diagnostic imaging of other body structures

586

3601

1.71

29.62

7.2

6.4

1.32

1.35

mmol/l

0.34

564

3474

Familial hypercholesterolemia, with ischemic heart disease

501

2966

1.80

29.62

7.1

6.1

1.45

1.35

mmol/l

1.35

480

2858

Ocular pain

369

1987

1.97

29.61

6.7

7.4

1.25

1.32

mmol/l

1.06

359

1910

Recurring oral aphthae, including avohilmo

619

3859

1.68

29.42

8.8

6.8

1.30

1.34

mmol/l

0.49

603

3712

ILD-related respiratory insufficiency

207

915

2.56

29.39

19.1

7.4

1.33

1.47

mmol/l

1.45

192

881

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

354

1889

2.00

29.28

5.6

6.3

1.42

1.40

mmol/l

0.10

341

1812

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2182

16687

1.31

29.28

7.0

6.9

1.28

1.32

mmol/l

0.76

2104

16119

Drug-induced hypoglycaemia without coma

120

405

3.46

29.19

11.4

6.5

1.58

1.38

mmol/l

0.76

114

377

Agoraphobia

141

510

2.97

29.08

9.6

7.3

1.28

1.34

mmol/l

0.32

135

489

Other diseases of oesophagus

489

2883

1.79

29.06

7.6

6.6

1.43

1.36

mmol/l

0.65

472

2774

Other mental disorders due to brain damage and dysfunction and to physical disease

567

3481

1.72

29.06

5.8

6.3

1.45

1.39

mmol/l

0.67

539

3326

Multiple myeloma, excluding all cancers (controls excluding all cancers)

248

1176

2.30

29.04

6.6

5.9

1.24

1.45

mmol/l

3.31

241

1129

Open wound of abdomen, lower back and pelvis

176

721

2.69

28.94

6.8

7.9

1.34

1.39

mmol/l

0.25

168

694

Endovascular or surgical operations to intracerebral aneurysms

327

1713

2.05

28.87

7.8

7.1

1.35

1.32

mmol/l

0.19

314

1654

Multiple myeloma and malignant plasma cell neoplasms

246

1166

2.30

28.85

6.6

5.9

1.23

1.45

mmol/l

3.33

239

1120

Benign neoplasm: Cerebral meninges

388

2140

1.92

28.84

6.3

6.2

1.46

1.38

mmol/l

0.56

378

2069

Myocardial infarction, with ST-elevation

913

6236

1.53

28.83

8.5

6.7

1.48

1.40

mmol/l

1.08

868

5934

Left bundle-branch block

320

1662

2.04

28.62

8.2

5.8

1.33

1.30

mmol/l

0.17

306

1600

Seropositive rheumatoid arthritis

1135

8034

1.45

28.60

6.6

6.5

1.37

1.33

mmol/l

0.50

1100

7719

Superficial injury of shoulder and upper arm

518

3109

1.75

28.58

5.0

6.8

1.37

1.36

mmol/l

0.04

497

2991

Pneumonia derived septicemia

198

862

2.53

28.57

8.6

7.9

1.63

1.41

mmol/l

0.66

188

818

Malignant neoplasm of respiratory system and intrathoracic organs

1075

6970

1.47

28.33

7.3

6.0

1.30

1.41

mmol/l

2.49

1024

6621

Carcinoma in situ of skin

380

2104

1.93

28.31

5.6

5.4

1.28

1.44

mmol/l

3.01

364

2021

Other and unspecified abdominal hernia

229

1064

2.36

28.30

7.6

7.2

1.33

1.39

mmol/l

0.38

224

1024

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

417

2375

1.85

27.94

4.5

5.0

1.21

1.37

mmol/l

2.61

406

2293

Pruritus

480

2840

1.77

27.90

6.4

6.6

1.33

1.32

mmol/l

0.08

460

2724

Gingival hyperplasia

188

809

2.56

27.85

13.2

7.7

1.21

1.38

mmol/l

2.17

183

774

Other disorders of bone

850

5742

1.53

27.82

6.9

7.1

1.39

1.34

mmol/l

0.61

820

5526

Faecal incontinence

388

2164

1.89

27.75

5.9

5.7

1.30

1.31

mmol/l

0.13

369

2100

Evidence of alcohol involvement determined by level of intoxication

215

4.37

27.58

11.6

8.5

1.82

1.34

mmol/l

1.86

208

Open wound of wrist and hand

1915

14642

1.32

27.53

7.7

1.39

1.37

mmol/l

0.42

1862

14104

Hypothyroidism, other/unspecified

4169

23000

1.21

27.52

7.1

6.8

1.33

1.35

mmol/l

0.42

4000

22159

Bulimia nervosa (incl. atypical)

140

519

2.88

27.48

6.6

6.2

1.22

1.20

mmol/l

0.12

134

493

Malignant neoplasm of mesothelium and soft tissue

255

1253

2.24

27.47

7.7

7.0

1.15

1.42

mmol/l

6.10

249

1204

Small fibre neuropathy

174

734

2.69

27.42

9.2

7.7

1.35

1.39

mmol/l

0.20

168

703

Fissure and fistula of anal and rectal regions

1035

7276

1.46

27.41

6.8

7.1

1.29

1.37

mmol/l

1.70

998

6995

Polyarthrosis

892

5853

1.51

27.35

5.0

6.5

1.35

1.34

mmol/l

0.09

850

5620

Emotional disorders starting during childhood or adolescence

213

955

2.34

27.31

6.3

8.2

1.39

1.37

mmol/l

0.12

193

898

Disorders of vitreous body and globe

2267

17481

1.29

27.29

7.3

6.8

1.29

1.33

mmol/l

1.40

2197

16886

Osteoporosis with pathological fracture (FG)

340

1841

1.98

27.24

7.8

4.9

1.41

1.36

mmol/l

0.28

325

1769

Disorders of vitreous body

2203

17002

1.30

27.17

7.3

6.9

1.29

1.33

mmol/l

1.22

2133

16427

Other inflammation of eyelid

586

3686

1.66

26.90

6.2

7.1

1.29

1.35

mmol/l

0.77

561

3547

Diseases of the ear and mastoid process

5817

25253

1.18

26.90

6.5

7.4

1.33

1.36

mmol/l

1.02

5604

24276

290

1476

2.03

26.83

6.9

5.5

1.20

1.24

mmol/l

0.30

284

1424

Other noninfective disorders of lymphatic vessels and lymph nodes

193

854

2.48

26.75

9.3

6.8

1.33

mmol/l

0.02

182

826

Fracture at wrist and hand level

1476

11034

1.37

26.74

7.7

7.6

1.34

1.36

mmol/l

0.30

1427

10623

Other blood glucose lowering drugs, excl. Insulins

794

5354

1.54

26.65

8.4

6.4

1.53

1.27

mmol/l

6.75

774

5154

Senility

187

4.47

26.50

3.0

3.5

1.45

1.50

mmol/l

0.14

174

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

158

645

2.74

26.47

9.3

6.0

1.18

1.41

mmol/l

2.98

147

625

Hypothyreosis and Thyroxine purchase for inclusion criteria

4295

23844

1.20

26.42

7.1

6.8

1.33

1.35

mmol/l

0.39

4119

22968

Basal cell carcinoma

2698

17364

1.26

26.33

5.7

6.4

1.37

1.36

mmol/l

0.11

2600

16662

Protozoal diseases

172

735

2.64

26.28

12.0

7.5

1.38

1.37

mmol/l

0.07

166

706

Allergic conjunctivitis

2263

17646

1.28

26.27

6.9

1.28

1.32

mmol/l

0.85

2180

17030

Other Crohn's disease

319

1704

1.98

26.25

7.6

1.23

1.37

mmol/l

1.55

304

1638

L01XE Protein kinase inhibitors

312

1671

2.03

26.21

6.6

7.0

1.51

1.36

mmol/l

1.60

296

1610

Basal cell carcinoma, including avohilmo

2758

17594

1.26

26.15

5.7

6.5

1.37

1.36

mmol/l

0.18

2654

16889

Biomechanical lesions, not elsewhere classified

253

1259

2.18

26.07

5.8

7.2

1.22

1.38

mmol/l

2.36

241

1214

Inflammatory disease of uterus

503

3056

1.70

26.04

5.9

1.23

1.25

mmol/l

0.23

485

2959

Specific development disorders of speech and language

282

1395

2.07

25.91

7.5

9.7

1.31

1.41

mmol/l

1.15

266

1309

Subarachnoid haemorrhage

501

3067

1.72

25.84

8.1

6.4

1.38

1.35

mmol/l

0.26

486

2945

Mixed disorders of conduct and emotions

120

426

3.06

25.80

8.6

6.9

1.34

1.46

mmol/l

0.56

110

401

Cervical disc disorders

1625

12397

1.34

25.75

6.4

7.6

1.34

1.35

mmol/l

0.14

1561

11990

Erosion of teeth, including avohilmo

753

4858

1.54

25.74

10.3

6.4

1.27

1.38

mmol/l

2.36

723

4700

Disorders of ocular muscles, binocular movement, accommodation and refraction

1934

14956

1.31

25.71

8.6

7.3

1.33

1.34

mmol/l

0.07

1842

14411

Lichen simplex chronicus and prurigo

319

1724

1.98

25.65

8.3

7.0

1.39

1.37

mmol/l

0.10

309

1657

Oter anti-inflammatory and antirheumatic agents, non-steroids

1222

4890

1.42

25.56

5.9

7.7

1.38

1.40

mmol/l

0.25

1168

4671

5-aminosalicylic acid

875

6048

1.49

25.36

8.2

7.2

1.32

1.34

mmol/l

0.17

839

5823

Special screening examination for neoplasms

236

1153

2.20

25.36

7.8

7.1

1.35

1.34

mmol/l

0.09

221

1110

Benign neoplasm: Adrenal gland

374

2135

1.87

25.34

7.6

7.1

1.25

1.35

mmol/l

1.01

364

2058

Other surgical follow-up care

167

709

2.56

25.25

7.0

7.5

1.35

mmol/l

0.01

151

684

Assault by sharp object

109

376

3.28

25.25

8.7

8.2

1.81

1.39

mmol/l

1.31

103

363

Other specified and unspecified disorders of eye and adnexa

209

979

2.32

25.23

7.8

6.7

1.22

1.38

mmol/l

1.83

198

939

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1519

6975

1.37

25.05

7.0

8.0

1.37

1.45

mmol/l

1.54

1463

6697

Sequelae of injuries of head

270

1394

2.08

24.95

7.0

8.1

1.56

1.39

mmol/l

1.49

259

1335

Methotrexate

632

4113

1.59

24.82

8.1

6.4

1.38

1.31

mmol/l

0.72

606

3966

Cardiomyopathy, Hypertrophic obstructive

113

402

3.17

24.75

17.7

5.5

1.53

1.34

mmol/l

0.97

106

386

Other and unspecified immunodeficiencies with predominantly antibody defects

262

3.84

24.72

19.7

7.7

1.25

1.28

mmol/l

0.12

249

Viral warts

434

2584

1.76

24.71

8.9

7.3

1.28

1.36

mmol/l

1.00

422

2483

Benign neoplasm of brain and other parts of central nervous system

291

1543

2.00

24.65

8.0

6.4

1.28

1.39

mmol/l

1.31

281

1488

Melanocytic naevi of trunk

463

2806

1.72

24.51

7.5

6.6

1.29

1.37

mmol/l

0.83

450

2700

Urticaria

1182

8660

1.40

24.50

7.6

7.3

1.30

1.32

mmol/l

0.32

1132

8331

Other fall from one level to another

988

7039

1.45

24.46

7.2

7.8

1.40

1.36

mmol/l

0.71

950

6746

Scoliosis

350

1963

1.86

24.43

6.9

6.2

1.21

1.30

mmol/l

0.92

337

1885

Malignant melanoma, excluding all cancers (controls excluding all cancers)

724

4881

1.54

24.24

6.0

6.6

1.37

1.39

mmol/l

0.22

696

4689

Acute appendicitis

3104

24212

1.23

24.20

7.4

1.35

mmol/l

0.01

3000

23349

Oxicams

1248

5194

1.40

23.98

6.3

7.8

1.40

mmol/l

0.05

1199

4972

Specific development disorders of scholastic skills

190

857

2.33

23.94

13.9

8.2

1.41

1.40

mmol/l

0.04

185

807

Atopic dermatitis

2192

14893

1.27

23.90

6.8

7.6

1.30

1.33

mmol/l

0.76

2097

14358

Rheumatism, unspecified

576

3708

1.61

23.76

4.7

6.5

1.31

1.27

mmol/l

0.38

549

3601

Other disorders of gingiva or/and edentulous alveolar ridge

250

1278

2.10

23.75

11.8

7.5

1.23

1.40

mmol/l

2.74

242

1226

Pedestrian injured in transport accident

330

1845

1.89

23.68

7.5

7.2

1.47

1.36

mmol/l

0.65

317

1775

Spondyloarthritis

792

5450

1.50

23.67

6.5

6.9

1.38

1.36

mmol/l

0.20

761

5228

Pneumococcal septicemia

187

863

2.38

23.61

8.4

8.6

1.65

1.39

mmol/l

0.79

177

821

Cholangitis (primary sclerosing, PSC), with reimbursement 202

116

431

3.05

23.57

15.4

9.2

1.20

1.32

mmol/l

0.78

109

412

Diseases of spleen

117

439

3.06

23.54

7.5

6.9

1.61

1.40

mmol/l

0.71

112

420

Acute suppurative otitis media

970

6446

1.43

23.52

9.1

8.0

1.35

mmol/l

0.06

928

6190

Disorders of synovium and tendon

2249

16234

1.27

23.51

6.9

7.3

1.28

1.35

mmol/l

2.35

2168

15657

Other diseases of jaws

306

1672

1.93

23.48

7.6

7.0

1.42

1.40

mmol/l

0.07

291

1608

Malnutrition

132

527

2.85

23.46

10.3

8.0

1.44

1.41

mmol/l

0.07

116

490

Acute gastritis

370

2148

1.82

23.34

6.0

6.8

1.38

1.33

mmol/l

0.46

356

2077

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

552

3545

1.63

23.33

6.3

5.2

1.39

1.46

mmol/l

0.83

525

3374

Arterial embolism and thrombosis of lower extremity artery

195

919

2.31

23.26

10.4

6.2

1.50

1.43

mmol/l

0.32

186

884

Internal derangement of knee

1667

12900

1.31

23.22

7.0

7.6

1.36

mmol/l

0.05

1618

12405

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

128

504

2.86

23.20

9.2

5.8

1.21

1.43

mmol/l

2.17

121

486

Inflammatory diseases of female pelvic organs

2232

13448

1.27

23.16

6.4

6.1

1.25

1.28

mmol/l

0.60

2146

13017

Otitis externa

926

6590

1.45

23.13

6.7

7.2

1.27

1.34

mmol/l

1.72

889

6339

Thyrotoxicosis

1011

7301

1.42

23.10

7.6

6.6

1.25

1.32

mmol/l

1.68

972

7043

152

654

2.62

22.97

7.1

7.2

1.56

1.47

mmol/l

0.31

141

624

Inguinal hernia

2930

16271

1.23

22.96

7.6

7.4

1.34

1.39

mmol/l

1.72

2819

15632

Congenital malformations and deformations of the musculoskeletal system

375

2177

1.79

22.92

8.7

9.2

1.31

1.37

mmol/l

0.37

357

2061

Coxarthrosis, primary

2826

20231

1.24

22.87

6.5

6.7

1.37

1.36

mmol/l

0.07

2738

19451

Use of biperiden

266

1410

2.02

22.77

5.3

7.9

1.32

1.40

mmol/l

0.56

260

1355

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

613

4048

1.57

22.75

6.0

6.5

1.37

1.40

mmol/l

0.20

587

3893

Rash and other nonspecific skin eruption

446

2739

1.71

22.72

6.5

7.3

1.26

1.35

mmol/l

1.55

425

2633

Diseases of appendix

3331

25408

1.21

22.68

7.5

7.3

1.35

mmol/l

0.08

3222

24500

Appendicitis, broad definition

3302

25261

1.21

22.61

7.4

7.3

1.35

mmol/l

0.04

3194

24356

Ingrowing nail

257

1348

2.03

22.57

6.0

7.9

1.28

1.39

mmol/l

1.07

249

1289

Procreative management

1249

7854

1.37

22.57

9.9

8.4

1.29

1.33

mmol/l

0.64

1208

7533

Carcinoma in situ of skin of other and unspecified parts of face

405

2447

1.77

22.51

5.2

5.4

1.38

1.42

mmol/l

0.34

386

2339

Weight loss

454

2813

1.70

22.50

7.1

1.33

1.36

mmol/l

0.22

428

2705

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

391

2333

1.77

22.49

7.3

6.2

1.42

1.36

mmol/l

0.38

374

2248

Nail disorders

379

2237

1.78

22.49

7.8

1.28

1.37

mmol/l

1.26

365

2146

Diseases of external ear

1464

11235

1.33

22.43

6.3

7.2

1.31

1.36

mmol/l

1.33

1401

10805

Presence of other functional implants

2657

15406

1.24

22.35

5.8

6.2

1.36

mmol/l

0.06

2559

14827

Ovarian cyst

1446

6324

1.35

22.26

5.9

6.2

1.22

1.32

mmol/l

4.25

1397

6085

Benign neoplasm: Skin of eyelid, including canthus

611

4048

1.56

22.25

5.9

6.3

1.32

1.39

mmol/l

0.86

597

3896

Other bursopathies

584

3835

1.58

22.24

6.9

7.2

1.37

1.33

mmol/l

0.44

565

3701

Herpesviral [herpes simplex] infections

492

3108

1.65

22.20

7.5

6.8

1.35

mmol/l

0.01

477

2998

Haemolytic anaemias

191

913

2.29

22.10

12.3

7.2

1.33

1.39

mmol/l

0.42

182

867

Symptoms and signs involving emotional state

147

627

2.54

22.03

9.6

7.2

1.45

1.32

mmol/l

0.76

142

602

Dislocation, sprain and strain of joint and ligaments of hip

196

948

2.26

21.98

7.0

6.5

1.45

1.40

mmol/l

0.15

188

905

Hypermobility syndrome

203

983

2.17

21.97

4.7

6.2

1.22

1.23

mmol/l

0.02

193

942

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2603

16863

1.24

21.92

5.8

6.4

1.38

1.36

mmol/l

0.24

2503

16184

Fibroblastic disorders

1064

7832

1.40

21.75

7.6

7.1

1.37

mmol/l

0.03

1021

7519

Crohn's disease NAS

298

1657

1.90

21.74

7.7

7.8

1.26

1.35

mmol/l

0.84

283

1585

Diffuse brain injury

176

814

2.31

21.64

8.1

7.9

1.58

1.35

mmol/l

1.68

168

791

Atopic dermatitis, strict definition with reimbursement

1104

7900

1.38

21.62

6.4

7.8

1.32

1.33

mmol/l

0.05

1057

7596

Other and unspecified injuries of lower leg

310

1744

1.86

21.62

6.2

7.4

1.33

1.32

mmol/l

0.04

289

1668

Mixed hyperlipidaemia

210

1048

2.16

21.50

11.1

6.5

1.51

1.39

mmol/l

0.70

202

1015

Thyrotoxicosis, other and/or unspecified

790

5536

1.47

21.49

8.1

6.6

1.25

1.32

mmol/l

1.44

756

5352

Ulcerative colitis, NAS

597

3965

1.56

21.46

8.1

7.5

1.38

1.36

mmol/l

0.21

576

3802

Vitamin D deficiency

106

394

3.01

21.43

9.8

6.8

1.67

1.36

mmol/l

1.33

382

Other congenital malformations

368

2183

1.76

21.24

11.6

8.4

1.26

1.35

mmol/l

1.34

358

2070

Conduct disorder

115

445

2.81

21.18

8.0

7.2

1.36

1.43

mmol/l

0.31

108

425

Metatarsalgia

390

2356

1.73

21.04

6.3

6.9

1.26

1.31

mmol/l

0.49

377

2276

Speech disturbances, not elsewhere classified

409

2514

1.71

20.97

7.8

6.5

1.33

1.38

mmol/l

0.46

394

2414

Cardiac murmurs and other cardiac sounds

373

2198

1.74

20.95

8.0

7.8

1.32

1.35

mmol/l

0.30

359

2096

Left hemicolectomy

150

669

2.52

20.94

11.3

7.3

1.39

1.42

mmol/l

0.10

144

639

Right bundle-branch block

174

815

2.30

20.94

13.8

5.8

1.24

1.35

mmol/l

1.09

166

787

Benign neoplasm: Small intestine

221

1141

2.12

20.89

6.7

6.9

1.34

1.37

mmol/l

0.21

214

1100

Olecranon bursitis

313

1795

1.85

20.86

9.3

8.4

1.46

1.39

mmol/l

0.46

300

1728

Other neurotic disorders

245

1303

2.00

20.76

6.0

7.7

1.38

1.40

mmol/l

0.06

240

1252

Retinal vascular occlusion

573

3817

1.57

20.75

7.9

6.1

1.36

1.38

mmol/l

0.16

550

3662

Superficial injuries involving multiple body regions

141

610

2.53

20.67

8.7

7.4

1.39

1.40

mmol/l

0.01

132

585

Haemorrhoids and perianal venous thrombosis

1221

9231

1.35

20.66

6.0

6.3

1.36

1.37

mmol/l

0.11

1176

8840

Retinal vascular disorders

582

3893

1.56

20.63

7.9

6.1

1.36

1.39

mmol/l

0.23

558

3732

Other enthesopathies

1219

9222

1.35

20.55

6.5

7.3

1.31

1.33

mmol/l

0.16

1172

8912

Disorders of sclera, cornea, iris and ciliary body

2343

19193

1.24

20.48

7.3

7.0

1.33

1.36

mmol/l

0.78

2260

18508

Vitamin B12 deficiency anaemia

507

3293

1.61

20.47

8.0

5.9

1.44

1.38

mmol/l

0.65

485

3149

Meniscus derangement

2611

14719

1.23

20.46

6.4

7.6

1.35

1.36

mmol/l

0.14

2543

14156

Fall involving bed

174

830

2.31

20.46

7.4

6.8

1.29

1.43

mmol/l

1.12

167

787

Dislocation, sprain and strain of joints and ligaments at neck level

577

3841

1.55

20.39

5.4

7.3

1.28

1.34

mmol/l

0.76

561

3696

Psoriasis

1222

9274

1.35

20.36

7.4

1.39

1.34

mmol/l

0.70

1167

8950

Disorders of speech understanding and production

210

1048

2.11

20.27

9.4

8.7

1.32

1.41

mmol/l

0.74

198

979

Infections with a predominantly sexual mode of transmission

1056

7824

1.37

20.19

7.2

7.1

1.30

1.32

mmol/l

0.23

1019

7553

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1238

9420

1.34

20.18

7.0

7.6

1.39

1.36

mmol/l

0.34

1186

9066

Lymphoid leukaemia

263

1447

1.94

20.12

12.2

6.7

1.14

1.45

mmol/l

8.71

251

1384

Mental retardation

210

1073

2.11

20.12

9.1

10.7

1.43

1.34

mmol/l

0.49

193

1014

Pyogenic arthritis

323

1884

1.81

20.12

7.9

7.2

1.35

1.40

mmol/l

0.47

315

1808

Specific developmental disorder of motor function

104

389

2.96

20.09

14.2

16.7

1.35

1.41

mmol/l

0.29

355

Other follicular disorders

300

1711

1.84

20.06

6.9

7.5

1.32

1.36

mmol/l

0.35

291

1642

Drug-induced adrenocortical insufficiency

109

428

2.89

20.05

10.5

8.4

1.35

1.33

mmol/l

0.09

103

409

Behavioural disorders

114

453

2.74

19.95

8.0

7.4

1.34

1.42

mmol/l

0.38

107

429

Polycystic ovarian syndrome, consortium definition

2669

13297

1.23

19.76

6.4

6.0

1.29

1.28

mmol/l

0.18

2555

12852

Other enthesopathy of foot (+metatarsalgia)

408

2533

1.67

19.76

6.2

7.0

1.32

1.30

mmol/l

0.09

394

2450

Other and unspecified glaucoma

345

2067

1.77

19.72

6.9

5.9

1.33

1.40

mmol/l

0.54

331

1978

Chondrocostal junction syndrome [Tietze]

184

904

2.20

19.69

6.0

6.5

1.35

1.32

mmol/l

0.19

178

871

Pain and other conditions associated with female genital organs and menstrual cycle

657

4319

1.49

19.67

5.2

6.4

1.20

1.31

mmol/l

2.77

623

4186

Crohn's disease of small intestine

299

1715

1.83

19.64

7.6

7.7

1.25

1.35

mmol/l

1.17

289

1649

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1443

6691

1.33

19.62

6.7

8.0

1.37

1.45

mmol/l

1.39

1387

6428

Parkinson's disease, excluding more controls

581

3815

1.54

19.51

4.5

6.3

1.34

1.32

mmol/l

0.21

560

3666

Benign neoplasm: Descending colon

339

2033

1.78

19.46

6.2

7.0

1.35

1.40

mmol/l

0.31

326

1964

Delayed milestone in childhood

132

519

2.62

19.39

17.0

17.4

1.41

1.39

mmol/l

0.11

120

466

Adhesive capsulitis of shoulder

718

5048

1.47

19.36

6.8

7.4

1.33

mmol/l

0.04

681

4875

Visual impairment including blindness (binocular or monocular)

319

1877

1.79

19.33

8.2

6.8

1.40

mmol/l

0.01

306

1793

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

211

1097

2.07

19.33

8.1

5.8

1.71

1.45

mmol/l

1.49

201

1058

Diffuse large B-cell lymphoma, helper endpoint

211

1097

2.07

19.33

8.1

5.8

1.71

1.45

mmol/l

1.49

201

1058

Viral agents as the cause of diseases classified to other chapters

125

531

2.61

19.29

8.1

7.8

1.29

1.32

mmol/l

0.14

120

507

Other abnormalities of plasma proteins

379

3.00

19.29

10.5

5.9

1.39

1.37

mmol/l

0.09

362

Burns and corrosions of multiple and unspecified body regions

127

543

2.58

19.25

8.3

10.2

1.49

1.38

mmol/l

0.42

120

525

Other encephalitis

151

696

2.38

19.21

9.0

7.7

1.41

1.37

mmol/l

0.19

139

661

Assault by unspecified means

108

427

2.77

19.20

7.3

9.3

1.40

1.41

mmol/l

0.05

103

418

Post-traumatic wound infection, not elsewhere classified

144

652

2.43

19.16

5.7

6.8

1.35

1.38

mmol/l

0.11

137

629

Encephalitis

158

742

2.32

19.16

8.7

7.7

1.39

1.37

mmol/l

0.12

146

705

Non-invasive ventilation

601

3816

1.51

19.15

15.1

5.9

1.39

1.20

mmol/l

3.26

574

3693

Strabismus

1074

8056

1.36

19.09

9.0

7.5

1.33

1.34

mmol/l

0.16

1017

7729

Acute appendicitis, no complications

2328

19133

1.23

19.07

7.0

7.6

1.35

1.34

mmol/l

0.13

2247

18470

Restless leg syndrome

521

3461

1.57

19.00

6.1

6.8

1.33

1.35

mmol/l

0.12

506

3342

Malignant neoplasm of head and neck

399

2504

1.68

18.95

9.2

7.3

1.23

1.39

mmol/l

3.31

378

2410

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

161

765

2.29

18.94

13.4

6.9

1.34

1.48

mmol/l

0.55

152

730

Multiple myeloma and malignant plasma cell neoplasms

246

1358

1.95

18.92

6.6

1.23

1.41

mmol/l

2.54

239

1306

Panniculitis affecting regions of neck and back

177

868

2.17

18.85

7.6

8.3

1.33

mmol/l

0.04

170

840

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

195

994

2.11

18.85

6.3

5.7

1.72

1.42

mmol/l

1.21

190

953

Nonhereditary hypogammaglobulinemia

228

3.61

18.84

16.7

8.2

1.28

1.29

mmol/l

0.03

218

Mixed specific developmental disorders

127

507

2.56

18.80

11.7

15.1

1.59

1.34

mmol/l

1.31

112

465

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

235

1249

1.94

18.77

10.3

10.6

1.42

1.37

mmol/l

0.16

229

1171

Lesion of lateral popliteal nerve

244

1342

1.94

18.75

8.6

7.9

1.40

mmol/l

0.02

235

1292

Car occupant injured in noncollision transport accident

178

879

2.17

18.71

8.2

8.0

1.36

1.35

mmol/l

0.05

173

842

Pure hyperglyceridaemia

124

532

2.57

18.67

8.1

6.4

1.47

1.40

mmol/l

0.33

117

513

Enthesopathies of lower limb, excluding foot

863

6291

1.40

18.66

6.6

7.7

1.29

1.34

mmol/l

0.72

834

6094

Other disorders of optic [2nd] nerve and visual pathways

293

1702

1.82

18.65

10.3

8.0

1.38

1.36

mmol/l

0.07

286

1632

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1088

6636

1.36

18.62

4.5

5.9

1.27

1.31

mmol/l

0.62

1052

6411

Other disorders of bladder

539

3626

1.55

18.54

7.9

7.1

1.31

1.37

mmol/l

0.51

510

3473

Benign neoplasm: Pituitary gland, craniopharyngeal duct

214

1129

2.01

18.49

6.6

7.1

1.20

1.38

mmol/l

2.72

202

1086

Benign neoplasm of ovary

594

4060

1.50

18.46

5.8

5.6

1.21

1.34

mmol/l

3.33

572

3912

Leiomyoma of uterus

1534

6752

1.30

18.46

6.3

1.23

1.30

mmol/l

2.24

1483

6510

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1118

8504

1.35

18.44

6.7

6.5

1.38

1.33

mmol/l

0.61

1083

8194

Polyarthritis, unspecified

187

947

2.12

18.42

8.0

7.2

1.28

1.37

mmol/l

0.68

176

915

Mental retardation, wide definition

218

1163

2.01

18.42

8.9

10.5

1.43

1.35

mmol/l

0.41

200

1098

Burns and corrosions

580

3960

1.51

18.33

7.4

8.0

1.37

1.38

mmol/l

0.09

557

3799

Shock, not elsewhere classified

196

3.78

18.29

21.0

6.4

2.19

1.41

mmol/l

1.84

189

Acquired haemolytic anaemia

136

615

2.45

18.27

13.2

7.1

1.37

1.41

mmol/l

0.16

128

585

Abnormal weight loss

406

2581

1.65

18.23

7.3

7.1

1.35

1.36

mmol/l

0.04

382

2486

Ulcer of oesophagus

351

2159

1.72

18.13

7.3

7.1

1.56

1.37

mmol/l

1.59

338

2085

Anorexia (incl.atypical)

229

1238

1.93

18.07

6.4

6.7

1.19

1.33

mmol/l

1.73

218

1175

1877

14345

1.26

18.07

5.6

5.9

1.35

1.38

mmol/l

0.50

1803

13750

Carcinoma in situ of skin of scalp and neck

131

588

2.49

18.06

6.3

5.8

1.33

1.55

mmol/l

1.98

123

563

Hypothermia

116

494

2.64

18.03

7.5

1.85

1.45

mmol/l

1.06

110

470

Hypothyroidism, strict autoimmune, 3 medication purchases required

3734

21885

1.18

18.02

6.8

6.7

1.34

mmol/l

0.11

3582

21080

Benign neoplasm of meninges

440

2855

1.61

17.99

6.3

1.44

1.33

mmol/l

1.07

427

2759

Other disorders of white blood cells

261

1484

1.87

17.97

9.5

7.3

1.49

1.39

mmol/l

0.35

252

1430

Secondary and unspecified malignant neoplasm of lymph nodes

392

2482

1.66

17.93

5.8

7.0

1.52

1.38

mmol/l

1.22

385

2388

Dental pulpitis 3

434

1985

1.61

17.83

7.1

7.7

1.35

1.37

mmol/l

0.13

414

1875

Septal defects

297

1714

1.79

17.82

13.8

10.0

1.38

1.35

mmol/l

0.12

285

1613

Alzheimer disease, excluding more controls

779

3727

1.44

17.81

3.5

5.7

1.54

1.32

mmol/l

6.58

739

3581

Opening and dilatation of root channel of tooth

268

1534

1.83

17.79

10.4

7.3

1.30

1.35

mmol/l

0.48

253

1471

Acute bronchiolitis

265

1351

1.84

17.76

8.3

10.7

1.35

1.41

mmol/l

0.38

240

1255

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1078

8192

1.34

17.66

6.8

7.7

1.33

1.34

mmol/l

0.16

1034

7900

Carcinoma in situ of skin of upper limb, including shoulder

123

542

2.53

17.65

9.3

5.2

1.27

1.49

mmol/l

2.15

115

520

IBD patients in KELA-register

917

6814

1.38

17.59

7.5

7.7

1.31

1.34

mmol/l

0.36

876

6564

Open wound of hip and thigh

160

779

2.21

17.54

9.1

8.1

1.39

1.36

mmol/l

0.13

154

746

Carcinoma in situ of skin of trunk

154

744

2.27

17.51

6.8

5.4

1.38

1.50

mmol/l

0.82

142

716

Secondary parkinsonism, excluding more controls

124

545

2.46

17.50

4.8

7.8

1.31

1.28

mmol/l

0.13

118

531

Trigger finger

571

3921

1.50

17.48

7.7

7.6

1.23

1.30

mmol/l

1.23

549

3790

Sleep disorders, other/unspecified

150

712

2.25

17.45

7.1

7.9

1.55

1.32

mmol/l

0.90

141

682

Other obstetric conditions, not elsewhere classified

832

3905

1.40

17.43

5.8

6.2

1.26

1.24

mmol/l

0.15

800

3763

Malignant neoplasm of bronchus and lung

880

6101

1.39

17.38

6.8

5.9

1.31

1.41

mmol/l

1.79

839

5778

Embolic stroke with flimmer

130

586

2.40

17.31

6.3

5.5

1.40

1.32

mmol/l

0.39

123

553

Amyloidosis

112

476

2.60

17.29

6.3

6.5

1.26

1.39

mmol/l

0.92

107

456

Other and unspecified paralytic syndromes

340

2.96

17.29

9.2

7.4

1.66

1.36

mmol/l

0.90

326

Acute laryngitis and tracheitis

431

2745

1.59

17.26

10.7

7.8

1.36

1.35

mmol/l

0.01

409

2631

Atopic dermatitis, strict definition

1049

7800

1.34

17.24

6.6

8.2

1.32

1.33

mmol/l

0.08

1003

7491

Benign neoplasm of mouth and pharynx

481

3210

1.56

17.23

6.6

6.9

1.40

1.35

mmol/l

0.36

458

3099

Hypopituitarism

314

1899

1.74

17.16

7.3

8.5

1.36

1.37

mmol/l

0.01

300

1807

Excessive attrition of teeth

1545

6624

1.29

17.12

7.0

6.2

1.33

1.38

mmol/l

0.87

1490

6400

Injury of urinary and pelvic organs

116

503

2.54

17.12

7.1

8.1

1.62

1.44

mmol/l

0.35

110

479

Postprocedural musculoskeletal disorders, not elsewhere classified

325

1991

1.73

17.11

7.6

6.8

1.31

1.37

mmol/l

0.49

310

1926

Sulfasalazine

1154

8894

1.32

17.10

6.9

6.8

1.34

1.33

mmol/l

0.05

1111

8592

Complications following infusion, transfusion and therapeutic injection

348

2.90

17.03

9.7

6.0

1.31

1.35

mmol/l

0.14

331

Atrial septal defect

198

1047

2.02

16.94

17.3

9.2

1.29

1.38

mmol/l

0.45

193

979

Diabetic retinopathy, strict definition

916

6047

1.38

16.83

13.0

8.2

1.33

1.54

mmol/l

6.66

874

5813

Malignant neoplasm of ovary

214

1171

1.95

16.81

7.7

5.4

1.15

1.28

mmol/l

1.32

209

1130

Cyst of kidney

330

2042

1.71

16.77

9.1

6.9

1.25

1.39

mmol/l

1.07

323

1972

Carbimazole or st.post thyroidectomy, condition for graves disease

778

5683

1.40

16.75

7.8

6.6

1.23

1.31

mmol/l

1.45

741

5497

Psoriasis vulgaris

797

5854

1.40

16.73

7.4

7.6

1.44

1.33

mmol/l

1.49

761

5644

Leisure time condition

736

5338

1.42

16.68

5.6

7.0

1.49

1.36

mmol/l

1.58

660

5117

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

789

5544

1.40

16.66

5.7

5.5

1.25

1.33

mmol/l

1.70

765

5342

Rheumatoid arthritis, including avohilmo

1611

12998

1.26

16.50

6.4

6.5

1.38

1.34

mmol/l

0.59

1552

12519

Other/unspecified seropositive rheumatoid arthritis

1124

8691

1.32

16.49

6.6

6.5

1.37

1.33

mmol/l

0.58

1089

8369

Disorders of optic nerve and visual pathways

389

2500

1.62

16.48

9.6

7.4

1.32

1.33

mmol/l

0.07

378

2404

Seropositive rheumatoid arthritis, wide

1135

8797

1.32

16.35

6.6

6.5

1.37

1.33

mmol/l

0.52

1100

8470

Corns and callosities

313

1919

1.71

16.33

7.6

7.2

1.35

1.34

mmol/l

0.01

301

1855

Paraplegia, diplegia of upper limbs

123

559

2.42

16.31

9.1

7.2

1.36

1.40

mmol/l

0.18

115

532

Motor disorders

104

440

2.63

16.25

14.2

14.5

1.35

1.46

mmol/l

0.54

398

Retinal detachments and breaks

1565

12629

1.27

16.16

7.7

6.7

1.33

1.36

mmol/l

0.58

1507

12161

Other congenital malformations of circulatory system

132

619

2.32

16.15

10.7

8.4

1.35

1.33

mmol/l

0.06

122

594

Drug-induced cataract

130

608

2.35

16.11

11.2

7.6

1.38

1.35

mmol/l

0.10

121

587

Embolic stroke

235

1339

1.86

16.07

8.1

6.1

1.30

1.41

mmol/l

1.01

224

1280

Carcinoma in situ of skin

380

2458

1.63

16.07

5.6

5.9

1.28

1.39

mmol/l

1.76

364

2366

Persistent delusional disorders

338

2119

1.67

16.04

5.0

6.8

1.48

1.36

mmol/l

0.91

318

2040

Thyroiditis, ILD-related definition

434

2881

1.55

15.75

8.2

6.7

1.28

1.27

mmol/l

0.08

416

2776

Entropion and trichiasis of eyelid

403

2648

1.59

15.74

5.6

6.0

1.38

1.41

mmol/l

0.17

381

2517

Suggestive for eosinophilic asthma

395

2583

1.59

15.61

6.8

7.2

1.24

1.36

mmol/l

2.21

377

2492

Polymyalgia rheumatica

590

4183

1.46

15.57

6.3

5.8

1.47

1.37

mmol/l

1.05

563

4020

Carpal tunnel syndrome

2586

19789

1.20

15.54

6.4

7.0

1.31

1.33

mmol/l

0.71

2512

19094

Amyloidosis, other/unspecified

395

2.68

15.50

7.0

6.5

1.22

1.37

mmol/l

1.17

377

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

796

3782

1.38

15.48

5.7

6.2

1.26

1.25

mmol/l

0.17

764

3646

Other epidermal thickening

204

1129

1.92

15.44

8.0

7.5

1.26

1.41

mmol/l

1.94

197

1079

Biological medication for rheuma

583

4114

1.46

15.43

7.7

1.28

1.34

mmol/l

0.59

561

3968

Inflammatory bowel disease, strict (require KELA)

917

6957

1.35

15.36

7.5

7.7

1.31

1.34

mmol/l

0.35

876

6704

Mixed connective tissue disease

275

1658

1.74

15.28

7.9

6.7

1.25

1.33

mmol/l

0.94

265

1597

Alzheimer’s disease, wide definition, excluding more controls

689

3382

1.42

15.21

3.4

5.7

1.53

1.32

mmol/l

6.24

662

3249

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

141

695

2.20

15.20

8.0

6.1

1.11

1.49

mmol/l

6.40

136

670

Chronic lymphocytic leukaemia, helper endpoint

141

695

2.20

15.20

8.0

6.1

1.11

1.49

mmol/l

6.40

136

670

Other diseases of blood and blood-forming organs

308

1917

1.69

15.20

8.7

7.3

1.46

1.35

mmol/l

0.70

300

1848

Other disorders of ear

4323

25336

1.15

15.15

6.7

7.2

1.35

1.36

mmol/l

0.14

4156

24383

Diseases of male genital organs

2739

11747

1.20

15.15

8.1

8.6

1.38

1.44

mmol/l

2.33

2615

11295

Excessive, frequent and irregular menstruation

1485

6596

1.27

15.08

6.6

6.2

1.30

1.32

mmol/l

0.51

1426

6339

Benign neoplasm of middle ear and respiratory system

328

2072

1.65

15.07

7.8

6.9

1.33

1.41

mmol/l

0.81

316

1990

Otalgia

327

2065

1.65

15.05

7.8

7.4

1.23

1.32

mmol/l

1.01

316

1977

Other specified/unspecified systemic involvement of connective tissue

250

1476

1.78

15.03

7.4

6.6

1.24

1.32

mmol/l

0.92

243

1428

Other infective otitis externa

264

1583

1.75

15.02

7.9

7.5

1.30

1.38

mmol/l

0.80

256

1517

D07AA Corticosteroids, weak (group I)

593

4214

1.44

14.98

7.0

7.7

1.38

1.35

mmol/l

0.26

572

4034

Papulosquamous disorders

1645

13445

1.24

14.97

7.3

7.1

1.39

1.34

mmol/l

0.84

1574

12983

Follicular cysts of skin and subcutaneous tissue

754

5589

1.39

14.97

7.4

7.2

1.31

1.36

mmol/l

0.47

729

5373

Other skin changes

705

5180

1.40

14.91

7.1

6.7

1.41

1.36

mmol/l

0.54

675

4972

Other/unspecified synovitis and tenosynovitis

462

3148

1.51

14.81

7.0

7.2

1.25

1.32

mmol/l

0.80

443

3030

Salpingitis and oophoritis

636

4591

1.42

14.76

7.8

6.3

1.22

1.25

mmol/l

0.38

611

4446

Oesophageal obstruction

180

976

1.98

14.68

9.6

7.0

1.44

1.39

mmol/l

0.14

171

940

Vascular syndromes of brain in cerebrovascular disorders

230

1343

1.83

14.68

5.9

6.5

1.46

1.39

mmol/l

0.35

223

1289

Bacterial, viral and other infectious agents

361

2345

1.60

14.66

9.5

8.4

1.33

1.39

mmol/l

0.45

348

2247

Mouth breathing

1760

14525

1.23

14.47

6.8

8.1

1.30

1.36

mmol/l

2.12

1690

14008

Dependent personality disorder

109

496

2.40

14.40

7.1

6.5

1.33

1.34

mmol/l

0.07

101

481

Reactive arthropathies

367

2401

1.58

14.39

8.0

7.5

1.30

1.35

mmol/l

0.50

355

2309

Wide developmental disorders, excluding more controls

108

478

2.35

14.39

3.9

12.2

1.63

1.38

mmol/l

0.81

101

453

Artificial joint operation, meniscal resection

4310

25316

1.14

14.37

6.3

7.2

1.36

mmol/l

0.10

4195

24354

Barrett oesophagus

230

1350

1.81

14.37

9.4

7.8

1.41

1.37

mmol/l

0.14

224

1307

Alzheimer’s disease (Late onset), excluding more controls

651

3136

1.42

14.35

3.3

5.5

1.54

1.32

mmol/l

6.25

624

3008

Dislocation, sprain and strain of joints and ligaments of knee

2408

18972

1.19

14.34

6.7

7.5

1.35

1.33

mmol/l

0.36

2331

18345

Skin changes due to chronic exposure to nonionizing radiation

1746

13655

1.23

14.33

5.6

5.8

1.34

1.38

mmol/l

0.61

1676

13088

Parkinson's disease, strict definition, excluding more controls

516

3545

1.47

14.32

4.6

6.2

1.32

1.33

mmol/l

0.07

496

3408

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

277

2.92

14.29

6.6

8.8

1.31

mmol/l

0.01

264

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

305

1916

1.65

14.25

10.0

6.6

1.22

1.36

mmol/l

2.00

292

1849

Other specified/unspecified soft tissue disorders

217

1252

1.82

14.17

5.7

5.9

1.35

1.34

mmol/l

0.13

209

1200

Infective dermatitis

481

3338

1.49

14.16

7.3

7.0

1.37

1.35

mmol/l

0.12

463

3209

Allergic urticaria

323

2061

1.63

14.15

6.5

7.4

1.27

1.33

mmol/l

0.43

310

1974

Benign neoplasm: Parotid gland

308

1947

1.65

14.13

9.6

6.8

1.34

1.40

mmol/l

0.53

299

1881

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

139

700

2.14

14.10

5.9

5.5

1.59

1.53

mmol/l

0.16

133

665

Otitis externa, unspecified

428

2905

1.52

14.09

6.4

7.3

1.24

1.36

mmol/l

2.46

413

2791

Complications of other internal prosthetic devices, implants and grafts

176

959

1.95

14.04

8.1

6.2

1.27

1.34

mmol/l

0.48

171

921

Redundant prepuce, phimosis and paraphimosis

896

6841

1.33

14.02

8.3

8.6

1.49

1.44

mmol/l

0.45

866

6587

Benign neoplasm: Tongue

129

633

2.19

14.00

6.8

6.1

1.29

1.41

mmol/l

0.50

122

610

Benign neoplasm: Cerebral meninges

388

2592

1.56

14.00

6.3

6.2

1.46

1.32

mmol/l

1.24

378

2505

Benign neoplasm of brain and other parts of central nervous system

291

1824

1.67

13.99

8.0

7.4

1.28

1.34

mmol/l

0.62

281

1760

Reactive arthropathies, FINNGEN

293

1834

1.66

13.97

7.8

7.6

1.30

1.36

mmol/l

0.54

285

1765

Suppurative and unspecified otitis media

1325

9419

1.26

13.96

8.4

7.6

1.36

1.35

mmol/l

0.13

1264

9058

Any dementia, excluding more controls

1537

8689

1.25

13.95

4.3

5.8

1.51

1.36

mmol/l

5.79

1451

8343

Foreign body in alimentary tract

249

1503

1.75

13.91

5.2

7.8

1.37

1.40

mmol/l

0.20

240

1439

Benign neoplasm: Kidney

147

757

2.08

13.91

7.0

5.3

1.14

1.40

mmol/l

4.01

140

724

Other hearing loss

1260

9929

1.27

13.87

6.2

1.34

1.38

mmol/l

0.73

1173

9497

Primary gonarthrosis, bilateral

2275

16876

1.20

13.85

6.2

6.8

1.36

1.35

mmol/l

0.05

2201

16239

Actinic keratosis

1698

13338

1.23

13.85

5.6

5.8

1.35

1.38

mmol/l

0.54

1632

12777

Hallux valgus (acquired)

1363

7930

1.26

13.82

5.6

6.8

1.26

1.33

mmol/l

1.94

1309

7622

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

167

901

1.98

13.79

6.0

5.6

1.60

1.48

mmol/l

0.36

160

853

Pulmonary oedema

422

2.49

13.78

13.1

6.6

1.37

1.48

mmol/l

0.34

401

Colonic or urogenital fistula

1123

8890

1.29

13.74

7.1

7.3

1.28

1.35

mmol/l

1.60

1083

8563

Keratitis

1419

11527

1.25

13.70

7.0

7.1

1.33

1.35

mmol/l

0.19

1367

11109

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

158

839

2.01

13.68

6.2

5.6

1.13

1.49

mmol/l

7.32

152

800

L04AC Interleukin inhibitors

202

1155

1.84

13.62

7.3

8.2

1.28

1.32

mmol/l

0.28

191

1110

Exposure to other and unspecified inanimate mechanical forces

289

1817

1.66

13.61

7.5

7.8

1.26

1.38

mmol/l

1.35

282

1743

Acute alcohol intoxication ICD-9

176

971

1.93

13.57

6.6

7.6

1.56

1.34

mmol/l

1.39

166

933

Dental pulpitis 3, only avohilmo

386

1861

1.55

13.54

6.8

7.7

1.32

1.38

mmol/l

0.40

368

1758

Crushed, pushed or stepped on by crowd or human stampede

280

1745

1.66

13.54

6.5

8.0

1.27

1.42

mmol/l

1.94

270

1667

Other disorders starting during childhood or adolescence

206

1174

1.81

13.52

10.7

10.3

1.39

1.38

mmol/l

0.03

200

1087

Social disorders starting during childhood or adolecense, excluding more controls

4.24

13.52

6.7

7.9

1.22

1.57

mmol/l

0.87

Fenamates

698

3471

1.39

13.47

7.1

7.9

1.27

1.37

mmol/l

1.88

664

3341

Other and unspecified medical devices associated with adverse incidents

132

4.16

13.46

7.8

7.4

1.45

1.35

mmol/l

0.20

126

Benign neoplasm of major salivary glands

373

2488

1.55

13.43

8.7

6.4

1.34

1.39

mmol/l

0.38

363

2394

Other benign neoplasms of connective and other soft tissue

355

2341

1.57

13.40

6.4

6.9

1.33

1.39

mmol/l

0.39

345

2254

Benign neoplasm of urinary organs

192

1089

1.86

13.39

7.0

5.7

1.19

1.45

mmol/l

4.09

185

1048

Spondylopathies in diseases classified elsewhere

271

2.91

13.34

11.6

7.3

1.34

1.33

mmol/l

0.03

262

Disorders of vestibular function (Vertigo)

1966

16426

1.21

13.30

5.6

6.7

1.30

1.35

mmol/l

2.11

1908

15809

Malignant neoplasm of oral cavity

173

959

1.94

13.30

8.6

7.1

1.20

1.39

mmol/l

2.06

162

921

Crohn disease (strict definition, require KELA, min 2 HDR)

249

1516

1.71

13.29

7.0

7.8

1.24

1.36

mmol/l

1.27

235

1455

Benign paroxysmal vertigo

1171

9363

1.28

13.22

5.8

6.6

1.27

1.34

mmol/l

2.00

1143

9010

Sarcoidosis

554

3994

1.43

13.22

11.1

7.2

1.42

1.35

mmol/l

0.81

538

3858

Other and unspecified disorders of white blood cells

190

1082

1.87

13.20

8.8

7.4

1.45

1.39

mmol/l

0.14

184

1036

Other and unspecified mental retardation

100

459

2.42

13.16

7.1

13.2

1.56

1.37

mmol/l

0.55

418

Postprocedural disorders of nervous system

248

1508

1.70

13.16

6.5

7.2

1.24

1.29

mmol/l

0.50

238

1447

Melanocytic naevi of trunk

463

3235

1.48

13.15

7.5

7.0

1.29

1.36

mmol/l

0.65

450

3113

Viral infections of the central nervous system

299

1910

1.63

13.15

6.6

7.1

1.33

1.35

mmol/l

0.11

285

1831

Generalized epilepsy

182

1020

1.87

13.14

6.0

8.7

1.27

1.35

mmol/l

0.54

169

970

Abnormal blood-pressure reading, without diagnosis

177

983

1.89

13.12

5.2

6.9

1.30

mmol/l

0.01

170

949

Other and unspecified psoriasis

287

1821

1.65

13.11

9.4

7.7

1.29

1.38

mmol/l

1.06

273

1752

Burns and corrosions of external body surface, specified by site

438

3033

1.49

13.06

7.6

7.9

1.36

1.38

mmol/l

0.20

420

2910

Other retinal artery occlusion

127

641

2.16

13.00

7.4

7.3

1.39

1.46

mmol/l

0.19

121

615

Carcinoma in situ of skin of lower limb, including hip

100

461

2.39

12.96

8.9

5.2

1.24

1.50

mmol/l

2.25

443

Crohn disease (strict definition, require KELA)

251

1544

1.69

12.88

6.9

7.9

1.24

1.36

mmol/l

1.33

237

1481

Deficiency of other B group vitamins

107

507

2.29

12.81

7.9

6.2

1.51

1.44

mmol/l

0.24

101

482

1319

9499

1.26

12.75

4.8

5.5

1.41

1.40

mmol/l

0.22

1249

9083

Other hammer toe(s) (acquired)

721

5100

1.36

12.72

6.1

6.3

1.27

1.34

mmol/l

1.01

691

4901

Macular pucker

644

4799

1.39

12.71

6.5

6.4

1.33

1.34

mmol/l

0.14

626

4632

Other sleep disorders

447

3125

1.47

12.67

6.4

7.3

1.39

1.34

mmol/l

0.46

410

3012

Malignant neoplasm of brain

156

847

1.96

12.67

4.9

7.4

1.29

1.42

mmol/l

1.15

150

808

Hyperkinetic disorders (excl. ADHD)

407

2.42

12.65

5.0

9.1

1.27

1.44

mmol/l

1.13

381

Microscopic polyangiitis

153

3.76

12.63

6.2

9.4

1.26

1.36

mmol/l

0.22

148

Melanocytic naevi

1102

8788

1.28

12.62

7.0

1.28

1.32

mmol/l

0.87

1066

8467

Anogenital herpesviral [herpes simplex] infection

211

1244

1.76

12.61

6.4

7.1

1.22

1.30

mmol/l

0.80

198

1201

Other and unspecified epidermal thickening

131

674

2.09

12.55

5.5

7.8

1.23

1.39

mmol/l

1.45

126

643

Disorders of purine and pyrimidine metabolism

143

3.79

12.48

12.6

4.7

1.87

1.40

mmol/l

0.75

137

Nonsuppurative otitis media

832

5525

1.32

12.46

9.3

7.3

1.28

1.35

mmol/l

1.27

809

5282

Parodontitis, under 40 years, or operation codes

270

1695

1.63

12.46

8.2

7.1

1.25

1.37

mmol/l

1.25

264

1622

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

264

1658

1.65

12.45

6.6

7.7

1.23

1.36

mmol/l

1.65

249

1589

Parodontitis, under 40 years

269

1690

1.63

12.38

8.2

7.1

1.25

1.37

mmol/l

1.21

263

1617

Carcinoma in situ of skin of scalp and neck

131

684

2.11

12.37

6.3

6.7

1.33

1.47

mmol/l

1.14

123

653

Rare circulating lymphoid malignancy

161

895

1.93

12.29

13.4

7.9

1.34

1.40

mmol/l

0.18

152

854

Pedestrian injured in collision with pedal cycle

150

813

1.96

12.25

8.7

7.1

1.35

1.33

mmol/l

0.06

141

775

Seborrhoeic keratosis

920

7222

1.30

12.24

5.2

6.4

1.33

1.34

mmol/l

0.09

878

6952

302

2.70

12.16

7.1

6.2

1.47

1.40

mmol/l

0.25

289

Chronic hepatitis, not elsewhere classified

151

822

1.95

12.15

8.2

7.1

1.68

1.28

mmol/l

3.00

145

787

Other strabismus

816

6285

1.32

12.11

9.6

7.7

1.32

1.34

mmol/l

0.23

770

6033

Acute nasopharyngitis (common cold)

484

3437

1.44

12.11

6.9

8.7

1.35

1.39

mmol/l

0.33

472

3309

Myasthenia gravis

429

2.39

12.08

8.8

6.8

1.32

1.34

mmol/l

0.05

408

Squamous cell neoplasms and carcinomas of the skin

552

4048

1.41

12.06

6.3

5.7

1.39

1.42

mmol/l

0.30

525

3857

Dermatitis due to substances taken internally

228

1397

1.70

11.98

7.9

7.1

1.55

1.35

mmol/l

1.14

219

1332

Malignant neoplasm of retroperitoneum and peritoneum

190

3.30

11.98

8.4

6.0

1.11

1.29

mmol/l

0.96

182

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

215

1292

1.71

11.89

9.0

6.4

1.18

1.21

mmol/l

0.30

207

1252

Gonarthrosis, primary, with knee surgery

2537

17937

1.17

11.88

5.8

6.8

1.39

1.36

mmol/l

0.64

2474

17262

Paranoid personality disorder

436

2.33

11.88

4.6

8.1

1.37

1.33

mmol/l

0.19

422

Hypotension due to drugs

350

2.55

11.83

10.4

6.6

1.25

1.41

mmol/l

1.09

331

Malignant neoplasm of stomach

240

1500

1.68

11.82

9.4

6.7

1.35

1.44

mmol/l

0.57

234

1441

Lymphoid leukaemia

263

1682

1.65

11.81

12.2

7.2

1.14

1.42

mmol/l

7.50

251

1615

Secondary uncertain malignant neoplasm

545

4000

1.41

11.80

5.4

6.7

1.57

1.37

mmol/l

2.59

529

3831

Benign lipomatous neoplasm

1044

8341

1.27

11.78

7.0

6.8

1.30

1.39

mmol/l

2.41

1012

8023

Striking against or struck by other objects

1283

10479

1.24

11.77

7.3

8.0

1.36

mmol/l

0.01

1222

10080

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

120

615

2.11

11.74

8.7

6.9

1.17

1.43

mmol/l

3.26

113

593

Acne

318

2103

1.55

11.71

9.1

7.5

1.23

1.35

mmol/l

1.65

307

2011

Family history of malignant neoplasm

343

2311

1.52

11.67

6.9

6.0

1.24

1.28

mmol/l

0.36

335

2231

Background retinopathy and retinal vascular changes

108

534

2.19

11.67

8.5

7.4

1.23

1.43

mmol/l

1.39

102

511

Monoarthritis, not elsewhere classified

183

1066

1.80

11.65

6.2

7.3

1.47

1.36

mmol/l

0.27

178

1027

Postmenopausal osteoporosis with pathological fracture

260

1664

1.64

11.63

6.2

4.7

1.45

1.33

mmol/l

0.65

248

1595

Visual field defects

358

2447

1.52

11.61

7.5

6.9

1.39

1.38

mmol/l

0.05

345

2352

Other disorders of nervous system

282

1836

1.60

11.59

7.3

1.36

mmol/l

0.04

270

1773

Crohn's disease of large intestine

210

1271

1.72

11.57

7.2

7.6

1.28

1.36

mmol/l

0.77

201

1220

Medical abortion

2335

10870

1.18

11.54

6.0

6.1

1.27

1.29

mmol/l

0.32

2250

10521

SLE (Finngen)

143

777

1.94

11.50

7.9

6.2

1.25

1.33

mmol/l

0.63

137

751

Other and unspecified intracranial injuries

142

773

1.96

11.48

6.0

7.0

1.69

1.37

mmol/l

2.06

134

734

Carcinoma in situ of skin of upper limb, including shoulder

123

645

2.09

11.46

9.3

6.4

1.27

1.44

mmol/l

1.40

115

614

Other specified/unspecified bacterial intestinal infections

277

1802

1.60

11.42

7.9

7.1

1.33

1.36

mmol/l

0.23

261

1737

Carcinoma in situ of skin of trunk

154

867

1.92

11.41

6.8

6.6

1.38

1.46

mmol/l

0.46

142

827

Diffuse large B-cell lymphoma

211

1293

1.73

11.38

8.1

7.1

1.71

1.39

mmol/l

2.11

201

1247

Malignant neoplasm of eye, brain and central nervous system

193

1152

1.77

11.37

5.3

7.8

1.27

1.41

mmol/l

1.70

184

1105

Unspecified visual impairment (binocular)

355

2.48

11.37

9.3

1.24

1.29

mmol/l

0.24

338

Giant cell arteritis

192

1151

1.77

11.26

6.2

1.42

1.36

mmol/l

0.31

180

1115

Premature rupture of membranes

301

3315

0.66

11.22

5.0

6.6

1.27

1.24

mmol/l

0.18

293

3190

Pregnancy hypertension

1247

9179

1.24

11.20

6.6

6.5

1.26

1.24

mmol/l

0.27

1205

8879

Single spontaneous delivery

1129

7426

0.80

11.15

4.8

6.1

1.29

1.31

mmol/l

0.27

1088

7167

Benign neoplasm: Rectosigmoid junction

171

994

1.82

11.12

6.5

5.9

1.30

1.46

mmol/l

1.26

158

961

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1423

10312

1.22

11.06

6.7

6.6

1.25

mmol/l

0.04

1376

9990

Other disorders of central nervous system

260

2.72

11.03

5.6

6.9

1.11

1.24

mmol/l

0.90

248

Injury of muscle and tendon at hip and thigh level

374

2601

1.49

11.03

8.0

7.8

1.40

1.36

mmol/l

0.37

354

2507

Superficial injury of neck

402

2.31

11.02

5.0

7.7

1.37

1.35

mmol/l

0.04

382

Degeneration of the brain due to alcohol

121

639

2.06

10.97

9.8

8.5

1.99

1.43

mmol/l

1.61

116

617

Trigeminal neuralgia

240

1524

1.64

10.96

5.5

7.0

1.29

1.34

mmol/l

0.31

231

1466

Neovascular glaucoma

184

1096

1.77

10.94

8.3

7.0

1.36

1.40

mmol/l

0.15

178

1049

Glaucoma secondary to other eye disorders

187

1119

1.76

10.94

8.2

7.1

1.36

1.40

mmol/l

0.20

181

1069

Other salmonella infections

158

900

1.85

10.94

9.1

7.0

1.34

1.38

mmol/l

0.14

148

866

Parodontitis, operation under 40 years and operation codes

250

1592

1.61

10.93

8.3

7.1

1.26

1.36

mmol/l

0.96

244

1524

Tumor necrosis factor alpha inhibitors

499

3647

1.40

10.91

8.0

7.7

1.29

1.33

mmol/l

0.41

482

3524

Temporal arteritis

173

1018

1.81

10.90

6.2

1.40

1.36

mmol/l

0.20

163

986

Malignant neoplasm of oesophagus

130

705

2.00

10.86

13.1

7.5

1.25

1.42

mmol/l

1.45

125

676

Other and unspecified urticaria

705

5424

1.33

10.86

7.8

7.1

1.32

mmol/l

0.04

673

5213

Degeneration of nervous system due to alcohol

121

642

2.05

10.82

9.8

8.0

1.99

1.43

mmol/l

1.60

116

616

Benign neoplasm: Pancreas

115

598

2.07

10.78

7.2

5.7

1.27

1.42

mmol/l

0.93

106

578

Parodontitis, under 40 years and operation codes

249

1591

1.60

10.74

8.3

7.1

1.26

1.36

mmol/l

0.92

243

1523

Other (seronegative) rheumatoid arthritis, wide

765

5969

1.31

10.71

6.2

6.4

1.47

1.33

mmol/l

1.39

735

5754

Contusion of ankle

155

883

1.84

10.68

6.1

7.7

1.35

1.37

mmol/l

0.09

150

841

Other/unspecified rheumatoid arthritis

512

3781

1.39

10.66

5.8

6.0

1.53

1.35

mmol/l

1.25

492

3634

Psoriatic and enteropathic arthropathies

451

3258

1.42

10.66

6.3

7.4

1.34

1.33

mmol/l

0.14

432

3142

Other and unspecified types of non-Hodgkin lymphoma, hilmo

195

1192

1.73

10.61

6.3

7.0

1.72

1.40

mmol/l

1.36

190

1142

Other misadventures during surgical and medical care

105

533

2.13

10.59

8.4

7.2

1.40

1.38

mmol/l

0.03

100

507

Artificial joint re-operation

303

2048

1.55

10.59

6.8

6.2

1.39

1.34

mmol/l

0.23

294

1971

Oligomenorrhoea

124

659

1.96

10.57

7.7

5.9

1.40

1.26

mmol/l

0.73

119

635

Molar incisor enamel hypoplasia

129

684

1.95

10.56

21.0

10.9

1.12

1.38

mmol/l

3.87

120

619

Benign neoplasm: Anus and anal canal

120

636

2.01

10.55

6.1

5.1

1.43

mmol/l

0.02

113

610

Paralytic strabismus

302

2041

1.54

10.47

7.2

6.9

1.35

1.40

mmol/l

0.36

289

1969

Benign neoplasm: Pituitary gland, craniopharyngeal duct

214

1341

1.67

10.40

6.6

7.7

1.20

1.35

mmol/l

2.15

202

1288

Asthma mixed form (mode), excluding more controls

175

1035

1.74

10.37

6.3

5.5

1.43

1.37

mmol/l

0.24

154

1001

Other/unspecified reactive arthropathies

262

1719

1.58

10.37

8.3

7.6

1.29

1.35

mmol/l

0.47

256

1658

Pre-eclampsia or poor fetal growth

850

6710

1.28

10.30

8.0

6.5

1.24

mmol/l

0.09

827

6485

Neuralgia and neuritis, unspecified

203

1257

1.68

10.30

8.1

7.2

1.35

mmol/l

0.00

197

1216

Metabolic disorder, other/unspecified

4.75

10.28

23.4

9.1

1.54

1.30

mmol/l

0.67

Pre-eclampsia or eclampsia

637

4865

1.33

10.26

6.9

6.5

1.22

1.24

mmol/l

0.31

621

4717

Propionic acid derivatives

1437

5991

1.22

10.23

7.1

7.9

1.42

1.40

mmol/l

0.21

1374

5719

Lesion of radial nerve

166

980

1.79

10.22

10.1

7.5

1.39

1.36

mmol/l

0.14

157

943

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

498

2.14

10.19

9.4

6.2

1.35

1.47

mmol/l

0.51

477

Other other unspecified disorders of the circulatory system

169

1006

1.78

10.17

7.0

7.6

1.27

1.39

mmol/l

0.80

162

968

Giant cell arteritis with polymyalgia rheumatica

173

1039

1.77

10.15

6.2

1.40

1.37

mmol/l

0.13

163

1005

Mild mental retardation

117

625

1.99

10.08

10.4

8.3

1.31

1.33

mmol/l

0.09

107

592

conjunctival haemorrhage

315

2165

1.51

10.07

8.8

6.7

1.32

1.36

mmol/l

0.30

301

2089

Pain associated with micturition

444

3234

1.41

10.06

7.0

6.9

1.37

1.35

mmol/l

0.14

423

3115

Pedal cyclist injured in transport accident

838

6662

1.28

10.01

5.8

7.6

1.38

1.35

mmol/l

0.37

804

6412

Personal history of certain other diseases

294

2.45

10.01

12.4

6.5

1.34

1.36

mmol/l

0.05

280

Other and/or unspecified nontoxic goitre

325

2246

1.50

9.99

4.7

6.2

1.24

1.30

mmol/l

0.70

320

2177

Sicca syndrome [Sjögren]

327

2262

1.49

9.98

8.3

6.2

1.27

1.28

mmol/l

0.03

317

2186

Wet age-related macular degeneration

751

5804

1.30

9.95

5.1

5.2

1.46

1.41

mmol/l

0.58

703

5552

Postmenopausal bleeding

1113

4975

1.25

9.94

6.1

6.4

1.23

1.33

mmol/l

3.20

1083

4790

Acne vulgaris

242

1567

1.58

9.93

8.7

7.3

1.25

1.34

mmol/l

0.88

234

1499

Disorders of refraction and accommodation

940

7543

1.26

9.93

8.4

7.8

1.33

mmol/l

0.05

894

7246

Oral leukoplakia and related diseases

248

1630

1.59

9.92

8.0

7.1

1.35

1.36

mmol/l

0.06

240

1567

Other specified/unspecified dorsopathies

142

807

1.84

9.91

9.6

7.8

1.31

1.32

mmol/l

0.01

132

782

Injury of nerves and spinal cord at neck level

113

603

2.02

9.90

6.4

6.9

1.43

1.40

mmol/l

0.09

107

576

Anti-inflammatory and antirheumatic products, non-steroids

1433

5994

1.22

9.87

7.0

7.9

1.37

1.40

mmol/l

0.35

1376

5721

Follicular lymphoma

169

1013

1.75

9.84

6.0

6.2

1.24

1.43

mmol/l

2.06

164

982

SLE, ICD10

139

788

1.86

9.84

7.5

6.0

1.23

1.31

mmol/l

0.64

133

753

SLE, strict definition

139

788

1.86

9.84

7.5

6.0

1.23

1.31

mmol/l

0.64

133

753

Diabetes mellitus in pregnancy

823

4199

1.28

9.83

6.2

7.0

1.30

1.23

mmol/l

1.19

790

4057

Diseases of tongue

249

1637

1.58

9.79

5.4

6.2

1.38

1.37

mmol/l

0.04

238

1579

Peritonsillar abscess

764

6019

1.29

9.78

7.4

7.7

1.31

1.36

mmol/l

0.61

735

5811

Inguinal or femoral hernia, bilateral

476

3532

1.39

9.75

7.3

7.4

1.31

1.43

mmol/l

1.15

453

3386

Bursitis of shoulder

114

611

1.98

9.73

4.1

7.3

1.32

1.33

mmol/l

0.02

108

586

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

208

1323

1.65

9.64

7.1

6.6

1.95

1.43

mmol/l

2.93

196

1262

Systemic lupus erythematosus

143

823

1.82

9.61

7.9

6.0

1.25

1.32

mmol/l

0.48

137

794

Injury of eye and orbit

517

3881

1.36

9.57

7.5

7.8

1.34

mmol/l

0.00

492

3738

Bitten or struck by other mammals

375

2676

1.44

9.55

8.8

7.5

1.36

1.32

mmol/l

0.21

365

2571

Bronchitis, not specified as acute or chronic

343

2413

1.46

9.52

7.2

7.3

1.45

1.40

mmol/l

0.37

326

2313

Coxarthrosis, primary, with hip surgery

2054

16911

1.17

9.51

6.3

6.5

1.34

1.36

mmol/l

0.36

1990

16262

Synovial cyst of popliteal space [Baker]

296

2032

1.51

9.45

7.3

6.7

1.39

1.34

mmol/l

0.30

289

1965

Pre-eclampsia

579

4418

1.33

9.44

6.7

6.5

1.24

1.23

mmol/l

0.08

563

4279

Maternal care for other conditions predominantly related to pregnancy

538

4011

1.34

9.32

7.5

6.9

1.27

1.22

mmol/l

0.47

518

3877

Impingement syndrome of shoulder

980

8000

1.25

9.28

6.7

7.6

1.26

1.34

mmol/l

2.16

953

7740

Special screening examination for other diseases and disorders

298

2048

1.49

9.27

9.7

6.3

1.35

1.32

mmol/l

0.20

290

1986

Single delivery by forceps and vacuum extractor

225

2094

0.64

9.26

5.5

7.7

1.20

1.24

mmol/l

0.41

212

2017

Other injuries of lower limb, level unspecified

192

2.88

9.26

5.5

8.1

1.32

1.35

mmol/l

0.08

185

Other and unspecified injuries of ankle and foot

155

921

1.75

9.23

7.5

7.7

1.39

1.36

mmol/l

0.13

150

879

Bullous disorders

246

1641

1.56

9.18

5.0

6.9

1.44

1.40

mmol/l

0.31

232

1576

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

247

2.60

9.17

5.9

6.3

1.32

1.39

mmol/l

0.16

240

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

485

3627

1.36

9.13

5.2

5.9

1.22

1.26

mmol/l

0.45

464

3504

Juvenile arthritis (FINNGEN)

163

983

1.72

9.11

6.8

7.5

1.29

1.37

mmol/l

0.29

151

937

Diphtheria

6.96

9.07

2.9

6.5

1.06

1.30

mmol/l

0.69

Dystonia

216

1402

1.60

9.07

5.0

7.5

1.24

1.31

mmol/l

0.64

211

1351

Cerebral palsy

389

2.20

9.04

8.3

10.5

1.33

1.34

mmol/l

0.02

364

Other noninflammatory disorders of uterus, except cervix

878

4822

1.26

9.03

4.8

6.0

1.28

1.33

mmol/l

0.57

850

4639

Lumbosacral root disorders, not elsewhere classified

313

2.39

8.98

5.5

6.6

1.24

1.30

mmol/l

0.20

298

Other and unspecified iridocyclitis

176

1093

1.68

8.96

4.9

7.4

1.26

1.38

mmol/l

0.81

165

1047

Benign neoplasm: Skin of eyelid, including canthus

611

4753

1.32

8.92

5.9

6.6

1.32

1.34

mmol/l

0.15

597

4584

Drug-induced Cushing's syndrome

10.19

8.92

10.8

2.2

1.78

1.08

mmol/l

1.55

Other juvenile arthritis

143

838

1.77

8.91

6.5

7.4

1.31

1.39

mmol/l

0.25

133

794

Noninflammatory disorders of female genital tract

1581

6741

1.19

8.90

5.4

6.2

1.23

1.33

mmol/l

3.70

1521

6476

Other ulcerative colitis

224

1471

1.58

8.89

9.2

7.7

1.30

1.38

mmol/l

0.50

212

1410

Chronic lymphocytic leukaemia

141

834

1.81

8.87

8.0

7.3

1.11

1.41

mmol/l

4.66

136

796

Diseases of inner ear

2265

19484

1.15

8.83

5.9

6.8

1.30

1.35

mmol/l

1.98

2195

18759

Inguinal hernia, bilateral

463

3479

1.37

8.79

7.4

1.31

1.43

mmol/l

1.16

440

3333

Hypoplasia of dental enamel , including avohilmo

114

623

1.90

8.77

19.8

11.0

1.08

1.36

mmol/l

4.61

106

561

Other/unspecified enthesopathies of lower limb, excluding foot

247

1659

1.53

8.73

6.6

7.4

1.24

1.31

mmol/l

0.59

238

1599

Essential (haemorrhagic) thrombocythaemia

146

871

1.76

8.70

6.4

5.4

1.42

1.41

mmol/l

0.01

141

838

Benign neoplasm: Tongue

129

747

1.84

8.68

6.8

6.6

1.29

1.40

mmol/l

0.44

122

715

Diseases of middle ear and mastoid

2205

15835

1.15

8.57

7.8

7.3

1.33

1.35

mmol/l

0.48

2122

15221

Iridocyclitis

870

7078

1.25

8.56

7.5

6.9

1.32

1.34

mmol/l

0.21

838

6811

Other intracranial haemorrhages

144

863

1.77

8.55

9.2

7.1

1.34

1.40

mmol/l

0.35

136

825

Malignant melanoma of skin

461

3476

1.36

8.53

5.8

6.6

1.38

1.36

mmol/l

0.17

443

3353

Spondylopathies (FG)

500

3802

1.34

8.52

6.1

7.3

1.36

1.35

mmol/l

0.05

481

3661

Palmar fascial fibromatosis [Dupuytren]

669

5297

1.29

8.48

7.7

7.0

1.37

1.39

mmol/l

0.18

637

5068

Oral leukoplakia and related diseases, including avohilmo

351

2540

1.43

8.46

7.9

7.0

1.40

1.36

mmol/l

0.23

340

2454

Malignant neoplasm of breast

1812

11314

1.17

8.43

5.0

6.1

1.26

1.29

mmol/l

0.42

1752

10938

Impetigo

164

1014

1.68

8.43

8.3

1.38

1.33

mmol/l

0.31

157

962

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

252

1715

1.51

8.39

8.3

6.5

1.25

1.34

mmol/l

1.02

240

1658

Vulvovaginal ulceration/inflammation in other diseases

172

1074

1.65

8.38

5.8

5.9

1.28

1.26

mmol/l

0.12

165

1030

Autism spe, excluding more controls

304

2.26

8.36

3.6

8.1

1.81

1.42

mmol/l

0.76

290

Atypical facial pain

196

1269

1.61

8.35

5.7

6.6

1.26

1.34

mmol/l

0.70

191

1219

Personal history of medical treatment

214

2.64

8.35

12.5

6.7

1.35

1.27

mmol/l

0.14

204

Bell's palsy

452

3404

1.36

8.35

6.7

7.2

1.37

1.35

mmol/l

0.15

428

3276

Benign neoplasm of middle ear and respiratory system

328

2354

1.44

8.32

7.8

7.3

1.33

1.40

mmol/l

0.69

316

2266

Polyarteritis nodosa and related conditions

322

2.28

8.31

5.7

6.9

1.33

1.37

mmol/l

0.16

310

Seronegative rheumatoid arthritis

451

3401

1.36

8.24

6.6

6.3

1.42

1.34

mmol/l

0.44

435

3284

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

216

1431

1.56

8.22

9.1

6.6

1.26

1.33

mmol/l

0.52

206

1387

Hydrocele

528

4077

1.33

8.21

7.6

8.1

1.42

1.45

mmol/l

0.19

506

3903

190

2.69

8.21

6.0

7.5

1.24

1.37

mmol/l

0.37

179

Other benign neoplasms of skin

1500

12876

1.18

8.20

6.1

6.6

1.29

1.36

mmol/l

1.75

1461

12372

Other and unspecified injuries of wrist and hand

144

869

1.73

8.18

6.3

7.5

1.41

1.33

mmol/l

0.38

138

834

Other and unspecified vascular occlusions

394

2925

1.39

8.15

7.4

5.9

1.34

1.38

mmol/l

0.25

376

2800

Non-allergic asthma

359

2622

1.41

8.14

7.7

7.8

1.29

1.39

mmol/l

1.44

342

2506

Delivery

1182

7448

0.83

8.12

4.9

6.2

1.28

1.31

mmol/l

0.37

1143

7189

Other peripheral vascular diseases

291

2050

1.46

8.12

6.2

1.37

1.35

mmol/l

0.13

276

1976

Non-Hodgkin lymphoma, all

179

1148

1.64

8.11

6.2

6.9

1.96

1.44

mmol/l

2.52

169

1098

Other congenital malformations of upper alimentary tract

194

2.76

8.11

7.2

10.5

1.59

1.32

mmol/l

0.88

183

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

590

4623

1.30

8.06

8.0

7.6

1.34

1.36

mmol/l

0.12

568

4443

Primary coxarthrosis, bilateral

1205

10190

1.20

8.03

6.9

6.4

1.36

1.37

mmol/l

0.13

1175

9794

Plantar fascial fibromatosis

341

2472

1.41

8.02

6.1

7.2

1.32

1.31

mmol/l

0.07

332

2387

Other and unspecified disorders of vitreous body

1625

13992

1.17

7.99

6.3

6.9

1.30

1.33

mmol/l

0.48

1575

13538

Radial styloid tenosynovitis [de Quervain]

187

1207

1.60

7.99

6.7

6.9

1.24

1.29

mmol/l

0.35

174

1167

Calculus of lower urinary tract

237

1619

1.53

7.98

5.5

7.4

1.31

1.44

mmol/l

1.57

228

1555

Temporomandibular joint disorders, including avohilmo

1376

11725

1.18

7.96

5.7

7.0

1.30

mmol/l

0.00

1317

11343

Disorder of external ear, unspecified

133

795

1.76

7.95

6.5

7.5

1.45

1.34

mmol/l

0.39

126

767

Otitis media, unspecified

388

2640

1.38

7.94

9.7

8.4

1.38

1.37

mmol/l

0.08

368

2504

Hordeolum and other deep inflammation of eyelid

211

1405

1.56

7.92

5.7

8.3

1.26

1.37

mmol/l

0.93

200

1347

Bullous pemphigoid

103

576

1.92

7.91

4.3

6.5

1.58

1.41

mmol/l

0.88

548

Benign neoplasm: Other and unspecified parts of mouth

131

783

1.75

7.79

6.5

5.8

1.35

1.37

mmol/l

0.05

121

754

Carcinoma in situ of skin of lower limb, including hip

100

559

1.94

7.77

8.9

5.8

1.24

1.42

mmol/l

1.28

531

Malignant neoplasm of breast, HER2-negative

1756

11216

1.16

7.76

5.0

6.0

1.27

1.29

mmol/l

0.28

1697

10844

Alzheimer’s disease (Atypical or mixed), excluding more controls

298

1833

1.45

7.75

3.0

5.4

1.60

1.36

mmol/l

2.57

278

1744

Generalized epilepsy, mode (most common among epilepsy diagnosis)

125

738

1.77

7.74

5.5

8.6

1.31

1.35

mmol/l

0.24

119

699

Acute appendicitis, with complications

776

6310

1.25

7.74

8.6

7.4

1.33

1.35

mmol/l

0.17

753

6062

Pemphigoid

123

728

1.80

7.73

4.3

6.0

1.61

1.41

mmol/l

1.28

115

697

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

134

809

1.74

7.73

4.5

6.0

1.56

1.45

mmol/l

0.42

129

772

Renal cell carcinoma of kidney

158

996

1.67

7.72

6.2

6.5

1.13

1.43

mmol/l

6.07

152

951

Malignant neoplasm of tongue

537

1.95

7.72

8.6

7.3

1.21

1.41

mmol/l

1.40

516

Secondary parkinsonism+Parkinsonism in other disease

126

750

1.78

7.72

4.7

7.3

1.30

1.46

mmol/l

1.09

120

722

Unspecified protein-energy malnutrition

140

3.06

7.64

2.9

6.3

1.45

1.35

mmol/l

0.24

129

Vascular dementia (subcortical)

131

790

1.75

7.63

3.8

5.8

1.62

1.43

mmol/l

1.18

125

744

Burn and corrosion of trunk

126

751

1.77

7.62

8.4

7.7

1.46

1.40

mmol/l

0.30

121

719

Other abnormal findings in urine

397

2.10

7.58

9.9

7.2

1.23

1.40

mmol/l

0.88

374

Acute generalized exanthematous pustulosis

175

1133

1.61

7.53

9.1

7.3

1.61

1.39

mmol/l

1.00

168

1085

Papilloedema, unspecified

524

1.92

7.51

11.1

8.5

1.34

1.33

mmol/l

0.04

506

Secondary parkinsonism

124

741

1.77

7.51

4.8

7.4

1.31

1.46

mmol/l

1.00

118

712

Fatigue fracture of vertebra

107

3.34

7.50

4.6

10.3

1.20

1.51

mmol/l

0.85

100

Injury of muscle and tendon at wrist and hand level

521

4065

1.31

7.47

7.6

8.1

1.35

1.37

mmol/l

0.10

512

3918

Retinal detachment with retinal break

525

4106

1.31

7.47

7.9

6.9

1.33

1.36

mmol/l

0.23

508

3941

Systemic lupus erythematosus, unspecified

117

687

1.79

7.45

7.2

6.1

1.26

1.32

mmol/l

0.34

112

656

Spontaneous rupture of synovium and tendon

312

2264

1.42

7.41

6.8

7.2

1.36

1.34

mmol/l

0.15

305

2186

Malignant neoplasm of liver and intrahepatic bile ducts

147

921

1.68

7.40

7.5

7.4

1.92

1.44

mmol/l

2.67

136

877

Unspecified threat to breathing

213

2.51

7.40

5.5

7.9

1.47

1.32

mmol/l

0.48

202

Burn and corrosion of hip and lower limb, except ankle and foot

100

563

1.88

7.40

10.1

8.1

1.36

mmol/l

0.00

534

Other lack of coordination

414

2.05

7.39

4.9

7.5

1.33

1.32

mmol/l

0.03

394

Abnormal findings on diagnostic imaging of central nervous system

166

1066

1.62

7.38

8.4

8.0

1.49

1.35

mmol/l

0.45

159

1023

Blepharochalasis

1155

9804

1.20

7.37

5.4

6.4

1.27

1.35

mmol/l

2.00

1122

9433

Chronic laryngitis and laryngotracheitis

528

4135

1.30

7.35

8.0

6.7

1.37

1.34

mmol/l

0.20

503

3988

Other disorders of conjunctiva

549

4325

1.30

7.35

8.4

6.7

1.33

1.35

mmol/l

0.12

525

4177

Lactose intolerance

112

651

1.79

7.33

12.6

6.6

1.32

1.39

mmol/l

0.38

106

624

Other congenital malformations of intestine

215

2.52

7.32

17.5

9.7

1.32

1.34

mmol/l

0.05

202

Seborrhoeic dermatitis

375

2809

1.37

7.29

6.3

7.1

1.44

1.37

mmol/l

0.66

356

2691

Atrophic disorders of skin

503

3920

1.31

7.27

5.1

6.2

1.30

mmol/l

0.04

490

3787

Excessive vomiting in pregnancy

230

1581

1.49

7.25

4.1

5.8

1.23

1.21

mmol/l

0.15

220

1527

Hereditary nephropathy, not elsewhere classified

4.13

7.24

39.8

5.7

1.29

1.34

mmol/l

0.09

Disorders of breast

1631

13161

1.16

7.23

6.4

6.1

1.23

1.28

mmol/l

1.12

1587

12729

Malignant melanoma

590

4702

1.28

7.21

6.1

6.6

1.38

1.35

mmol/l

0.25

570

4505

Carcinoma in situ of oral cavity, oesophagus and stomach

109

3.21

7.21

6.9

5.4

1.65

1.41

mmol/l

0.30

103

Adalimumab

303

2196

1.41

7.20

8.6

7.8

1.28

1.34

mmol/l

0.49

290

2119

Hydrocephalus

316

2314

1.41

7.19

5.8

6.5

1.47

1.37

mmol/l

0.99

302

2226

Contact with heat and hot substances

203

1370

1.53

7.19

6.6

8.6

1.38

mmol/l

0.00

197

1313

Inguinal of femoral hernia, unilateral

117

696

1.77

7.18

5.7

7.4

1.25

1.38

mmol/l

0.82

112

665

Inguinal hernia, unilateral

117

696

1.77

7.18

5.7

7.4

1.25

1.38

mmol/l

0.82

112

665

Femoral hernia, unilateral

117

696

1.77

7.18

5.7

7.4

1.25

1.38

mmol/l

0.82

112

665

Generalized skin eruption due to drugs and medicaments

154

980

1.64

7.18

8.9

7.2

1.64

1.40

mmol/l

0.95

148

936

Benign neoplasm: Kidney

147

928

1.67

7.17

7.0

6.5

1.15

1.37

mmol/l

3.36

140

890

Benign neoplasm of urinary organs

192

1288

1.55

7.09

7.0

6.9

1.19

1.38

mmol/l

2.65

185

1233

Thyrotoxicosis with toxic multinodular goitre

231

1606

1.49

7.08

6.0

5.7

1.16

1.32

mmol/l

2.65

226

1545

Asthma mixed form (mode)

175

1144

1.57

7.07

6.3

5.7

1.43

1.39

mmol/l

0.17

154

1107

Chondropathies

560

4437

1.29

7.07

6.4

7.4

1.42

1.34

mmol/l

0.76

539

4275

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

193

2.57

7.07

8.7

5.0

1.26

1.40

mmol/l

0.47

184

Vasomotor and allergic rhinitis

1366

11595

1.17

7.07

6.7

7.6

1.28

1.34

mmol/l

1.86

1306

11185

Erectile dysfunction

369

2781

1.37

7.07

16.3

7.5

1.38

1.41

mmol/l

0.26

352

2663

Pyoderma

470

1.94

7.05

9.7

7.6

1.32

1.38

mmol/l

0.29

447

Ulcerative colitis (strict definition, require KELA)

606

4847

1.27

7.04

7.9

7.7

1.35

mmol/l

0.05

583

4662

Hyperprolactinaemia

114

673

1.76

7.04

8.8

7.6

1.12

1.29

mmol/l

1.75

114

645

Hepatocellular carcinoma

568

1.87

7.03

6.6

8.0

2.06

1.48

mmol/l

2.11

540

Nosocomial condition (hospital)

128

2.99

7.00

5.2

6.0

1.94

1.33

mmol/l

0.50

120

Seropositive rheumatoid arthritis, strict definition

564

4483

1.28

6.99

8.0

6.6

1.31

1.32

mmol/l

0.18

550

4329

Polyp of the female genital tract

1147

5646

1.20

6.96

5.9

6.3

1.26

1.31

mmol/l

1.05

1116

5432

Pilonidal cyst

288

2080

1.42

6.96

9.3

8.1

1.40

1.36

mmol/l

0.24

279

1997

Drug-induced polyneuropathy

221

2.47

6.94

7.5

7.6

1.29

1.28

mmol/l

0.03

205

Congenital deformities of hip

400

2.01

6.93

7.6

10.8

1.42

1.32

mmol/l

0.17

376

Other disorders of penis

409

3131

1.34

6.91

9.8

9.2

1.37

1.42

mmol/l

0.43

389

3001

L02BA Anti-estrogens

554

4397

1.28

6.90

4.6

6.2

1.27

1.26

mmol/l

0.05

531

4262

Rheumatic fever incl heart disease

138

867

1.66

6.83

10.4

6.6

1.33

1.43

mmol/l

0.59

130

828

Other keratitis

390

2964

1.34

6.82

7.9

7.0

1.43

1.37

mmol/l

0.37

377

2858

Other and unspecified bullous disorders

235

2.38

6.80

6.2

6.9

1.51

1.36

mmol/l

0.45

224

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

655

5307

1.25

6.79

8.5

7.8

1.33

1.35

mmol/l

0.13

629

5109

Femoral hernia

180

1202

1.56

6.79

7.7

6.6

1.20

1.39

mmol/l

2.35

175

1153

Other acquired deformities of musculoskeletal system and connective tissue

190

1285

1.54

6.74

7.2

7.4

1.32

1.39

mmol/l

0.49

185

1239

Social disorders starting during childhood or adolescence

153

2.69

6.74

6.7

9.5

1.22

1.32

mmol/l

0.28

137

Certain conditions originating in the perinatal period

284

1819

1.41

6.73

11.5

9.2

1.28

1.36

mmol/l

0.73

266

1710

Other injuries of upper limb, level unspecified

222

2.38

6.73

9.7

6.9

1.40

1.37

mmol/l

0.08

214

Dental caries 2

3013

21453

1.11

6.72

8.1

7.4

1.25

1.34

mmol/l

5.83

2906

20715

Liposarcoma, excluding all cancers (controls excluding all cancers)

244

2.33

6.65

9.6

5.5

0.99

1.46

mmol/l

5.18

236

Pedal cyclist injured in noncollision transport accidents

403

3090

1.33

6.64

6.0

7.7

1.31

1.36

mmol/l

0.58

391

2961

Hyperplasia of prostate

1802

9044

1.15

6.63

7.2

8.2

1.36

1.44

mmol/l

2.41

1718

8704

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

169

2.67

6.61

4.3

6.4

1.48

1.36

mmol/l

0.33

162

Malignant neoplasm of corpus uteri

312

2314

1.39

6.59

3.9

5.1

1.28

1.30

mmol/l

0.13

303

2235

Schizotypal disorder

508

1.85

6.58

5.3

7.9

1.41

1.34

mmol/l

0.27

492

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

148

955

1.62

6.57

7.5

6.4

1.22

1.39

mmol/l

1.61

140

916

Corneal ulcer

663

5404

1.25

6.54

6.8

7.1

1.28

1.35

mmol/l

1.07

641

5203

Anankastic personality disorder

127

788

1.67

6.53

6.5

6.9

1.26

1.31

mmol/l

0.33

122

761

Injury of nerves at lower leg level

219

2.38

6.52

12.2

6.6

1.43

1.33

mmol/l

0.26

207

Psoriatic arthropathies

366

2777

1.35

6.51

6.5

7.5

1.36

1.33

mmol/l

0.27

350

2676

Benign neoplasm: Parotid gland

308

2284

1.39

6.50

9.6

7.3

1.34

1.37

mmol/l

0.22

299

2200

Benign neoplasm: Pancreas

115

703

1.73

6.49

7.2

6.9

1.27

1.39

mmol/l

0.75

106

673

Other and unspecified acquired haemolytic anaemias

234

2.35

6.47

15.1

6.7

1.38

1.37

mmol/l

0.04

221

Nontoxic goitre/thyroid nodule

1117

9561

1.18

6.46

4.8

6.1

1.26

1.32

mmol/l

1.47

1079

9237

Other specified/unspecified spondylopathies

107

641

1.75

6.43

6.0

7.4

1.24

1.38

mmol/l

1.13

102

620

Myeloproliferative diseases

336

2531

1.37

6.41

6.5

1.48

1.36

mmol/l

0.78

324

2439

Other abnormal findings of blood chemistry

168

1120

1.56

6.41

8.2

7.5

1.53

1.38

mmol/l

0.89

162

1080

Acute and subacute iridocyclitis

716

5897

1.23

6.40

7.7

6.9

1.33

1.34

mmol/l

0.05

688

5679

Acute lymphadenitis

205

1418

1.49

6.40

7.4

7.5

1.29

1.39

mmol/l

0.96

199

1353

Lactose intolerance, other/unspecified

572

1.78

6.38

13.3

6.7

1.29

1.40

mmol/l

0.62

548

Dental caries 2 and operation codes

2933

21147

1.11

6.38

7.9

7.4

1.26

1.34

mmol/l

5.55

2827

20420

L01XX Other antineoplastic agents

230

1634

1.46

6.37

6.3

6.6

1.34

1.39

mmol/l

0.30

223

1570

Childhood allergy (age < 16)

428

2723

1.31

6.37

7.3

8.7

1.43

1.36

mmol/l

0.48

404

2589

Injury of muscle and tendon at forearm level

479

1.88

6.36

6.6

8.5

1.46

1.34

mmol/l

0.53

460

Scar conditions and fibrosis of skin

142

913

1.61

6.33

6.4

6.6

1.26

1.34

mmol/l

0.55

137

875

Benign neoplasm: salivary glands, exclude unknown (D119)

339

2561

1.36

6.32

9.3

7.2

1.32

1.37

mmol/l

0.46

329

2471

Benign neoplasm: Appendix

222

2.34

6.32

8.9

5.5

1.23

1.43

mmol/l

1.07

212

Prolonged pregnancy

198

2600

0.69

6.31

4.2

6.8

1.39

1.24

mmol/l

0.70

193

2506

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

267

1939

1.41

6.29

8.3

7.7

1.32

1.34

mmol/l

0.09

257

1865

Other/unspecified disorders of vestibular function

157

1038

1.58

6.28

6.0

6.7

1.17

1.36

mmol/l

2.41

149

995

Presence of other devices

647

7875

0.81

6.24

6.1

5.7

1.32

1.39

mmol/l

0.98

588

7538

Ectropion of eyelid

170

1146

1.55

6.21

4.9

5.7

1.30

1.46

mmol/l

1.33

162

1087

Recurrent dislocation and subluxation of joint

227

1607

1.44

6.21

8.3

7.5

1.32

1.36

mmol/l

0.17

217

1544

Benign neoplasm of ovary

594

4816

1.25

6.20

5.8

1.21

1.27

mmol/l

1.04

572

4653

Benign neoplasm: Rectosigmoid junction

171

1157

1.54

6.17

6.5

7.1

1.30

1.39

mmol/l

0.63

158

1115

Pedal cyclist injured in other and unspecified transport accidents

402

3115

1.32

6.17

5.8

7.3

1.45

1.38

mmol/l

0.55

382

2999

878

7006

1.21

6.16

4.4

5.3

1.39

1.40

mmol/l

0.11

834

6688

Vascular dementia (mixed)

376

1.99

6.15

3.4

5.9

1.49

1.45

mmol/l

0.10

353

Gastrointestinal stromal tumor and sarcoma

294

2.16

6.13

5.9

6.9

1.32

1.34

mmol/l

0.04

280

Sacrococcygeal disorders, not elsewhere classified

104

624

1.73

6.12

8.3

6.4

1.27

1.28

mmol/l

0.04

603

Benign neoplasm: Larynx

121

758

1.66

6.09

5.0

6.5

1.45

1.47

mmol/l

0.05

114

733

Erythema nodosum

113

696

1.69

6.08

4.7

5.7

1.21

1.29

mmol/l

0.55

108

669

Autoimmune hyperthyroidism

202

1409

1.47

6.05

6.5

6.3

1.35

1.29

mmol/l

0.23

192

1363

Dementia in other diseases classified elsewhere

181

1245

1.51

5.98

7.0

6.6

1.27

1.40

mmol/l

1.37

170

1194

Recurrent dislocation of patella

146

954

1.57

5.97

8.7

7.0

1.31

1.30

mmol/l

0.01

139

912

Other symptoms and signs involving the nervous and musculoskeletal systems

1568

13827

1.14

5.95

7.1

7.0

1.37

1.34

mmol/l

0.44

1505

13329

Achilles tendinitis

367

2826

1.33

5.92

7.1

8.3

1.34

1.33

mmol/l

0.06

354

2738

Other otitis externa (chronic)

239

1729

1.42

5.91

7.7

7.5

1.23

1.36

mmol/l

1.88

226

1668

Degenerative macular diseases

490

3920

1.28

5.90

5.4

5.9

1.33

1.38

mmol/l

0.51

468

3766

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

210

2.35

5.89

9.2

5.0

1.06

1.40

mmol/l

2.42

204

Unspecified/other endometriosis

244

1765

1.41

5.86

3.9

6.0

1.14

1.28

mmol/l

3.06

239

1703

Myeloid leukaemia

589

1.74

5.84

9.8

6.6

1.45

mmol/l

0.02

560

Muscular dystrophy

205

2.36

5.79

5.3

9.8

1.44

1.31

mmol/l

0.35

196

Accidental poisoning by and exposure to alcohol

411

1.89

5.79

12.7

6.7

1.90

1.44

mmol/l

1.03

385

Sequelae of poisoning by drugs, medicaments and biological substances

6.27

5.79

3.4

12.7

1.93

1.10

mmol/l

1.21

Other noninflammatory disorders of vulva and perineum

283

2105

1.37

5.77

5.5

6.0

1.17

1.30

mmol/l

2.41

268

2039

Exposure to other and unspecified animate mechanical forces

104

636

1.70

5.76

7.2

7.7

1.29

1.32

mmol/l

0.19

602

Systemic atrophies primarily affecting the central nervous system

167

1141

1.52

5.74

5.9

7.2

1.26

1.43

mmol/l

1.76

154

1093

Contact with other sharp object(s)

222

1592

1.43

5.73

9.1

8.4

1.41

1.39

mmol/l

0.08

217

1531

Arthropod-borne viral fevers and viral haemorrhagic fevers

366

2834

1.32

5.73

5.9

7.6

1.45

1.38

mmol/l

0.65

361

2733

Anterior Iridocyclitis

750

6277

1.21

5.72

7.7

7.0

1.33

1.34

mmol/l

0.04

722

6040

Other/unspecified enthesopathies, not elsewhere classified

322

2450

1.34

5.70

6.1

7.0

1.34

mmol/l

0.02

309

2365

Foreign body or object entering through skin

231

1673

1.42

5.68

7.0

7.9

1.34

1.37

mmol/l

0.15

220

1608

Personality and behavioural disorders due to brain disease, damage and dysfunction

386

1.93

5.67

7.0

8.6

1.40

1.44

mmol/l

0.16

368

Intentional self-harm by crashing of motor vehicle

7.24

5.67

12.4

14.8

1.32

1.22

mmol/l

—

Macular hole

225

1629

1.43

5.66

5.2

6.3

1.29

1.37

mmol/l

0.67

217

1572

Hallux rigidus

528

4275

1.26

5.66

6.3

7.0

1.27

1.33

mmol/l

0.96

507

4110

Thyrotoxicosis with diffuse goitre

446

3538

1.28

5.65

7.0

6.9

1.27

1.30

mmol/l

0.22

428

3422

Other and unspecified mononeuropathies of upper limb

116

734

1.65

5.63

5.9

7.6

1.38

1.35

mmol/l

0.13

111

705

Gestational [pregnancy-induced] hypertension

665

5490

1.22

5.60

6.2

6.3

1.30

1.24

mmol/l

0.94

637

5305

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

295

2.06

5.60

7.3

4.2

1.47

1.37

mmol/l

0.33

284

Other disorders of the genitourinary system

457

3650

1.28

5.57

7.7

6.0

1.34

1.31

mmol/l

0.27

444

3526

Any dementia

1614

10081

1.14

5.56

4.2

5.7

1.52

1.37

mmol/l

5.95

1522

9635

Cryoglobulinemia

5.60

5.56

10.8

8.0

1.30

1.45

mmol/l

0.12

205

1453

1.44

5.55

5.7

5.1

1.52

1.46

mmol/l

0.32

197

1380

Varicella [chickenpox]

170

1171

1.50

5.53

14.1

9.6

1.38

1.39

mmol/l

0.05

164

1122

Injury of nerves at wrist and hand level

138

913

1.56

5.49

11.1

9.1

1.38

1.34

mmol/l

0.14

132

880

Benign neoplasm of eye and adnexa

322

2464

1.33

5.48

7.2

6.6

1.37

mmol/l

0.01

312

2373

Astigmatism

226

1640

1.41

5.47

11.1

8.0

1.35

1.39

mmol/l

0.27

214

1549

Endometriosis

1201

6194

1.16

5.46

5.1

6.3

1.29

1.32

mmol/l

0.50

1162

5962

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

177

1232

1.48

5.46

5.1

5.7

1.40

1.52

mmol/l

0.82

171

1160

Dislocation, sprain and strain of joints and ligaments of elbow

211

1518

1.42

5.38

6.3

8.1

1.36

1.34

mmol/l

0.11

197

1452

Early lumbar disc prolapse, operated

282

2119

1.35

5.37

7.3

8.4

1.45

1.35

mmol/l

0.60

272

2047

Motor neuron disease (with DMD)

414

1.85

5.37

6.8

7.5

1.16

1.31

mmol/l

0.90

405

Perineal laceration during delivery

220

2692

0.72

5.37

4.4

6.2

1.39

1.26

mmol/l

1.03

211

2597

Other diseases of spinal cord

117

752

1.62

5.35

8.1

8.0

1.44

1.32

mmol/l

0.56

110

720

Fall on and from ladder

313

2402

1.34

5.34

7.1

7.9

1.32

1.41

mmol/l

1.35

302

2309

Sequelae of infectious and parasitic diseases

280

2110

1.36

5.34

8.0

6.9

1.37

1.39

mmol/l

0.06

265

2032

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

141

2.58

5.31

6.6

6.2

1.12

1.48

mmol/l

2.91

135

Hypertensive encephalopathy

3.14

5.31

5.3

7.2

1.08

1.24

mmol/l

0.69

Abrasion of teeth

922

5791

1.18

5.30

5.8

6.2

1.24

1.37

mmol/l

4.09

894

5615

Malignant immunoproliferative diseases

226

2.21

5.29

14.2

8.6

1.52

1.45

mmol/l

0.14

216

Melanocytic naevi, other sites/unspecified

240

1768

1.39

5.28

7.3

6.9

1.27

1.41

mmol/l

1.03

225

1707

Malignant neoplasm of adrenal gland

3.10

5.28

22.5

8.1

1.08

1.41

mmol/l

1.61

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

262

1956

1.37

5.27

7.6

5.9

1.21

1.25

mmol/l

0.25

257

1890

Allergic rhinitis

1008

8611

1.17

5.27

7.1

7.9

1.28

1.32

mmol/l

0.74

965

8273

Ankylosing spondylitis

311

2382

1.33

5.26

6.7

8.0

1.39

1.36

mmol/l

0.18

297

2302

Urethral stricture

228

1673

1.40

5.25

6.4

7.9

1.32

1.40

mmol/l

0.49

217

1615

Other and unspecified mononeuropathies, also in other diseases

123

804

1.59

5.25

6.4

6.8

1.40

1.37

mmol/l

0.10

114

771

Maternal care related to the fetus and amniotic cavity and possible delivery problems

988

6765

0.85

5.25

5.3

7.2

1.27

1.25

mmol/l

0.15

960

6543

Deviated nasal septum

1365

12038

1.15

5.24

7.9

7.8

1.29

1.38

mmol/l

3.40

1313

11635

Effects of foreign body entering through natural orifice

928

7972

1.18

5.23

6.4

8.0

1.34

1.37

mmol/l

0.35

891

7661

Etanercept

210

1519

1.42

5.21

7.9

7.7

1.27

1.32

mmol/l

0.27

204

1466

Fibrosis of liver

149

2.51

5.19

9.1

7.1

1.57

1.16

mmol/l

1.36

143

Rheumatoid lung disease

101

2.95

5.18

4.4

6.5

1.64

1.44

mmol/l

0.62

Benign neoplasm of major salivary glands

373

2938

1.30

5.17

8.7

6.9

1.34

1.37

mmol/l

0.19

363

2833

Delivery, wide proxy

1026

6320

0.86

5.17

4.7

5.8

1.31

1.32

mmol/l

0.03

990

6098

Neurofibromatosis, type 2

4.79

5.16

9.9

7.0

1.09

1.17

mmol/l

0.18

All dysplastic lesions of the vulva

138

925

1.54

5.16

7.1

5.7

1.16

1.26

mmol/l

0.77

130

891

Other ill-defined and unspecified causes of mortality

246

1836

1.38

5.12

4.2

6.1

1.66

1.45

mmol/l

2.10

229

1754

Use of donepezil

562

6526

0.82

5.10

3.3

5.2

1.52

1.43

mmol/l

1.25

535

6204

Other diseases of peritoneum

166

1159

1.48

5.10

5.6

7.1

1.40

1.35

mmol/l

0.19

160

1110

Osteosarcoma, excluding all cancers (controls excluding all cancers)

3.09

5.08

43.1

4.9

1.10

1.49

mmol/l

1.77

Viral haemorrhagic fevers, not elsewhere classified/unspecified

293

2245

1.34

5.03

5.7

7.7

1.45

1.39

mmol/l

0.50

288

2164

Melanocytic naevi of lower limb, including hip

136

914

1.53

5.03

6.4

6.8

1.18

1.34

mmol/l

1.57

130

879

Ovarian dysfunction

178

1255

1.44

5.02

5.1

5.4

1.28

1.21

mmol/l

0.57

171

1204

Haemangioma and lymphangioma, any site

276

2094

1.34

5.02

6.1

6.7

1.30

1.37

mmol/l

0.58

269

2022

Ductal carcinoma of pancreas

192

2.32

5.01

4.3

7.0

1.48

1.25

mmol/l

0.79

186

Other benign neoplasms of connective and other soft tissue

355

2792

1.30

4.96

6.4

7.1

1.33

1.36

mmol/l

0.20

345

2691

Benign lipomatous neoplasm of other sites/unspecified

300

2310

1.33

4.94

6.4

1.26

1.42

mmol/l

2.59

290

2221

Correction of physiology of bite - demanding therapy visit

217

1592

1.39

4.94

8.9

6.8

1.40

1.29

mmol/l

0.67

211

1534

Conductive and sensorineural hearing loss

3552

22794

1.09

4.91

6.3

7.0

1.38

1.36

mmol/l

0.39

3420

21942

Dermatographic urticaria

208

1518

1.40

4.89

7.1

7.2

1.22

1.32

mmol/l

1.12

202

1460

All dysplastic lesions of the cervix uteri, vagina or vulva

742

6245

1.19

4.88

6.8

6.3

1.20

1.24

mmol/l

0.63

711

6039

TMD related operations

535

4406

1.23

4.88

8.6

7.6

1.31

mmol/l

0.00

523

4250

Tongue abnormality

228

1695

1.38

4.87

5.0

6.8

1.40

1.33

mmol/l

0.42

218

1632

Haemangioma, any site

258

1948

1.35

4.87

6.2

6.7

1.26

1.36

mmol/l

1.14

251

1885

Myeloproliferative diseases (CML excluded)

296

2285

1.33

4.87

5.8

6.6

1.47

1.38

mmol/l

0.52

288

2204

Benign neoplasm: Skin of ear and external auricular canal

135

914

1.53

4.86

5.6

5.5

1.19

1.46

mmol/l

2.40

129

877

Congenital and developmental myasthenia

6.11

4.84

4.8

9.7

2.24

1.87

mmol/l

—

Impotence

223

1656

1.39

4.84

10.2

8.8

1.47

1.41

mmol/l

0.32

215

1599

Other puerperal infections

172

1214

1.44

4.83

5.7

1.24

1.20

mmol/l

0.17

165

1164

Problems related to social environment

102

650

1.63

4.83

4.9

6.1

1.30

1.38

mmol/l

0.44

618

TMD related pain

109

706

1.59

4.80

9.4

6.1

1.50

1.32

mmol/l

0.90

109

684

Myocardial infarction, unclassifiable

967

7482

1.17

4.80

7.7

5.8

1.53

1.42

mmol/l

1.69

902

7108

Benign neoplasm: Anus and anal canal

120

799

1.57

4.77

6.1

6.3

1.43

1.36

mmol/l

0.20

113

763

Acquired absence of limb

229

2.12

4.74

7.2

5.4

1.33

1.46

mmol/l

0.39

214

Scleritis and episcleritis

200

1463

1.40

4.69

7.3

7.6

1.44

1.34

mmol/l

0.39

193

1406

Tuberculosis, IBD comorbidity

287

2217

1.32

4.67

7.8

5.9

1.38

1.43

mmol/l

0.46

275

2118

Frostbite

258

2.03

4.65

6.1

8.1

1.87

1.48

mmol/l

0.56

248

Communicating hydrocephalus

565

1.67

4.65

6.2

7.5

1.38

1.34

mmol/l

0.13

541

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

163

1154

1.45

4.63

4.2

5.2

1.52

1.50

mmol/l

0.07

154

1096

Benign neoplasm: Other and unspecified parts of mouth

131

893

1.52

4.63

6.5

7.2

1.35

1.36

mmol/l

0.02

121

857

Carcinoma in situ of oral cavity, oesophagus and stomach

138

2.49

4.63

6.9

5.4

1.65

1.46

mmol/l

0.21

129

Follicular lymphoma, hilmo

169

1212

1.44

4.58

6.0

7.3

1.24

1.37

mmol/l

1.26

164

1164

Benign neoplasm of breast

343

2712

1.28

4.57

6.6

5.5

1.23

1.33

mmol/l

1.55

333

2614

Acute epiglottitis

346

1.85

4.55

11.1

7.2

1.12

1.33

mmol/l

1.87

330

Infection due to other mycobacteria

362

1.83

4.52

10.7

6.4

1.32

1.37

mmol/l

0.13

344

Dental caries 1 and operation codes, only avohilmo

1150

5065

1.15

4.52

7.3

8.4

1.34

1.32

mmol/l

0.25

1104

4902

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

406

3284

1.26

4.46

6.6

7.0

1.28

1.36

mmol/l

1.03

400

3162

Menorrhagia

1227

5981

1.14

4.44

7.0

6.3

1.30

1.32

mmol/l

0.30

1178

5756

Other and unspecified disorders of psychological development

243

2.01

4.44

3.4

11.4

1.34

1.39

mmol/l

0.15

221

Rheumatic valve diseases

602

1.63

4.44

10.9

5.6

1.28

1.49

mmol/l

1.32

567

Vascular dementia

328

2507

1.29

4.42

3.9

5.1

1.57

1.47

mmol/l

0.78

305

2346

Caught, crushed, jammed or pinched in or between objects

171

1234

1.42

4.40

8.2

8.9

1.28

1.39

mmol/l

0.98

163

1186

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

285

1.94

4.40

16.2

7.4

1.17

1.42

mmol/l

1.71

274

Wide developmental disorders

108

714

1.56

4.38

3.9

9.9

1.63

1.44

mmol/l

0.56

101

663

Tuberculosis, wide

295

2309

1.31

4.37

7.7

5.9

1.37

1.43

mmol/l

0.60

283

2206

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

2.77

4.35

8.6

4.5

1.30

1.55

mmol/l

0.66

Complications predominantly related to the puerperium

687

5847

1.19

4.35

7.4

6.5

1.24

1.25

mmol/l

0.03

661

5669

Outcome of delivery

407

2028

1.25

4.32

4.9

7.1

1.24

1.26

mmol/l

0.12

374

1952

Adenocarcinoma and ductal carcinoma of pancreas

134

934

1.49

4.29

4.5

7.3

1.56

1.41

mmol/l

0.61

129

896

Other hereditary haemolytic anaemias

129

2.44

4.29

6.3

6.4

1.23

1.40

mmol/l

0.51

121

Foreign body entering into or through eye or natural orifice

292

2288

1.30

4.28

7.1

7.8

1.49

1.40

mmol/l

0.43

282

2192

Dementia, including avohilmo

1895

11877

1.11

4.26

4.3

6.0

1.48

1.37

mmol/l

4.94

1806

11377

Parkinson's disease, including avohilmo

621

5269

1.20

4.25

4.6

6.4

1.37

1.39

mmol/l

0.22

595

5037

Carcinoma in situ of breast, intraductal

227

1721

1.34

4.21

5.2

5.7

1.23

1.30

mmol/l

0.42

219

1665

Triptan medication for migraine, min. 3 purchases

1752

12511

1.11

4.21

5.7

7.4

1.25

1.30

mmol/l

1.29

1689

12105

Brachial plexus disorders

279

2178

1.30

4.16

4.7

7.4

1.29

1.31

mmol/l

0.17

269

2105

Other/unspecified soft tissue disorders related to use, overuse and pressure

101

667

1.56

4.15

8.4

6.7

1.28

1.34

mmol/l

0.22

643

Benign neoplasm: Appendix

262

1.96

4.15

8.9

6.3

1.23

1.32

mmol/l

0.37

246

Lichen simplex chronicus

130

906

1.48

4.13

9.9

7.0

1.38

1.36

mmol/l

0.06

125

864

Divergent concomitant strabismus

255

1972

1.32

4.13

7.9

7.8

1.29

1.35

mmol/l

0.42

240

1893

Varicose veins

2610

18208

1.09

4.09

6.1

6.6

1.34

mmol/l

0.01

2507

17517

Spirochaetal infections, other/unspecified

298

2359

1.29

4.07

6.5

7.3

1.32

1.36

mmol/l

0.19

286

2272

Carcinoma in situ of skin of eyelid, including canthus

3.78

4.05

2.9

4.3

1.54

1.52

mmol/l

0.01

Flatulence and related conditions

199

2.07

4.04

6.2

6.6

1.91

1.30

mmol/l

0.51

188

Malignant neoplasm of endocrine gland

245

1893

1.32

4.04

8.9

7.3

1.23

1.32

mmol/l

1.09

236

1827

Other acute skin changes due to ultraviolet radiation

133

936

1.47

4.02

5.7

6.8

1.27

1.39

mmol/l

0.94

128

897

Dental caries 3 and operation codes, only avohilmo

1322

5920

1.13

4.00

7.2

8.1

1.35

1.31

mmol/l

0.50

1265

5722

Disorders of lysine and hydroxylysine metabolism

18.04

4.00

31.3

4.7

1.08

2.38

mmol/l

—

Moderate mental retardation

140

2.31

3.98

6.5

10.8

1.21

1.23

mmol/l

0.08

130

Myopia

374

3038

1.25

3.98

8.7

7.4

1.34

1.33

mmol/l

0.06

353

2927

Other congenital malformations of urinary system

108

2.53

3.98

16.2

11.0

1.15

1.45

mmol/l

1.22

102

Unspecified lump in breast

497

4156

1.21

3.97

6.5

5.8

1.17

1.27

mmol/l

2.10

477

4030

Pleural plaque

394

3233

1.24

3.94

6.3

6.2

1.39

1.42

mmol/l

0.21

382

3086

Dementia

1758

11036

1.11

3.93

4.2

5.8

1.50

1.37

mmol/l

5.68

1676

10575

Nummular dermatitis

299

2379

1.28

3.93

8.6

7.1

1.27

1.36

mmol/l

1.22

285

2284

Use of levodopa decarboxylase inhibitor

516

4345

1.21

3.91

4.7

6.1

1.30

1.39

mmol/l

1.37

497

4156

malignant neoplasm of male genital organs

1899

11008

1.11

3.89

6.5

7.5

1.36

1.42

mmol/l

1.30

1815

10550

Ulcerative proctitis

199

1502

1.35

3.87

7.4

7.5

1.34

1.37

mmol/l

0.15

192

1436

Peroneal tendinitis

318

1.80

3.87

5.1

7.1

1.32

1.24

mmol/l

0.32

310

Amoebiasis

122

2.40

3.87

10.2

9.5

1.95

1.13

mmol/l

0.47

117

Drug-induced acute pancreatitis

4.08

3.86

38.1

3.9

1.07

1.62

mmol/l

1.11

Ill-defined and unknown causes of mortality

265

2087

1.30

3.83

4.2

6.3

1.69

1.44

mmol/l

2.84

246

1987

Adenomyosis (Endometriosis of uterus)

447

3716

1.22

3.83

5.4

6.0

1.33

1.31

mmol/l

0.14

434

3588

Intermittent heterotropia

191

1436

1.36

3.82

12.9

8.5

1.30

1.37

mmol/l

0.50

182

1352

Juvenile rheumatoid arthirtis

425

1.67

3.81

7.3

7.4

1.39

1.32

mmol/l

0.15

407

Disorder of pancreatic internal secretion, other and/or unspecified

163

2.18

3.81

9.0

7.5

1.35

1.42

mmol/l

0.17

158

Tuberculosis of other organs, strict

101

683

1.54

3.80

6.0

6.6

1.29

1.42

mmol/l

0.99

651

Exposure to other and unspecified man-made environmental factors

359

1.75

3.77

5.7

7.6

1.23

1.39

mmol/l

0.97

345

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

3.29

3.76

26.7

6.7

1.04

1.75

mmol/l

1.26

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

212

1624

1.33

3.75

6.6

7.1

1.40

mmol/l

0.03

203

1572

Immunodeficiency with increased immunoglobulin M [IgM]

15.42

3.74

6.3

3.3

0.92

0.96

mmol/l

—

Complications of labour and delivery

1690

10366

0.90

3.72

5.8

6.7

1.32

1.25

mmol/l

1.69

1641

10053

Fitting and adjustment of external prosthetic device

3.06

3.72

5.6

6.0

1.59

1.35

mmol/l

0.24

Crohn disease (strict definition, all UC cases excluded)

164

1211

1.39

3.72

8.9

7.4

1.25

1.36

mmol/l

0.81

152

1157

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

639

1.54

3.67

4.7

6.1

1.59

1.48

mmol/l

0.28

609

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

287

1.83

3.65

5.2

5.6

1.57

1.35

mmol/l

0.74

277

Degenerative diseases of the nervous system

1383

9400

1.12

3.64

3.9

5.6

1.60

1.38

mmol/l

7.60

1306

8951

Heterophoria

253

1990

1.29

3.64

10.1

7.5

1.31

1.35

mmol/l

0.28

236

1906

Nontoxic multinodular goitre

714

6202

1.16

3.64

5.2

6.0

1.28

1.34

mmol/l

1.06

686

5987

Benign neoplasm: Skin of other and unspecified parts of face

347

2831

1.24

3.62

4.7

6.1

1.38

1.39

mmol/l

0.04

340

2712

Injury of muscle and tendon at shoulder and upper arm level

1438

13035

1.11

3.62

6.6

7.5

1.34

1.36

mmol/l

0.24

1409

12577

Lateral epicondylitis

428

3563

1.22

3.62

6.8

7.9

1.28

1.31

mmol/l

0.24

410

3445

Autism

439

1.64

3.61

4.5

8.0

1.80

1.43

mmol/l

0.77

412

Polypectomy (DHB20)

255

2014

1.29

3.61

7.6

7.8

1.17

1.40

mmol/l

5.38

245

1946

Simple and mucopurulent chronic bronchitis

158

1167

1.39

3.61

7.1

6.8

1.37

1.44

mmol/l

0.29

144

1117

Tinnitus

869

7657

1.15

3.60

7.3

1.26

1.33

mmol/l

1.41

845

7393

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

2.77

3.58

6.2

5.7

1.09

1.30

mmol/l

0.75

Use of antiglaucoma preparations and miotics

312

2526

1.26

3.57

7.1

5.4

1.38

1.40

mmol/l

0.07

302

2421

Other disorders of cornea

329

2677

1.25

3.56

7.5

6.9

1.36

mmol/l

0.03

318

2582

Combined immunodeficiencies

268

1.85

3.56

16.6

7.3

1.19

1.33

mmol/l

0.69

252

Pustular psoriasis

160

1189

1.38

3.53

6.2

7.2

1.30

1.32

mmol/l

0.10

152

1141

Nasal polyp

736

6426

1.16

3.51

7.0

7.3

1.24

1.38

mmol/l

4.78

708

6190

Murder, homicide, or other assault by handgun discharge

8.88

3.51

9.6

14.7

1.27

1.02

mmol/l

—

Other and unspecified vaccines and biological substances

134

2.24

3.51

6.3

6.2

1.29

1.21

mmol/l

0.19

126

Right side

186

0.25

3.49

1.2

6.4

1.68

1.40

mmol/l

—

177

Thyroiditis

225

1756

1.31

3.48

7.8

6.5

1.20

1.31

mmol/l

1.52

216

1689

Marginal zone B-cell lymphoma

227

1.94

3.47

5.7

7.5

1.24

1.37

mmol/l

0.40

216

Benign neoplasm of bone and articular cartilage

239

1878

1.29

3.47

7.2

7.0

1.22

1.38

mmol/l

2.26

232

1815

Alzheimer disease, including avohilmo

1411

9232

1.11

3.46

3.3

5.5

1.54

1.39

mmol/l

5.69

1343

8792

Coeliac disease

403

3354

1.22

3.46

7.3

7.1

1.33

1.31

mmol/l

0.10

387

3215

Motor neuron disease

399

1.67

3.45

7.3

1.07

1.30

mmol/l

1.81

390

Carcinoma in situ of stomach

8.22

3.44

7.3

5.7

0.76

1.35

mmol/l

—

Superficial frostbite

149

2.15

3.43

5.6

7.9

2.13

1.43

mmol/l

0.62

143

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

103

2.44

3.41

11.4

7.2

0.93

1.39

mmol/l

2.85

Chromosomal abnormalities, not elsewhere classified

510

1.58

3.41

15.0

13.7

1.28

1.32

mmol/l

0.13

476

Other congenital malformations, not elsewhere classified

199

1.98

3.39

10.8

1.11

1.23

mmol/l

0.48

186

Myeloid leukaemia

676

1.50

3.38

9.8

7.2

1.45

1.38

mmol/l

0.33

644

Atlantoaxial subluxation

150

2.14

3.38

3.8

7.3

1.09

1.26

mmol/l

0.39

144

Carcinoma in situ of lip, oral cavity and pharynx

3.09

3.35

6.0

6.4

2.24

1.41

mmol/l

0.60

Liposarcoma

194

2.00

3.33

9.3

6.7

1.00

1.36

mmol/l

1.94

188

Fractures involving multiple body regions

3.36

3.32

14.6

5.1

1.23

1.22

mmol/l

0.02

Sensorineural hearing loss

3338

21944

1.07

3.31

5.9

7.0

1.38

1.36

mmol/l

0.35

3212

21118

Disorders of orbit

146

1081

1.38

3.31

6.4

7.3

1.23

1.36

mmol/l

1.27

137

1035

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

125

2.28

3.29

15.8

5.8

1.10

1.39

mmol/l

1.50

118

Sixth [abducent] nerve palsy

126

915

1.42

3.28

6.7

7.5

1.27

1.40

mmol/l

1.20

120

873

Congenital malformations of genital organs

262

2083

1.27

3.28

8.1

7.6

1.43

1.28

mmol/l

0.73

251

1977

Chalazion

383

3191

1.22

3.28

5.4

7.3

1.39

1.37

mmol/l

0.14

372

3059

Bruxism

373

1.67

3.27

6.4

7.7

1.28

mmol/l

0.02

359

Sequelae of other and unspecified infectious and parasitic diseases

181

1385

1.33

3.27

9.6

7.7

1.37

mmol/l

0.01

174

1335

Disorders of urea cycle metabolism

6.48

3.25

6.8

4.9

1.81

1.19

mmol/l

—

Hypertrophy of breast in women and men

569

4902

1.17

3.24

6.9

7.0

1.37

1.28

mmol/l

1.00

557

4741

APECED

9.30

3.24

9.7

3.0

1.13

1.20

mmol/l

—

Other bullous disorders

101

707

1.48

3.24

6.0

7.1

1.44

1.36

mmol/l

0.38

673

Ganglion

664

5786

1.16

3.23

6.5

7.3

1.29

1.31

mmol/l

0.09

639

5595

Injury of muscle and tendon at lower leg level

535

4595

1.18

3.23

8.0

1.31

1.36

mmol/l

0.67

518

4431

Viral meningitis

113

805

1.44

3.23

7.1

7.4

1.37

1.35

mmol/l

0.07

106

767

Fitting and adjustment of other devices

1090

11261

0.89

3.21

6.0

5.8

1.39

1.38

mmol/l

0.04

1005

10811

Other disorders of carbohydrate metabolism

2.43

3.18

8.2

6.4

2.12

1.32

mmol/l

1.14

Abscess of Bartholin gland

495

1.56

3.16

7.5

5.3

1.20

1.28

mmol/l

0.42

473

Gestational diabetes (for exclusion)

849

5311

1.14

3.14

6.2

6.8

1.30

1.23

mmol/l

1.13

815

5126

Other secondary gonarthrosis

194

1514

1.31

3.10

7.7

7.6

1.31

1.37

mmol/l

0.37

189

1463

LSIL lesion of the vulva

604

1.50

3.09

8.1

5.9

1.03

1.28

mmol/l

3.69

580

Other specified/unspecified nutritional deficiencies

155

2.05

3.09

7.8

5.8

1.26

1.35

mmol/l

0.22

149

Malignant immunoproliferative diseases

274

1.79

3.09

14.2

9.4

1.52

1.37

mmol/l

0.34

260

Pedestrian injured in other and unspecified transport accidents

280

1.76

3.08

6.8

5.7

1.52

1.28

mmol/l

0.78

267

Other and unspecified myoneural disorders

2.47

3.05

9.9

5.0

1.30

1.19

mmol/l

0.26

Convergent concomitant strabismus

178

1375

1.32

3.02

9.3

8.3

1.36

1.37

mmol/l

0.05

166

1315

Parkinson's disease

581

5057

1.16

3.00

4.5

6.4

1.34

1.39

mmol/l

0.49

560

4833

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

136

2.11

3.00

11.4

4.3

1.20

1.30

mmol/l

0.28

131

Arthropathic psoriasis

382

3216

1.20

2.97

6.7

7.5

1.36

1.34

mmol/l

0.17

367

3093

Benign leiomyoma with endometriosis

442

3768

1.19

2.93

5.8

5.6

1.33

mmol/l

0.01

430

3638

Other psoriatic arthropathies

345

2884

1.21

2.92

6.1

7.6

1.37

1.34

mmol/l

0.23

329

2780

Infectious mononucleosis

217

1725

1.27

2.90

6.8

7.1

1.42

1.36

mmol/l

0.22

201

1653

Unspecified drowning and submersion

6.02

2.90

3.4

16.4

1.06

1.10

mmol/l

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

314

1.67

2.89

6.4

6.8

1.21

1.22

mmol/l

0.05

299

Contact with other specified venomous animals

131

2.11

2.89

9.3

8.0

1.34

1.16

mmol/l

0.94

126

Psoriatic arthropathies, ICD10

354

2970

1.21

2.88

6.5

7.6

1.36

1.35

mmol/l

0.13

338

2861

Hereditary ataxia

341

1.66

2.87

4.5

8.0

1.36

mmol/l

0.02

325

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1655

14640

0.92

2.87

6.1

7.0

1.23

1.31

mmol/l

3.27

1590

14145

Malignant neoplasm of breast, HER-negative

682

6009

1.15

2.87

5.8

1.27

1.30

mmol/l

0.47

658

5812

Congenital iodine-deficiency syndrome/hypothyroidism

106

766

1.42

2.87

7.3

5.6

1.61

1.34

mmol/l

0.57

736

Malignant neoplasm of peripheral nerves and autonomic nervous system

4.43

2.86

6.3

4.1

0.91

1.48

mmol/l

—

Preparation and fitting of bite rail to mouth

417

3548

1.19

2.86

8.6

7.5

1.29

1.31

mmol/l

0.11

407

3427

Glucosamine medication

2084

15482

1.08

2.84

6.0

6.5

1.30

1.36

mmol/l

1.69

2009

14883

Ulcerative colitis (strict definition, all Crohn cases excluded)

475

4088

1.17

2.83

7.6

1.34

1.36

mmol/l

0.19

456

3925

Pustulosis palmaris et plantaris

139

1052

1.35

2.80

6.2

7.2

1.31

1.32

mmol/l

0.03

132

1009

Sequelae of injuries of upper limb

319

2660

1.22

2.78

7.3

7.9

1.40

1.34

mmol/l

0.41

308

2562

Additional codes for the location of defect, injury or illness

188

1483

1.29

2.78

7.9

7.3

1.35

1.37

mmol/l

0.06

175

1431

Injury of blood vessels at abdomen, lower back and pelvis level

2.34

2.77

11.0

7.2

1.48

1.42

mmol/l

0.06

HSIL lesion of the cervix uteri, vagina or vulva

465

4001

1.17

2.74

7.5

6.1

1.25

1.24

mmol/l

0.10

446

3866

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

305

1.67

2.73

5.9

7.9

1.12

1.35

mmol/l

1.68

290

Other peripheral vertigo

318

2659

1.22

2.73

4.9

6.4

1.36

1.35

mmol/l

0.06

308

2560

Caries in Clefts patients

169

1.91

2.72

20.9

8.8

1.03

1.34

mmol/l

1.75

160

Periodic paralysis

6.71

2.71

3.7

8.6

1.72

1.30

mmol/l

—

Fasciculation

260

1.73

2.70

11.9

6.9

1.05

1.38

mmol/l

2.60

249

Anomalies of pupillary function

467

1.52

2.67

7.4

8.0

1.54

1.33

mmol/l

0.45

447

Papillary adenocarcinoma of thyroid gland

169

1323

1.30

2.67

8.1

7.0

1.23

1.31

mmol/l

0.57

164

1275

Traumatic subcutaneous emphysema

4.11

2.67

7.3

5.2

1.32

1.15

mmol/l

—

Ectopic pregnancy

464

4004

1.17

2.66

5.5

6.5

1.27

1.25

mmol/l

0.25

450

3882

Malignant neoplasm of cervix uteri

316

1.64

2.63

7.6

4.9

1.24

1.28

mmol/l

0.10

304

Air embolism (traumatic)

8.91

2.60

3.2

6.5

1.48

0.91

mmol/l

—

Contracture of joint

302

1.66

2.60

6.3

6.9

1.30

1.38

mmol/l

0.24

290

Status post-ami

204

2076

0.79

2.59

6.3

5.1

1.46

1.41

mmol/l

0.30

193

1976

Injury of blood vessels at ankle and foot level

3.97

2.58

7.4

0.99

1.10

mmol/l

—

Dementia in Alzheimer disease

522

5099

0.87

2.57

2.9

5.2

1.61

1.42

mmol/l

2.58

486

4829

Tuberculosis

234

1911

1.25

2.57

7.9

5.9

1.37

1.44

mmol/l

0.55

222

1819

Noise effects on inner ear

1237

0.71

2.56

8.0

8.4

1.42

1.44

mmol/l

0.06

1194

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

2.24

2.56

12.3

6.9

1.05

1.36

mmol/l

1.34

Conductive hearing loss, unspecified

287

2393

1.22

2.55

10.3

7.1

1.31

1.35

mmol/l

0.21

277

2301

Disorders of plasma-protein metabolism, not elsewhere classified

145

1.97

2.54

25.2

5.1

1.52

1.26

mmol/l

0.71

140

Other predominantly sexually transmitted diseases, not elsewhere classified

457

3955

1.16

2.53

7.9

6.8

1.30

1.32

mmol/l

0.15

441

3825

Poor fetal growth

251

2061

1.23

2.53

10.8

6.0

1.25

1.23

mmol/l

0.10

244

1992

Toxic effect of other gases, fumes and vapours

124

2.06

2.53

10.2

6.4

1.03

1.53

mmol/l

2.42

119

Spinal enthesopathy

101

738

1.39

2.52

4.3

4.8

1.58

1.45

mmol/l

0.34

696

Other and unspecified injuries of forearm

145

1.96

2.52

6.6

8.4

1.26

1.31

mmol/l

0.15

136

Ankylosing spondylitis, ICD10

296

2479

1.21

2.51

6.8

7.7

1.40

1.36

mmol/l

0.23

283

2388

Eustachian salpingitis and obstruction

216

1751

1.25

2.50

6.6

7.5

1.16

1.34

mmol/l

2.88

206

1685

Malignant neoplasm of prostate

1828

10743

1.08

2.50

6.3

7.4

1.37

1.42

mmol/l

1.06

1744

10302

Albinism

7.59

2.50

28.8

14.0

1.32

1.01

mmol/l

—

Dermatopolymyositis, unspecified

125

2.06

2.50

7.4

6.7

1.32

1.38

mmol/l

0.16

120

Hypertrophy of breast

454

3934

1.16

2.49

7.1

6.6

1.35

1.24

mmol/l

1.13

446

3811

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

176

1.87

2.48

11.3

6.1

1.14

1.47

mmol/l

2.01

167

Autism spe

449

1.51

2.48

3.6

8.1

1.81

1.46

mmol/l

0.64

424

Burn and corrosion of ankle and foot

346

1.59

2.48

7.3

7.9

1.26

1.42

mmol/l

0.72

327

Unspecified parasitic disease

206

1.79

2.47

6.4

6.7

1.13

1.29

mmol/l

0.80

195

Other appendicitis

274

2282

1.22

2.47

8.0

7.2

1.40

1.36

mmol/l

0.25

269

2197

Respiratory and cardiovascular disorders specific to the perinatal period

101

665

1.40

2.45

14.8

16.0

1.21

1.33

mmol/l

0.93

597

Benign neoplasm: Larynx

121

919

1.35

2.45

5.0

7.8

1.45

1.44

mmol/l

0.04

114

885

Normal-pressure hydrocephalus

188

1514

1.27

2.42

3.0

6.0

1.57

1.42

mmol/l

1.21

178

1452

Melanocytic naevi of lower limb, including hip

136

1050

1.32

2.42

6.4

7.4

1.18

1.35

mmol/l

1.79

130

1004

Labour and delivery complicated by fetal stress [distress]

397

3084

0.85

2.41

5.2

6.5

1.28

1.23

mmol/l

0.39

380

2971

Benign mammary dysplasia

460

4006

1.16

2.41

5.9

5.7

1.16

1.28

mmol/l

2.93

447

3876

Malignant neoplasm of thyroid gland

215

1754

1.25

2.41

7.1

7.4

1.24

1.32

mmol/l

0.73

206

1696

Other disorders of patella

535

4703

1.15

2.41

6.5

7.8

1.34

mmol/l

0.02

522

4538

Other spirochaetal diseases

896

8122

1.11

2.40

5.9

7.2

1.30

1.33

mmol/l

0.20

859

7839

Early lumbar disc prolapse operation

291

2443

1.20

2.38

7.5

8.0

1.43

1.34

mmol/l

0.58

281

2352

LSIL lesion of the cervix uteri, vagina or vulva

339

2883

1.19

2.38

5.4

6.2

1.11

1.24

mmol/l

2.15

323

2785

Herpesviral keratitis and keratoconjunctivitis

150

1178

1.30

2.37

6.5

7.2

1.21

1.39

mmol/l

2.34

145

1129

Benign neoplasm: Bladder

201

1.77

2.35

4.9

5.0

1.49

1.51

mmol/l

0.03

191

Respiratory tuberculosis, confirmed and not-confirmed

201

1635

1.25

2.33

8.3

6.1

1.38

1.43

mmol/l

0.34

192

1553

Respiratory tuberculosis

201

1636

1.25

2.32

8.3

6.1

1.38

1.43

mmol/l

0.34

192

1554

Rosacea

348

2977

1.18

2.32

9.1

6.9

1.29

1.33

mmol/l

0.31

331

2872

Benign neoplasm: Skin of lower limb, including hip

617

1.41

2.30

8.3

6.4

1.12

1.34

mmol/l

2.09

592

Burn and corrosion of wrist and hand

120

918

1.33

2.30

6.0

8.4

1.37

mmol/l

0.03

114

878

Tooth eruption problems

363

3082

1.18

2.30

11.4

7.1

1.29

1.34

mmol/l

0.48

340

2935

Dental caries 2 and operation codes, only avohilmo

2524

16597

0.94

2.30

6.7

7.6

1.27

1.34

mmol/l

3.45

2437

16057

Lyme disease

885

8039

1.11

2.30

5.8

7.2

1.30

1.33

mmol/l

0.23

851

7758

Pregnancy examination and test

365

1945

1.18

2.29

5.5

6.7

1.20

1.26

mmol/l

0.55

355

1868

Malignant neoplasm of pancreas

221

1822

1.24

2.28

4.0

6.3

1.63

1.39

mmol/l

1.94

213

1742

Reduction defects of upper limb

2.53

2.28

8.9

12.3

1.19

1.40

mmol/l

0.58

Presbycusis

548

4832

1.14

2.25

5.0

5.4

1.34

1.43

mmol/l

1.46

519

4596

Unspecified maternal hypertension

158

1.83

2.23

6.3

5.7

1.25

1.21

mmol/l

0.09

152

Burn and corrosion of shoulder and upper limb, except wrist and hand

496

1.45

2.20

8.6

8.2

1.25

1.39

mmol/l

1.00

477

Pregnancy with abortive outcome

2239

11011

1.07

2.17

5.8

6.0

1.31

1.29

mmol/l

0.37

2164

10656

Demyelinating diseases of the central nervous system

240

2002

1.21

2.16

8.9

7.4

1.23

1.33

mmol/l

0.68

228

1925

Carrier of infectious disease

540

1.43

2.15

8.3

6.5

1.41

1.36

mmol/l

0.10

517

Femoral hernia, bilateral

2.29

2.15

4.2

5.7

1.32

1.24

mmol/l

0.09

Blindness (ICD-9)

5.64

2.15

4.2

2.5

1.10

1.51

mmol/l

—

Alzheimer’s disease (Late onset)

833

6489

1.11

2.13

3.1

5.2

1.60

1.42

mmol/l

3.85

795

6155

Injury of nerves at hip and thigh level

2.12

2.13

4.0

5.4

1.11

1.16

mmol/l

0.17

Other facial nerve disorders

687

1.37

2.12

5.2

7.6

1.27

1.33

mmol/l

0.25

654

Other noninflammatory disorders of vagina

227

1889

1.22

2.11

5.8

1.19

1.31

mmol/l

1.00

219

1832

Cutis laxa senilis

178

1.77

2.10

3.8

5.7

1.21

1.26

mmol/l

0.15

167

Other and unspecified rosacea

262

2212

1.20

2.09

7.7

6.8

1.33

1.32

mmol/l

0.06

246

2133

Non-small cell lung cancer, squamous

177

1442

1.25

2.08

5.1

6.1

1.40

1.48

mmol/l

0.48

171

1363

Non-small cell lung cancer, squamous, helper endpoint

177

1442

1.25

2.08

5.1

6.1

1.40

1.48

mmol/l

0.48

171

1363

Other abnormal uterine and vaginal bleeding

779

5032

1.11

2.07

5.6

5.9

1.31

1.32

mmol/l

0.12

744

4840

Presbyopia

188

1542

1.24

2.05

7.8

1.37

1.33

mmol/l

0.18

181

1492

Drug-induced aplastic anaemia

3.06

2.04

8.1

2.8

1.02

1.21

mmol/l

—

Flat foot [pes planus] (acquired)

289

2473

1.18

1.98

6.3

7.1

1.29

1.33

mmol/l

0.25

277

2383

Lesion of sciatic nerve

167

1361

1.25

1.98

3.7

5.9

1.42

1.38

mmol/l

0.22

160

1301

Other menopausal disorders

744

4731

0.90

1.97

6.4

6.7

1.18

1.30

mmol/l

2.58

729

4585

Acute mastoiditis

189

1.71

1.95

9.9

7.6

1.16

1.44

mmol/l

1.01

184

Injury of blood vessels at wrist and hand level

159

1.78

1.95

7.1

8.3

1.34

1.47

mmol/l

0.34

151

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

226

1897

1.21

1.95

8.6

7.2

1.31

1.39

mmol/l

0.44

217

1833

Hereditary corneal dystrophies

111

865

1.31

1.94

7.5

6.2

1.15

1.39

mmol/l

1.72

106

829

Benign neoplasm: Connective and other soft tissue of abdomen

2.38

1.94

11.0

4.8

1.58

1.49

mmol/l

0.07

Inflammatory diseases of prostate (prostatitis)

504

4495

1.13

1.93

7.0

8.5

1.30

1.44

mmol/l

2.85

485

4329

All dysplastic lesions of the cervix uteri

588

5267

1.12

1.93

6.9

6.4

1.19

1.24

mmol/l

0.82

564

5089

Benign neoplasm of male genital organs

519

1.41

1.92

6.6

6.9

1.49

1.51

mmol/l

0.05

503

Perforation of tympanic membrane

330

2864

1.17

1.90

9.6

6.7

1.33

1.36

mmol/l

0.20

315

2755

Congenital deformities of feet

544

1.39

1.90

6.5

7.8

1.29

1.31

mmol/l

0.09

521

Preterm labour and delivery

677

6132

1.11

1.89

5.9

7.0

1.27

1.23

mmol/l

0.44

653

5955

Nondiabetic hypoglycaemic coma

2.13

1.88

8.9

6.4

1.15

1.53

mmol/l

0.88

Other, unspecified and serous retinal detachments

106

825

1.32

1.88

6.8

7.7

1.45

1.39

mmol/l

0.18

101

792

Other disorders of male genital organs

130

1037

1.28

1.87

6.4

8.8

1.16

1.44

mmol/l

3.75

124

1001

Colorectal neuroendocrine tumor and carcinoma

345

1.50

1.87

5.2

6.1

1.57

1.30

mmol/l

0.96

336

Other disorders of breast

346

3015

1.16

1.87

5.7

6.1

1.21

1.25

mmol/l

0.46

339

2916

FESS (DNB20)

304

3511

0.86

1.86

5.5

7.6

1.25

1.34

mmol/l

1.12

292

3386

Cervical root disorders

177

1.72

1.86

4.5

5.8

1.02

1.28

mmol/l

1.67

168

Tonsillectomy and adenotomy

1867

12247

1.07

1.86

6.6

8.1

1.29

1.33

mmol/l

1.04

1800

11768

Foreign body in respiratory tract

166

1361

1.24

1.86

7.7

8.0

1.24

1.36

mmol/l

1.03

157

1298

Supervision of high-risk pregnancy

490

2628

1.13

1.86

5.3

7.5

1.24

1.25

mmol/l

0.08

476

2536

Crushing injury of head

2.81

1.84

1.6

7.6

1.37

1.40

mmol/l

—

Congenital malformations of posterior segment of eye

132

1.85

1.84

34.1

11.4

1.24

1.33

mmol/l

0.24

126

Nocardiosis

3.81

1.84

36.7

7.4

1.22

0.99

mmol/l

—

Unequal limb length (acquired)

154

1.74

1.82

4.5

5.9

1.03

1.35

mmol/l

1.92

142

Spontaneous abortion

1149

8415

0.92

1.79

5.5

6.5

1.24

1.27

mmol/l

0.33

1103

8165

Melanocytic naevi, other sites/unspecified

240

2044

1.19

1.79

7.3

7.7

1.27

1.36

mmol/l

0.57

225

1965

Infections of genitourinary tract in pregnancy

239

2034

1.19

1.77

5.7

6.2

1.38

1.24

mmol/l

1.42

233

1967

Benign neoplasm: Nasopharynx

195

1.65

1.77

7.3

5.6

1.83

1.29

mmol/l

0.87

187

Glaucoma

2292

19121

1.06

1.76

5.8

6.5

1.35

1.36

mmol/l

0.28

2198

18374

Malignant neoplasm of penis

2.04

1.76

5.4

6.9

0.99

1.39

mmol/l

2.75

Need for immunization against other single infectious diseases

3.65

1.76

32.3

10.9

0.98

1.04

mmol/l

—

Lichen sclerosus et atrophicus

303

2635

1.16

1.73

4.4

5.9

1.33

1.30

mmol/l

0.26

296

2543

Medicines for HER+ breast cancer

1166

10586

1.08

1.72

4.6

6.1

1.27

1.28

mmol/l

0.12

1129

10256

Episcleritis

151

1237

1.24

1.72

7.6

7.7

1.52

1.32

mmol/l

0.66

146

1188

614

1.34

1.72

12.3

14.7

1.22

1.36

mmol/l

0.95

551

Carcinoma in situ of breast, other/unspecified

341

0.57

1.71

3.5

5.0

1.18

1.35

mmol/l

0.64

328

Enterohaemorrhagic Escherichia coli infection

3.03

1.70

8.0

10.2

1.37

1.34

mmol/l

—

Benign neoplasm: Skin of ear and external auricular canal

135

1096

1.26

1.70

5.6

6.8

1.19

1.42

mmol/l

1.90

129

1052

Malignant neoplasm of other and unspecified parts of mouth

159

1.74

1.70

7.0

6.5

1.32

1.31

mmol/l

0.02

150

Haemorrhage in early pregnancy

710

6329

1.10

1.69

5.0

6.7

1.25

1.23

mmol/l

0.27

688

6130

Granulomatous disorders of skin and subcutaneous tissue

591

1.35

1.69

6.8

6.7

1.41

1.33

mmol/l

0.35

567

Other and unspecified hypertrophic disorders of skin

120

1.83

1.69

7.6

6.4

1.35

1.30

mmol/l

0.08

114

Embedded teeth, including avohilmo

225

1914

1.19

1.68

9.1

7.1

1.31

1.33

mmol/l

0.16

208

1832

Bacterial agents resistant to antibiotics

4.01

1.68

8.2

3.9

1.68

1.26

mmol/l

—

699

1.31

1.66

16.2

14.6

1.29

1.34

mmol/l

0.20

628

Parkinson's disease, strict definition

516

4656

1.12

1.66

4.6

6.3

1.32

1.39

mmol/l

0.87

496

4453

Atopic conjunctivitis

127

1027

1.25

1.64

5.8

7.3

1.28

1.33

mmol/l

0.30

120

977

Livedoid vasculitis

100

1.94

1.63

6.3

6.9

1.34

1.22

mmol/l

0.26

Supervision of normal pregnancy

420

2701

0.88

1.63

4.2

7.5

1.20

1.25

mmol/l

0.44

404

2610

Other fusion of spine

3.22

1.62

5.0

3.8

1.35

1.15

mmol/l

—

Early syphilis

306

1.49

1.62

7.7

8.6

1.52

1.41

mmol/l

0.33

297

Leiomyoma of uterus

2095

11308

1.06

1.61

5.9

6.2

1.28

mmol/l

0.04

2025

10935

Dysplasia of cervi uteri

637

4485

1.10

1.61

6.6

6.7

1.21

1.32

mmol/l

2.31

609

4350

Alzheimer’s disease, wide definition

904

7000

1.09

1.61

3.2

5.2

1.58

1.41

mmol/l

4.14

864

6643

Other infiltrative disorders of skin and subcutaneous tissue

123

1.81

1.60

12.5

6.2

1.22

1.32

mmol/l

0.19

117

Other and unspecified firearm discharge, undetermined intent

2.89

1.59

2.1

5.6

1.24

1.16

mmol/l

—

Mucinous and mucinous cystic tumor of rectum

116

1.84

1.58

9.4

7.0

1.53

1.29

mmol/l

0.55

111

Other endocrine disorders

177

1431

1.21

1.58

10.4

10.3

1.57

1.34

mmol/l

1.45

169

1339

Unspecified chronic bronchitis

118

952

1.26

1.58

10.5

6.2

1.51

1.42

mmol/l

0.27

109

912

Crossbite

202

1590

1.19

1.57

16.2

8.6

1.42

1.32

mmol/l

0.57

187

1495

Crushing injury of ankle and foot

2.01

1.57

4.5

7.3

1.79

1.32

mmol/l

1.23

Other histiocytosis syndromes

3.14

1.56

2.8

20.1

1.58

1.11

mmol/l

—

Other and unspecified pemphigus

2.13

1.56

11.8

5.6

1.22

1.34

mmol/l

0.19

Fetal death of unspecified cause

3.06

1.55

20.8

4.0

1.27

1.89

mmol/l

—

Ethmoidectomy

326

3689

0.88

1.54

6.0

7.7

1.27

1.34

mmol/l

0.64

314

3557

Ankylosing spondylitis, strict definition

130

1063

1.24

1.54

7.6

8.1

1.32

1.36

mmol/l

0.19

123

1028

Amblyopia ex anopsia

127

1037

1.24

1.53

9.4

7.6

1.22

1.36

mmol/l

1.33

121

978

Benign neoplasm: Bladder

227

1.55

1.53

4.9

6.8

1.49

1.30

mmol/l

0.47

211

Filariasis

2.78

1.52

5.9

4.3

1.13

1.06

mmol/l

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

2.77

1.52

9.6

5.3

1.37

mmol/l

—

Crushing injury of hip and thigh

3.10

1.51

9.5

3.1

0.85

1.46

mmol/l

—

Crowding of teeth, including avohilmo

237

1686

1.17

1.50

10.3

8.0

1.33

1.36

mmol/l

0.18

223

1593

Disorders of optic chiasm

3.55

1.50

8.8

3.6

1.04

1.36

mmol/l

—

Alzheimer disease

1159

8184

1.07

1.50

3.2

5.3

1.57

1.40

mmol/l

5.68

1094

7774

207

2409

0.85

1.50

8.2

7.3

2.82

1.42

mmol/l

7.20

192

2294

Pollen allergy

515

4619

1.11

1.49

7.2

8.0

1.29

1.33

mmol/l

0.59

489

4417

Congenital malformations of eye, ear, face and neck

191

1625

1.19

1.49

10.4

8.0

1.48

1.38

mmol/l

0.53

185

1541

Other specified disorders of external ear

134

1107

1.23

1.49

4.9

7.7

1.42

1.44

mmol/l

0.08

125

1070

Generalized epilepsy, strict definition

525

1.34

1.48

7.1

9.5

1.45

1.38

mmol/l

0.24

498

Migraine, single triptan purchase ok & required. ICD-code if available is included

2793

18121

1.05

1.48

6.5

7.6

1.26

1.33

mmol/l

3.19

2721

17503

Triptan medication for migraine, single purchase ok

2793

18121

1.05

1.48

6.5

7.6

1.26

1.33

mmol/l

3.19

2721

17503

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

157

1.66

1.48

6.0

4.7

2.03

1.39

mmol/l

0.35

151

Benign neoplasm: Parathyroid gland

229

1.53

1.48

3.8

4.7

1.04

1.34

mmol/l

2.66

220

Pemphigus

173

1.63

1.48

6.7

4.8

1.30

1.27

mmol/l

0.06

161

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1338

9893

1.07

1.47

6.1

6.5

1.19

1.27

mmol/l

3.09

1287

9587

Hydatidiform mole

265

0.55

1.47

3.5

5.6

1.13

1.19

mmol/l

0.10

255

Rapidly progressive nephritic syndrome

2.34

1.47

44.6

8.1

1.07

1.20

mmol/l

—

Malignant neoplasm of base of tongue

150

1.69

1.46

6.8

7.6

1.16

1.45

mmol/l

0.92

144

Drug-induced tremor

166

1.65

1.46

5.3

6.8

1.15

1.22

mmol/l

0.17

156

Other and unspecified neuropathies

104

1.83

1.44

5.0

6.5

1.68

1.47

mmol/l

0.36

Adenocarcinoma of pancreas

759

1.28

1.44

4.7

7.3

1.59

1.42

mmol/l

0.52

727

Pelvic region

3.43

1.43

2.6

7.8

1.02

1.11

mmol/l

—

Alzheimer’s disease (Early onset)

101

1246

0.80

1.40

3.7

5.4

1.70

1.43

mmol/l

1.39

1173

Contraceptive management

1201

8980

0.94

1.40

8.0

8.3

1.31

1.33

mmol/l

0.15

1162

8685

Meningitis, viral

1.95

1.39

3.8

5.9

1.09

1.47

mmol/l

0.85

Puerperal sepsis

346

3087

1.13

1.39

8.1

6.8

1.28

1.23

mmol/l

0.52

332

2985

Deformity of finger(s)

152

1.65

1.38

4.0

6.8

1.12

1.36

mmol/l

1.23

146

Other disorders of pigmentation

136

1134

1.22

1.37

6.2

7.1

1.25

1.37

mmol/l

0.91

126

1087

Malignant otitis externa

2.55

1.35

23.6

5.2

1.19

1.38

mmol/l

—

Ulcerative rectosigmoiditis

251

2202

1.15

1.34

8.7

7.4

1.27

1.36

mmol/l

0.91

240

2120

L02BB Anti-androgens

343

3076

1.13

1.32

5.2

6.8

1.31

1.44

mmol/l

2.44

325

2922

Congenital malformations of oesophagus

139

1.67

1.31

13.0

8.9

0.81

1.42

mmol/l

5.85

131

Long labour

467

4482

0.91

1.31

7.0

7.1

1.27

1.24

mmol/l

0.40

446

4326

Glaucoma, exfoliation

324

3619

0.89

1.31

4.2

5.3

1.36

1.42

mmol/l

0.32

306

3465

Melanoma in situ of lower limb, including hip

115

1.72

1.30

4.6

5.1

1.19

1.36

mmol/l

0.40

109

Use of glatiramer acetate

294

1.42

1.30

11.2

6.8

1.23

1.26

mmol/l

0.07

285

Contact with other and unspecified heat and hot substances

155

1.61

1.29

5.3

10.1

1.34

1.46

mmol/l

0.22

145

Contact with and exposure to communicable diseases

881

8199

1.07

1.28

8.5

7.6

1.30

1.34

mmol/l

0.52

668

7951

Operations 1 for CAVS

1.89

1.28

15.7

12.4

0.95

1.36

mmol/l

2.04

Disorders of puberty

295

1.42

1.28

8.8

8.6

1.59

1.28

mmol/l

0.91

279

Monocytic leukaemia

1.91

1.28

6.5

5.2

1.32

1.39

mmol/l

0.14

False labour

599

4091

0.92

1.27

4.2

7.3

1.19

1.24

mmol/l

0.67

576

3944

L02BX Other hormone antagonists and related agents

201

1750

1.17

1.26

4.2

7.2

1.26

1.41

mmol/l

2.31

191

1686

Primary open-angle glaucoma

1108

11443

0.94

1.26

5.8

5.9

1.37

1.38

mmol/l

0.04

1062

10969

Cleft lip, lip and palate or palate

313

1.40

1.26

17.3

9.3

1.11

1.32

mmol/l

1.15

298

Disorders of puberty, all

339

1.38

1.25

10.5

8.2

1.55

1.34

mmol/l

0.61

321

Pediculosis and phthiriasis

1.93

1.25

4.3

5.7

2.51

1.51

mmol/l

0.39

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

188

1624

1.17

1.25

9.4

5.4

1.20

1.23

mmol/l

0.18

183

1571

Benign neoplasm: Choroid

162

1387

1.18

1.23

5.9

1.40

1.42

mmol/l

0.06

154

1341

Nanophthalmos, microphthalmos and macrophthalmos

3.01

1.23

6.2

10.8

1.16

1.49

mmol/l

—

Rhinophyma

174

1.57

1.23

5.3

6.9

1.45

mmol/l

0.01

165

HSIL lesion of the cervix uteri

389

3520

1.11

1.23

8.1

6.1

1.23

mmol/l

0.00

374

3403

Unspecified transport accident

1.78

1.22

7.1

7.9

1.06

1.34

mmol/l

1.15

Obstructed labour due to malposition and malpresentation of fetus

420

4350

0.91

1.21

5.3

7.5

1.21

1.22

mmol/l

0.07

408

4205

Carcinoma in situ of liver, gallbladder and bile ducts

2.86

1.21

16.6

6.6

2.02

mmol/l

—

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

191

1.51

1.19

5.2

6.2

1.30

1.38

mmol/l

0.21

182

Benign lipomatous neoplasm

1044

9854

1.06

1.17

7.0

7.2

1.30

1.34

mmol/l

0.73

1012

9489

Tularaemia

330

0.65

1.17

3.4

7.5

1.19

1.38

mmol/l

0.80

315

Benign neoplasm: Nasopharynx

217

1.48

1.17

7.3

7.0

1.83

1.31

mmol/l

0.81

209

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

234

1.46

1.17

7.2

6.6

1.49

1.38

mmol/l

0.29

225

Transient global amnesia

313

2816

1.12

1.16

4.3

6.3

1.26

1.34

mmol/l

0.86

298

2715

Haemangioma, any site

258

2294

1.14

1.16

6.2

7.3

1.26

1.33

mmol/l

0.72

251

2213

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

104

1.73

1.16

9.8

7.0

1.26

1.19

mmol/l

0.20

Motor- or nonmotor-vehicle accident in traffic area

127

1.62

1.15

9.1

7.4

1.67

1.49

mmol/l

0.28

121

Hypermetropia

212

1863

1.15

1.14

8.3

8.2

1.35

mmol/l

0.03

205

1766

Sequelae of transport accidents

104

1.71

1.14

8.1

7.6

1.47

1.33

mmol/l

0.19

Benign lipomatous neoplasm of other sites/unspecified

300

2697

1.12

1.13

6.4

6.7

1.26

1.38

mmol/l

1.66

290

2599

Other and unspecified degenerative diseases of nervous system

631

1.26

1.12

3.3

7.2

1.44

1.43

mmol/l

0.04

604

Other demyelinating diseases of the central nervous system

783

1.23

1.12

12.1

7.5

1.25

1.33

mmol/l

0.24

758

Maternal care for known or suspected malpresentation of fetus

313

2593

0.90

1.12

5.8

6.8

1.22

1.24

mmol/l

0.15

306

2494

Occupant of pick-up truck or van injured in other and unspecified transport accidents

121

1.63

1.10

7.4

6.9

1.54

1.44

mmol/l

0.13

114

Haemangioma and lymphangioma, any site

276

2474

1.13

1.10

6.1

7.4

1.30

1.35

mmol/l

0.36

269

2385

Other superficial injuries of ankle and foot

121

1.62

1.09

10.4

8.5

1.29

1.27

mmol/l

0.03

113

Benign neoplasm: Skin of lower limb, including hip

696

1.24

1.09

8.3

7.3

1.12

1.34

mmol/l

2.01

665

Benign neoplasm of eye and adnexa

322

2916

1.11

1.07

7.2

6.7

1.37

1.35

mmol/l

0.15

312

2813

Venous complications and haemorrhoids in the puerperium

212

1.45

1.07

4.1

5.9

1.35

1.26

mmol/l

0.25

203

Other noninflammatory disorders of cervix uteri

148

1276

1.17

1.07

4.9

5.9

1.35

1.31

mmol/l

0.10

143

1234

Vestibular neuronitis

287

2585

1.12

1.06

5.2

6.9

1.34

1.36

mmol/l

0.11

282

2493

Non-neuropathic heredofamilial amyloidosis

2.44

1.06

6.4

3.4

1.03

1.41

mmol/l

—

Benign neoplasm: Scapula and long bones of upper limb

205

1.45

1.04

4.7

4.9

1.21

1.34

mmol/l

0.40

197

Carcinoma in situ of prostate

148

1.55

1.03

4.0

7.1

1.33

1.39

mmol/l

0.13

143

Disorders of male genital organs in diseases classified elsewhere

156

1.53

1.03

9.9

10.3

1.33

1.39

mmol/l

0.15

148

Other and unspecified nerve root and plexus disorders, also in other diseases

595

5545

1.08

1.02

6.6

7.6

1.34

1.33

mmol/l

0.03

577

5352

MS-disease / Multiple Sclerosis

186

1636

1.15

1.02

7.4

7.0

1.20

1.32

mmol/l

1.18

177

1578

Alzheimer’s disease (Atypical or mixed)

304

2748

1.11

1.01

3.1

5.0

1.65

1.48

mmol/l

1.21

284

2585

Other/unspecified mastoiditis and related conditions

108

1.64

1.01

27.2

5.6

1.81

1.34

mmol/l

0.26

100

Congenital lens malformations

108

1.63

1.01

6.8

8.9

1.40

1.09

mmol/l

0.84

101

Cleft lip and cleft lip and palate

157

1.51

0.99

19.1

9.7

1.10

1.32

mmol/l

0.68

148

Dacryoadenitis

200

1.45

0.98

5.5

4.9

1.21

1.28

mmol/l

0.18

185

ILD medications: acetylcysteine

174

1.47

0.98

11.0

4.6

1.18

1.42

mmol/l

1.05

164

Constitutional tall stature

116

0.50

0.97

2.3

15.1

2.57

1.31

mmol/l

—

108

Other maternal disorders predominantly related to pregnancy

1627

9806

1.05

0.96

6.4

6.8

1.31

1.24

mmol/l

1.80

1575

9511

Acquired stenosis of external ear canal

244

1.39

0.95

5.1

6.9

1.53

1.35

mmol/l

0.35

231

Polycystic ovarian syndrome

834

1.20

0.95

3.3

5.6

1.36

1.20

mmol/l

1.01

802

Use of galantamine

234

2104

1.12

0.94

2.5

5.3

1.59

1.43

mmol/l

1.31

217

1988

Contact urticaria

1.82

0.94

8.6

5.0

1.73

1.27

mmol/l

0.34

Pregnancy, childbirth and the puerperium

997

5496

0.95

0.92

4.4

5.6

1.35

1.32

mmol/l

0.21

958

5296

Unspecified urinary incontinence

267

2420

1.11

0.91

8.4

6.0

1.32

mmol/l

0.03

258

2325

Benign neoplasm: Uterine tubes and ligaments

136

1.52

0.90

3.2

4.0

1.34

1.31

mmol/l

0.04

130

Other specified and unspecified disorders of conjunctiva

238

1.38

0.90

21.3

5.7

1.18

1.36

mmol/l

0.60

230

Postpartum care and examination

239

1695

0.90

7.4

6.3

1.39

1.26

mmol/l

0.75

211

1631

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

212

1901

1.13

0.90

6.6

7.5

1.40

1.39

mmol/l

0.06

203

1835

Erythema annulare centrifugum

2.11

0.89

4.7

5.5

1.50

1.55

mmol/l

—

Postmenopausal atrophic vaginitis

766

4884

0.94

0.89

5.4

6.5

1.20

1.32

mmol/l

2.90

744

4711

Use of rivastigmine

489

4549

1.08

0.88

3.1

5.1

1.53

1.44

mmol/l

0.90

474

4319

Inflammatory disease of cervix uteri

146

1662

0.87

0.88

5.5

5.4

1.18

1.26

mmol/l

0.99

141

1600

Interstitial emphysema and related conditions originating in the perinatal period

1.85

0.88

16.7

22.3

0.81

1.21

mmol/l

2.40

Carcinoma in situ of breast, other/unspecified

286

0.69

0.87

3.5

4.6

1.18

1.39

mmol/l

0.88

276

Malignant neoplasm of breast, HER-positive

1074

10105

1.05

0.87

4.5

6.1

1.27

mmol/l

0.01

1039

9796

Traumatic amputation of part of head

1.97

0.84

13.7

10.2

1.32

1.85

mmol/l

—

Use of ropinirole

122

1063

1.16

0.84

4.5

7.4

1.31

1.39

mmol/l

0.41

117

1029

Postprocedural disorders of ear and mastoid process, not elsewhere classified

212

0.64

0.83

7.9

7.0

1.38

1.36

mmol/l

0.04

203

Hyperprolactinaemia, drug-induced

122

1.52

0.83

10.2

6.5

1.09

1.26

mmol/l

0.56

117

Use of anticholinesterases

1147

9695

0.95

0.83

3.2

5.5

1.52

1.39

mmol/l

3.64

1096

9224

N06DA Anticholinesterases

1147

9695

0.95

0.83

3.2

5.5

1.52

1.39

mmol/l

3.64

1096

9224

Scissor bite

598

1.21

0.82

12.6

9.4

1.29

mmol/l

0.00

561

Single delivery by caesarean section

418

2605

0.92

0.82

4.8

7.8

1.25

1.27

mmol/l

0.07

406

2518

Respiratory distress of newborn

491

1.24

0.82

18.1

17.5

1.27

1.37

mmol/l

0.49

440

Maternal care for known or suspected fetal abnormality and damage

318

2599

1.09

0.81

5.7

7.0

1.14

1.23

mmol/l

1.23

309

2501

Benign neoplasm of breast

343

3169

1.09

0.80

6.6

5.6

1.23

1.27

mmol/l

0.40

333

3066

LSIL lesion of the cervix uteri

238

2162

1.11

0.79

4.5

5.8

1.10

1.23

mmol/l

1.79

226

2090

Primary open-angle glaucoma, strict

897

9385

0.95

0.79

6.0

5.9

1.36

1.38

mmol/l

0.21

863

8999

576

1.21

0.79

9.1

8.3

1.62

1.30

mmol/l

1.01

561

Spermatocele

276

2531

1.10

0.79

7.3

8.7

1.33

1.43

mmol/l

1.14

270

2432

Other changes in lacrimal passages

2.31

0.79

3.0

2.7

1.06

1.21

mmol/l

—

Carcinoma in situ of cervix uteri

169

1508

1.13

0.78

7.3

5.2

1.40

1.26

mmol/l

0.58

164

1446

Otosclerosis

201

2223

0.90

0.78

8.2

6.8

1.26

1.35

mmol/l

0.70

195

2140

Benign neoplasm: Scapula and long bones of upper limb

218

1.36

0.78

4.7

5.9

1.21

1.38

mmol/l

0.54

211

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

188

1690

1.12

0.78

9.4

6.0

1.20

1.21

mmol/l

0.08

183

1630

Exposure to electric transmission lines

2.23

0.77

2.4

8.3

2.02

1.25

mmol/l

—

Exposure to high and low air pressure and changes in air pressure

2.23

0.77

19.8

6.1

1.00

1.36

mmol/l

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

2.21

0.77

1.6

4.8

1.28

1.31

mmol/l

—

Ankylosis of teeth

2.19

0.77

14.0

4.8

1.14

1.05

mmol/l

—

Polycystic ovarian syndrome, broad definition

202

1825

1.11

0.76

6.3

5.4

1.30

1.25

mmol/l

0.39

195

1759

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

2.14

0.76

5.8

6.6

1.38

1.10

mmol/l

—

Other contact dermatitis

230

2095

1.10

0.75

8.5

7.0

1.36

1.33

mmol/l

0.15

218

2012

Acquired keratosis [keratoderma] palmaris et plantaris

110

0.53

0.75

66.2

6.6

1.12

1.27

mmol/l

—

104

Benign neoplasm of bone and articular cartilage

239

2182

1.10

0.75

7.2

7.8

1.22

1.37

mmol/l

2.01

232

2104

Circumscribed brain atrophy

554

1.21

0.74

5.1

7.0

1.38

1.43

mmol/l

0.21

532

Adrenogenital disorders

101

1.53

0.73

12.1

5.1

1.15

1.34

mmol/l

0.50

Female infertility, cervigal, vaginal, other or unspecified origin

724

4601

1.06

0.72

6.0

6.9

1.22

1.30

mmol/l

1.97

707

4460

Postpartum haemorrhage due to anatomy

138

1552

0.89

0.72

7.4

5.3

1.37

1.22

mmol/l

0.59

131

1498

Benign neoplasm: Extrahepatic bile ducts

1.71

0.71

6.2

5.1

1.61

1.39

mmol/l

—

Other and unspecified parapsoriasis

119

1.48

0.70

23.8

5.3

1.21

1.27

mmol/l

0.14

114

Physiological and behavioural disorders associated with sexual development and orientation

1.92

0.70

3.6

5.0

0.98

1.57

mmol/l

—

Stenosis and insufficiency of lacrimal passages

286

2644

1.09

0.69

4.6

6.7

1.27

1.35

mmol/l

1.04

276

2538

Unspecific neurodegenerative disorder

1600

10674

1.04

0.69

3.5

5.7

1.52

1.37

mmol/l

6.41

1531

10193

Cutaneous autosensitization

1.87

0.68

5.6

2.9

2.51

1.31

mmol/l

—

Erosion and ectropion of cervix uteri

716

1.17

0.68

6.3

6.2

1.53

1.30

mmol/l

0.37

689

Endometriosis of pelvic peritoneum

394

3639

1.07

0.67

5.2

6.8

1.25

1.29

mmol/l

0.37

387

3528

Other abnormal products of conception

714

4524

1.05

0.67

5.2

7.0

1.19

1.25

mmol/l

0.76

694

4375

Optic neuritis

108

950

1.15

0.67

5.2

6.9

1.19

1.31

mmol/l

1.19

103

915

Carcinoma in situ of breast, intraductal

227

2083

1.10

0.66

5.2

5.8

1.23

1.24

mmol/l

0.02

219

2017

Other osteochondropathies

208

1902

1.10

0.66

7.0

8.1

1.47

1.37

mmol/l

0.43

197

1829

Explosion and rupture of other specified pressurized devices

1.82

0.66

9.2

12.8

1.80

1.56

mmol/l

—

Graves disease, strict definition

256

2364

1.09

0.65

5.1

6.8

1.24

1.29

mmol/l

0.22

241

2277

Medical treatment for female infertility

361

3850

0.93

0.65

5.6

6.3

1.21

1.22

mmol/l

0.10

351

3713

Use of other anti-dementia drugs

927

7745

1.05

0.64

3.1

5.1

1.60

1.41

mmol/l

4.53

882

7345

Use of memantine

927

7745

1.05

0.64

3.1

5.1

1.60

1.41

mmol/l

4.53

882

7345

Miliaria rubra

0.00

0.64

0.0

4.7

—

1.21

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.60

0.64

7.9

4.6

1.42

1.30

mmol/l

0.14

Venous complications and haemorrhoids in pregnancy

252

1.28

0.63

5.7

6.5

1.13

1.21

mmol/l

0.27

239

Benign neoplasm: Bone and articular cartilage, unspecified

164

0.66

0.63

6.9

7.9

1.07

1.28

mmol/l

1.02

158

Cleft palate

182

1.34

0.63

13.5

11.6

1.12

1.41

mmol/l

1.28

171

Benign neoplasm: Connective and other soft tissue of thorax

105

1.47

0.63

4.3

5.7

1.44

1.37

mmol/l

0.06

100

Impacted cerumen

321

2998

1.08

0.62

5.6

6.8

1.31

1.39

mmol/l

0.95

303

2874

Convergence insufficiency and excess

262

1.28

0.62

15.1

6.3

1.54

1.26

mmol/l

1.45

246

Monocytic leukaemia

1.51

0.62

6.5

7.0

1.32

1.30

mmol/l

0.05

Sequelae of burns, corrosions and frostbite

105

1.47

0.62

5.4

8.1

1.15

1.21

mmol/l

0.11

Benign neoplasm: Parathyroid gland

272

1.28

0.62

3.8

5.8

1.04

1.31

mmol/l

2.08

261

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.55

0.62

5.7

7.8

1.25

1.19

mmol/l

0.12

Qualitative platelet defects

1.50

0.62

8.0

5.3

1.14

1.24

mmol/l

0.23

Nontoxic single thyroid nodule

208

1912

1.09

0.61

4.3

6.6

1.22

1.31

mmol/l

0.76

201

1853

Pedal cyclist injured in collision with pedestrian or animal

175

1.35

0.60

12.4

6.0

1.03

1.39

mmol/l

1.86

166

Idiopathic progressive neuropathy

1.80

0.60

1.3

4.5

1.37

1.62

mmol/l

—

Suppurative otitis media, unspecified

594

1.17

0.60

6.1

6.5

1.30

1.35

mmol/l

0.16

563

Benign neoplasm of male genital organs

614

1.17

0.60

6.6

8.8

1.49

1.42

mmol/l

0.20

591

Mandibular retrognathia

138

1522

0.90

0.58

5.4

8.2

1.22

1.28

mmol/l

0.47

131

1453

Other and unspecified disorders of skin and subcutaneous tissue

160

1755

0.91

0.58

5.8

7.1

1.40

1.36

mmol/l

0.23

153

1691

Idiopathic peripheral autonomic neuropathy

1.50

0.58

6.6

4.8

1.23

1.31

mmol/l

0.14

Inflammation of lacrimal passages (chronic)

421

1.21

0.58

5.0

6.1

1.60

1.46

mmol/l

0.12

397

Sequelae of tuberculosis

495

1.19

0.57

4.5

5.8

1.23

1.49

mmol/l

1.81

467

Pityriasis rosea

151

1.35

0.55

2.8

6.2

1.52

1.31

mmol/l

0.18

144

Anomalies of dental arch relationship, including avohilmo

546

4671

1.05

0.55

8.0

7.5

1.28

1.34

mmol/l

0.82

523

4464

Antenatal screening

528

2826

1.05

0.55

5.1

7.5

1.28

1.25

mmol/l

0.29

504

2728

Traumatic cerebral oedema

1.56

0.54

6.0

5.9

1.55

1.47

mmol/l

—

Other and unspecified disease of Bartholin gland

705

1.15

0.53

8.6

5.7

1.43

1.29

mmol/l

0.27

678

Thyrotoxicosis with toxic single thyroid nodule

188

1.30

0.53

2.9

5.6

1.12

1.33

mmol/l

0.55

180

L02BG Aromatase inhibitors

900

8685

1.04

0.52

4.6

6.1

1.28

1.27

mmol/l

0.07

870

8424

Malignant neoplasm, without specification of site

849

1.13

0.51

4.8

6.2

1.66

1.43

mmol/l

0.88

809

Retained placenta and membranes, without haemorrhage

257

2747

0.93

0.51

5.3

6.5

1.38

1.23

mmol/l

1.75

246

2654

Melanoma in situ of lower limb, including hip

145

1.34

0.51

4.6

5.9

1.19

1.33

mmol/l

0.32

139

Pityriasis lichenoides chronica

110

0.62

0.50

5.7

7.6

1.44

1.32

mmol/l

—

103

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

102

1.40

0.48

8.9

4.5

1.34

1.31

mmol/l

0.04

Tooth agenesis EXCLUDE clefts and syndromes

738

1.13

0.48

15.3

8.0

1.23

1.27

mmol/l

0.18

692

Other and unspecified disorders of pigmentation

155

1.31

0.48

4.4

5.2

1.24

1.34

mmol/l

0.15

146

Melanocytic naevi of ear and external auricular canal

111

1.38

0.48

6.4

6.7

1.52

1.40

mmol/l

0.19

104

Carcinoma in situ of endometrium

1.42

0.47

1.8

3.2

1.16

1.31

mmol/l

0.40

Benign neoplasm: Skin of other and unspecified parts of face

347

3288

1.06

0.47

4.7

6.5

1.38

1.36

mmol/l

0.12

340

3157

Other cestode infections

0.59

0.47

14.0

6.7

2.00

1.24

mmol/l

—

Postpartum hemorraghe, parous women as controls

508

4250

1.05

0.47

6.5

6.2

1.30

1.22

mmol/l

0.90

490

4110

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

856

1.12

0.46

6.9

6.7

1.35

1.43

mmol/l

0.43

818

Adhesive middle ear disease

384

0.82

0.46

5.3

7.0

1.35

1.43

mmol/l

0.29

359

Carcinoma in situ of prostate

175

1.29

0.46

4.0

7.3

1.33

1.40

mmol/l

0.14

167

Undefined dementia

348

3369

0.95

0.45

3.5

4.7

1.65

1.49

mmol/l

1.20

309

3161

Defects in glycoprotein degradation

0.00

0.44

0.0

3.0

—

1.52

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1.49

0.44

20.4

5.2

1.14

1.51

mmol/l

—

Iliac crest spur

0.00

0.42

0.0

6.4

—

1.49

—

Drowning and submersion while in natural water

114

1.35

0.42

2.9

7.7

1.85

1.50

mmol/l

0.38

106

Use of benzatropine

0.00

0.42

0.0

3.8

—

1.30

—

Crushing injury of forearm

1.52

0.41

25.8

6.1

1.72

1.47

mmol/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

149

0.73

0.41

6.9

6.8

1.07

1.33

mmol/l

1.34

142

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

106

1.36

0.41

7.6

7.1

1.08

1.33

mmol/l

0.80

100

Other operation for atrial fibrillation

160

1.28

0.41

10.4

6.8

1.15

1.28

mmol/l

0.50

153

LSIL lesion of the vagina

269

1.20

0.40

6.7

5.9

1.32

1.21

mmol/l

0.14

258

Fibrosarcoma

187

1.25

0.40

5.7

6.4

1.33

1.28

mmol/l

0.10

178

Factitial dermatitis

133

1.31

0.40

5.1

4.7

1.30

1.38

mmol/l

0.12

128

Melanoma in situ of upper limb, including shoulder

170

0.75

0.40

7.2

5.7

1.38

mmol/l

0.01

162

Disorders of muscle tone of newborn

1.46

0.40

3.8

21.8

1.76

1.31

mmol/l

—

Allergic colitis

541

1.13

0.39

12.6

11.3

1.22

1.34

mmol/l

0.56

495

Other complications of labour and delivery, not elsewhere classified

174

1793

0.93

0.39

3.2

6.1

1.18

1.28

mmol/l

1.16

169

1728

Vitamin A deficiency

1.35

0.39

20.4

5.1

1.57

1.36

mmol/l

0.25

Deep endometriosis

217

2301

0.94

0.38

4.3

5.4

1.28

1.25

mmol/l

0.14

207

2224

Oral lichen ruber planus, including avohilmo

143

1537

0.93

0.38

6.9

6.8

1.21

1.32

mmol/l

0.83

135

1484

Female infertility

793

4748

1.03

0.37

6.3

6.8

1.23

1.30

mmol/l

1.72

777

4597

Dental caries 2, only avohilmo

2732

21203

1.02

0.37

6.7

7.6

1.26

1.34

mmol/l

3.99

2631

20470

Chronic suppurative otitis media, including avohilmo

243

2303

1.06

0.37

8.1

7.5

1.34

1.39

mmol/l

0.25

235

2206

Androgenic alopecia

171

1.25

0.37

16.0

5.3

1.13

1.17

mmol/l

0.07

165

Other benign neoplasms of uterus

147

1371

1.08

0.37

4.2

4.4

1.31

1.40

mmol/l

0.66

137

1324

Respiratory tuberculosis, not confirmed

131

1217

1.08

0.36

7.4

6.5

1.37

1.45

mmol/l

0.45

126

1159

Donors of organs and tissues

255

1.19

0.35

12.3

6.7

1.12

1.33

mmol/l

1.18

249

Chronic diseases of tonsils and adenoids

3079

19209

1.02

0.34

6.9

7.8

1.33

1.34

mmol/l

0.31

2975

18564

Contact with machinery

333

3474

0.96

0.34

8.7

8.2

1.39

mmol/l

0.00

325

3340

Galactorrhea

182

1.22

0.34

4.6

5.4

1.26

1.20

mmol/l

0.13

176

Secondary malignant neoplasm of other and unspecified sites

370

0.85

0.33

5.4

6.7

1.68

1.39

mmol/l

0.53

355

Disorders of parathyroid gland, other and/or unspecified

192

1.22

0.33

5.7

5.9

1.35

1.33

mmol/l

0.05

182

Chronic suppurative otitis media

200

1893

1.06

0.33

9.0

7.2

1.30

1.40

mmol/l

0.58

194

1821

Use of selegiline

145

1361

1.07

0.32

4.0

6.5

1.23

1.42

mmol/l

1.44

137

1309

Migraine, unspecified, drug-induced

156

1.24

0.32

5.9

6.5

1.26

1.20

mmol/l

0.12

150

Congenital malformations of breast

262

0.83

0.31

6.0

4.8

1.25

1.21

mmol/l

0.11

252

Bullous keratopathy

218

0.81

0.31

4.8

4.4

1.41

1.44

mmol/l

0.07

203

Other benign neoplasms of uterus

147

1562

0.94

0.31

4.2

4.5

1.31

1.32

mmol/l

0.01

137

1503

Benign neoplasm: Uterine tubes and ligaments

166

1.23

0.31

3.2

5.4

1.34

1.41

mmol/l

0.18

159

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

406

3918

1.04

0.30

6.6

7.4

1.28

1.33

mmol/l

0.60

400

3777

Vasomotor rhinitis (mode)

187

1972

0.94

0.30

5.5

7.1

1.21

1.35

mmol/l

2.09

173

1903

Other benign neoplasm of uterus: Other parts/unspecified

117

1093

1.08

0.30

3.7

4.1

1.34

1.44

mmol/l

0.71

109

1058

Ménière disease

274

2857

0.96

0.29

4.0

6.4

1.35

mmol/l

0.03

264

2755

Melanoma of uvea

279

0.85

0.28

9.2

7.5

1.55

1.37

mmol/l

0.30

269

Viral infections of central nervous system, not elsewhere classified/unspecified

252

1.16

0.28

6.3

6.1

1.07

1.36

mmol/l

1.55

243

Complications associated with artificial fertilization

224

1.17

0.27

3.2

6.3

1.07

1.20

mmol/l

0.47

214

Respiratory tuberculosis, clinically confirmed

338

1.13

0.27

8.4

6.5

1.39

1.47

mmol/l

0.16

316

Vaginal lichen planus

1.30

0.27

2.5

6.8

1.39

1.27

mmol/l

0.15

Postpartum haemorrhage

508

4552

0.97

0.27

6.5

7.2

1.30

1.23

mmol/l

0.71

490

4393

Lichen planopilaris

0.67

0.27

17.8

4.4

1.08

1.26

mmol/l

—

Other acantholytic disorders

1.30

0.27

5.3

7.1

1.13

1.57

mmol/l

—

Maternal care for other known or suspected fetal problems

495

3082

1.03

0.26

5.9

6.9

1.24

mmol/l

0.01

479

2963

Melanocytic naevi of eyelid, including canthus

224

0.84

0.26

4.4

6.4

1.65

1.29

mmol/l

0.70

218

Down's syndrome

105

1.26

0.26

10.8

19.8

1.22

1.26

mmol/l

0.08

Carcinoma in situ of breast, lobular

170

0.81

0.26

2.9

4.7

1.52

1.25

mmol/l

0.20

163

Other benign neoplasm of uterus: Other parts/unspecified

117

1241

0.94

0.25

3.7

4.4

1.34

mmol/l

0.00

109

1190

Cleft hard palate NOS

1.21

0.25

12.7

15.8

1.11

1.36

mmol/l

—

Obstructed labour due to maternal pelvic abnormality

384

3721

1.03

0.25

5.9

7.0

1.34

1.22

mmol/l

1.30

367

3602

Other disorders of amniotic fluid and membranes

242

2496

0.96

0.25

4.5

6.9

1.33

1.23

mmol/l

0.62

236

2406

Melanoma in situ, other sites/unspecified

0.69

0.25

2.2

6.4

1.03

1.28

mmol/l

—

Vascular dementia (undefined)

105

977

1.07

0.25

2.9

5.2

1.50

1.48

mmol/l

0.07

907

Acquired coagulation factor deficiency

1.38

0.24

3.8

3.6

1.48

1.40

mmol/l

—

Foreign body on external eye

450

4620

0.97

0.22

6.5

8.5

1.37

1.40

mmol/l

0.27

433

4449

Alopecia mucinosa

0.00

0.22

0.0

3.1

—

0.77

—

Miliaria crystallina

0.00

0.22

0.0

5.6

—

0.85

—

Pseudomembranous colitis, drug-induced

0.00

0.22

0.0

8.3

—

1.33

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

440

1.10

0.22

18.0

15.9

1.61

1.31

mmol/l

0.80

393

Other congenital malformations of eye

1.21

0.22

4.4

10.7

1.10

1.43

mmol/l

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.22

0.0

6.1

—

1.05

—

Multiple sites

0.00

0.22

0.0

5.8

—

1.25

—

Drug-induced androgenic alopecia

0.00

0.22

0.0

11.2

—

1.16

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.22

0.0

4.6

—

0.92

—

Infliximab

156

0.83

0.22

2.0

6.6

1.23

1.31

mmol/l

0.18

149

Other acute disseminated demyelination

201

1.15

0.21

6.9

6.1

1.43

1.19

mmol/l

0.36

192

Other fluke infections

0.00

0.21

0.0

4.6

—

1.12

—

Benign leiomyoma with endometriosis

442

4535

0.97

0.21

5.8

5.7

1.33

1.26

mmol/l

0.82

430

4394

Female genital prolapse

953

5403

1.02

0.21

4.8

6.3

1.32

mmol/l

0.04

931

5203

Lesion of plantar nerve

175

1678

1.05

0.21

6.4

1.40

1.30

mmol/l

0.41

167

1616

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.21

0.0

6.6

—

0.83

—

Contact with other specified venomous plants

0.00

0.21

0.0

3.6

—

0.93

—

Lens-induced iridocyclitis

1.28

0.21

2.5

8.1

1.10

1.26

mmol/l

—

Other obstructed labour

156

1630

0.95

0.21

5.9

6.7

1.27

1.22

mmol/l

0.27

149

1571

Varicose veins of other sites

196

1886

1.04

0.21

6.3

7.7

1.41

1.36

mmol/l

0.23

187

1814

Plasmodium vivax malaria

0.00

0.21

0.0

10.6

—

1.40

—

Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)

108

1.22

0.21

12.1

6.2

1.36

1.42

mmol/l

0.07

103

Haemorrhagic and haematological disorders of fetus and newborn

588

1.08

0.20

20.5

17.1

1.12

1.35

mmol/l

2.10

529

Lymphangioma, anys site

155

1.17

0.20

5.7

6.0

1.78

1.31

mmol/l

0.52

146

Ovarian hyperstimulation (induction)

239

0.87

0.19

3.8

4.7

1.04

1.30

mmol/l

0.93

226

Peripheral retinal degeneration

802

1.06

0.19

2.9

6.7

1.28

1.36

mmol/l

0.44

770

Endometriosis ASRM stages 1,2

407

3971

1.03

0.19

5.2

6.4

1.25

1.24

mmol/l

0.09

400

3839

Parapsoriasis

483

1.08

0.18

9.9

6.9

1.33

1.32

mmol/l

0.03

460

Deep bite

307

2612

1.03

0.18

8.1

8.3

1.24

1.35

mmol/l

1.54

293

2478

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

113

1184

0.95

0.18

3.6

6.6

1.14

1.22

mmol/l

0.80

113

1142

Transitory endocrine and metabolic disorders specific to fetus and newborn

445

1.09

0.18

18.0

15.8

1.61

1.32

mmol/l

0.77

398

Carcinoma in situ of endometrium

110

1.20

0.18

1.8

5.1

1.16

1.39

mmol/l

0.57

105

Felty syndrome

148

1.16

0.17

3.1

5.2

1.67

1.44

mmol/l

0.21

141

Chronic iridocyclitis

135

1296

1.04

0.17

6.0

7.3

1.34

1.37

mmol/l

0.09

128

1245

Maxillary prognathism

101

1.20

0.17

1.2

11.4

0.96

1.26

mmol/l

1.17

Other congenital malformations of male genital organs

225

0.88

0.17

17.0

13.8

1.25

1.41

mmol/l

0.64

203

Maternal care for known or suspected abnormality of pelvic organs

555

3756

1.02

0.16

6.1

7.0

1.23

1.24

mmol/l

0.04

540

3611

Other female pelvic inflammatory diseases

409

4180

0.98

0.16

6.8

5.9

1.28

1.26

mmol/l

0.22

395

4043

Normotensive glaucoma

272

2649

1.03

0.16

6.5

6.1

1.21

1.36

mmol/l

3.03

265

2555

Use of amantadine

399

1.08

0.16

11.1

6.0

1.35

mmol/l

0.01

378

Chronic respiratory disease originating in the perinatal period

1.18

0.16

6.8

28.1

1.40

1.25

mmol/l

—

Acute myringitis

161

0.86

0.15

5.0

10.2

1.13

1.37

mmol/l

0.67

152

Mesial bite

182

0.87

0.15

7.8

9.2

1.08

1.23

mmol/l

0.70

172

Persons encountering health services in circumstances related to reproduction

1971

13478

0.99

0.15

8.7

8.4

1.33

1.34

mmol/l

0.11

1896

12994

Whooping cough

102

1.19

0.15

26.8

5.2

1.00

1.38

mmol/l

1.27

Nail dystrophy

160

0.87

0.14

21.7

7.4

1.19

1.27

mmol/l

0.17

153

Endometriosis diagnosis and infertility diagnosis occurring together

213

2073

1.03

0.14

4.5

5.9

1.23

mmol/l

0.03

207

2002

Use of cabergoline

274

0.91

0.14

4.3

6.4

1.13

1.25

mmol/l

0.45

264

Squamous cell neoplasms and carcinoma of cervix

122

1.16

0.14

8.9

4.9

1.34

1.40

mmol/l

0.08

117

Cholesteatoma of middle ear

150

1549

0.97

0.14

7.9

6.8

1.28

1.42

mmol/l

1.03

145

1486

Melanocytic naevi of ear and external auricular canal

132

1.15

0.13

6.4

5.9

1.52

1.30

mmol/l

0.41

126

Open bite that required surgery (Lefort1 or BSSRO)

159

0.88

0.13

1.3

6.0

1.16

1.29

mmol/l

0.37

154

Gender identity disorders

200

0.90

0.12

5.3

8.6

1.29

1.34

mmol/l

0.11

189

Glaucoma suspect

1279

12678

1.01

0.12

5.6

6.5

1.33

1.35

mmol/l

0.36

1222

12212

Abnormal findings on diagnostic imaging of breast

312

0.92

0.11

6.0

5.3

1.40

1.38

mmol/l

0.04

298

Retinal breaks without detachment

494

4870

1.02

0.11

7.5

7.0

1.28

1.32

mmol/l

0.43

477

4701

Benign neoplasm: Choroid

162

1662

0.97

0.11

5.9

6.7

1.40

1.36

mmol/l

0.15

154

1598

Allergic contact dermatitis

353

3472

1.02

0.11

6.7

6.8

1.35

1.29

mmol/l

0.42

344

3350

Endometriosis of rectovaginal septum and vagina

195

1991

0.98

0.09

4.5

5.5

1.30

mmol/l

0.02

185

1935

Endometriosis of ovary

439

4321

1.01

0.09

6.1

6.3

1.22

1.30

mmol/l

1.05

426

4185

Occupant of special vehicle mainly used on industrial premises injured in transport accident

117

1.12

0.08

2.5

7.2

1.13

1.47

mmol/l

0.82

112

Sudden idiopathic hearing loss

313

3087

1.02

0.08

7.6

7.1

1.30

1.35

mmol/l

0.47

305

2975

Contact with venomous snakes and lizards

244

1.07

0.08

1.7

8.1

1.45

1.22

mmol/l

0.66

234

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

368

0.95

0.08

2.7

5.9

1.28

1.41

mmol/l

0.52

346

Dermatitis due to ingested food

862

1.03

0.08

14.4

10.9

1.32

1.36

mmol/l

0.18

797

Postpartum hemorraghe, all women as controls

508

5008

1.01

0.07

6.5

1.30

1.24

mmol/l

0.63

490

4834

Other specified and unspecified disorders of choroid

0.86

0.07

3.3

6.1

0.98

1.26

mmol/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

452

0.96

0.07

8.5

17.6

1.63

1.31

mmol/l

0.84

407

Oral lichen ruber planus wide, hypothyreosis or thyroxin

139

1415

0.98

0.06

5.8

6.0

1.24

1.30

mmol/l

0.19

133

1362

Lichen ruber planus, wide definition including periferal and oral lichen planus

647

6516

0.99

0.06

6.3

6.8

1.37

1.32

mmol/l

0.52

626

6298

Endometriosis ASRM stages 3,4

595

5994

0.99

0.06

5.4

5.9

1.26

mmol/l

0.03

574

5806

Unspecified dementia

346

3147

0.99

0.05

3.5

4.9

1.65

1.46

mmol/l

1.49

307

2956

Alzheimer’s disease (Early onset), excluding more controls

101

938

1.02

0.04

3.7

6.0

1.70

1.36

mmol/l

1.96

892

Embedded and impacted teeth

628

5364

0.99

0.04

7.7

7.1

1.29

1.35

mmol/l

0.77

595

5156

Mixed conductive and sensorineural hearing loss

393

3954

0.99

0.03

6.9

6.6

1.33

1.35

mmol/l

0.17

379

3807

Uterine polyps

241

2428

0.99

0.03

7.0

6.3

1.19

1.32

mmol/l

1.56

235

2359

Carcinoma in situ of cervix uteri, endocervix

199

0.95

0.03

10.3

5.2

1.23

mmol/l

0.00

191

Hair colour and hair shaft abnormalities

112

1.08

0.03

6.2

7.7

1.07

1.24

mmol/l

0.51

107

Melanoma of uvea

231

1.04

0.03

9.2

6.0

1.55

1.37

mmol/l

0.31

222

Melanoma in situ of upper limb, including shoulder

138

0.94

0.02

7.2

5.1

1.38

1.37

mmol/l

0.00

131

Impacted teeth

417

3863

1.00

0.02

7.2

7.0

1.31

1.35

mmol/l

0.39

397

3704

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

226

2275

0.99

0.02

8.6

7.5

1.31

1.34

mmol/l

0.15

217

2195

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

222

1.04

0.02

4.3

5.3

1.23

1.21

mmol/l

0.06

212

Carcinoma in situ of breast

103

1.07

0.02

4.1

5.3

1.11

1.22

mmol/l

0.17

Malignant neoplasm of gallbladder

117

0.94

0.02

4.5

6.7

3.05

1.32

mmol/l

0.43

112

Discontinuity and dislocation of ear ossicles

117

0.94

0.02

6.0

4.9

1.14

1.45

mmol/l

0.85

111

Lichen planus

381

3797

1.00

0.01

6.4

6.7

1.43

1.32

mmol/l

0.84

368

3671

Carcinoma in situ of cervix uteri

169

1696

1.00

0.00

7.3

5.6

1.40

1.25

mmol/l

0.64

164

1632

Lichen planus, including avohilmo

562

5617

1.00

0.00

6.2

6.6

1.39

1.32

mmol/l

0.70

546

5423

Other melanin hyperpigmentation

585

0.99

0.00

6.8

6.3

1.26

1.37

mmol/l

0.49

560

Calcific tendinitis

218

1.01

0.00

3.6

7.6

1.34

1.41

mmol/l

0.17

210

Benign neoplasm: Eye, unspecified

106

1.04

0.00

8.9

3.5

1.27

1.36

mmol/l

0.18

101

Feeding problems of newborn

136

1.03

0.00

10.4

16.7

1.46

1.44

mmol/l

0.02

120

Carcinoma in situ of breast, lobular

139

1.01

0.00

2.9

3.9

1.52

1.32

mmol/l

0.14

133

Lymphangioma, anys site

181

0.99

0.00

5.7

8.8

1.78

1.25

mmol/l

0.62

174

Cicatricial alopecia [scarring hair loss]

191

0.99

0.00

9.2

6.4

1.17

1.25

mmol/l

0.34

182

Carcinoma in situ of cervix uteri, endocervix

191

0.99

0.00

10.3

6.1

1.23

1.22

mmol/l

0.05

182

Use of entacapone

211

0.99

0.00

4.1

6.5

1.03

1.26

mmol/l

0.78

198

Degenerative myopia

163

0.98

0.00

4.7

6.9

1.20

mmol/l

0.02

157

Melanocytic naevi of eyelid, including canthus

195

0.97

0.00

4.4

6.1

1.65

1.30

mmol/l

0.70

188

Foreign body in genitourinary tract

214

0.98

0.00

5.3

6.2

1.70

1.31

mmol/l

0.26

202

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

2.0

—

0.84

—

Congenital viral diseases

0.00

0.0

8.8

—

1.02

—

Neuropathic heredofamilial amyloidosis

0.00

0.0

2.3

—

1.06

—

Sclerodactyly

0.00

0.0

9.4

—

1.20

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

0.0

1.8

—

1.24

—

Other transitory neonatal endocrine disorders

0.00

0.0

6.6

—

1.02

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.0

5.6

—

1.42

—

Benign neoplasm: Mesothelial tissue of pleura

0.00

0.0

7.6

—

1.24

—

Plague

0.00

0.0

3.0

—

0.96

—

Dysplastic lesion of unknown severity of the cervix uteri

170

1.00

0.00

4.2

5.5

1.19

1.23

mmol/l

0.07

165

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.0

3.3

—

1.60

—

Transitory neonatal disorders of calcium and magnesium metabolism

0.00

0.0

20.0

—

0.92

—

Miliaria, unspecified

0.00

0.0

2.0

—

1.19

—

Leukoderma, not elsewhere classified

0.00

0.0

6.3

—

1.18

—

Visual disturbances in diseases classified elsewhere

0.00

0.0

7.0

—

0.99

—

Radiological devices associated with adverse incidents

0.00

0.0

2.0

—

2.18

—

Malignant neoplasm of other and ill-defined sites

0.89

0.00

3.8

7.0

1.35

1.22

mmol/l

—

Chondrolysis

0.00

0.0

2.0

—

1.01

—

Deficiency of vitamin K

0.00

0.0

10.4

—

3.68

—

Hypervitaminosis D

0.00

0.0

3.0

—

1.03

—

Carcinoma in situ of rectosigmoid junction

0.00

0.0

11.6

—

0.97

—

Hereditary angioödema type 2

0.00

0.0

6.2

—

0.98

—

GM2 gangliosidosis

0.00

0.0

3.0

—

1.88

—

Pinta [carate]

0.00

0.0

5.4

—

1.00

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS